<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38887284</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>18</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1664-3224</ISSN><JournalIssue CitedMedium="Internet"><Volume>15</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Frontiers in immunology</Title><ISOAbbreviation>Front Immunol</ISOAbbreviation></Journal><ArticleTitle>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.</ArticleTitle><Pagination><StartPage>1386607</StartPage><MedlinePgn>1386607</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1386607</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fimmu.2024.1386607</ELocationID><Abstract><AbstractText>Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) is a chronic, debilitating disease characterised by a wide range of symptoms that severely impact all aspects of life. Despite its significant prevalence, ME/CFS remains one of the most understudied and misunderstood conditions in modern medicine. ME/CFS lacks standardised diagnostic criteria owing to variations in both inclusion and exclusion criteria across different diagnostic guidelines, and furthermore, there are currently no effective treatments available. Moving beyond the traditional fragmented perspectives that have limited our understanding and management of the disease, our analysis of current information on ME/CFS represents a significant paradigm shift by synthesising the disease's multifactorial origins into a cohesive model. We discuss how ME/CFS emerges from an intricate web of genetic vulnerabilities and environmental triggers, notably viral infections, leading to a complex series of pathological responses including immune dysregulation, chronic inflammation, gut dysbiosis, and metabolic disturbances. This comprehensive model not only advances our understanding of ME/CFS's pathophysiology but also opens new avenues for research and potential therapeutic strategies. By integrating these disparate elements, our work emphasises the necessity of a holistic approach to diagnosing, researching, and treating ME/CFS, urging the scientific community to reconsider the disease's complexity and the multifaceted approach required for its study and management.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Arron, Marsh, Kell, Khan, Jaeger and Pretorius.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Arron</LastName><ForeName>Hayley E</ForeName><Initials>HE</Initials><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marsh</LastName><ForeName>Benjamin D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>MRCPCH Consultant Paediatric Neurodisability, Exeter, Devon, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kell</LastName><ForeName>Douglas B</ForeName><Initials>DB</Initials><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>The Novo Nordisk Foundation Centre for Biosustainability, Technical University of Denmark, Lyngby, Denmark.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>M Asad</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Directorate of Respiratory Medicine, Manchester University Hospitals, Wythenshawe Hospital, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jaeger</LastName><ForeName>Beate R</ForeName><Initials>BR</Initials><AffiliationInfo><Affiliation>Long COVID department, Clinic St Georg, Bad Aibling, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pretorius</LastName><ForeName>Etheresia</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Physiological Sciences, Faculty of Science, Stellenbosch University, Stellenbosch, South Africa.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Biochemistry and Systems Biology, Institute of Systems, Molecular and Integrative Biology, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Immunol</MedlineTA><NlmUniqueID>101560960</NlmUniqueID><ISSNLinking>1664-3224</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058069" MajorTopicYN="N">Neglected Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="N">Dysbiosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="N">Gastrointestinal Microbiome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">diagnostic criteria</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis/chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">pathology</Keyword><Keyword MajorTopicYN="N">pathophysiology</Keyword><Keyword MajorTopicYN="N">treatment</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>18</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>18</Day><Hour>3</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>1</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38887284</ArticleId><ArticleId IdType="pmc">PMC11180809</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2024.1386607</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Clayton EW. Beyond myalgic encephalomyelitis/chronic fatigue syndrome: an IOM report on redefining an illness. Jama. (2015) 313:1101&#x2013;2. doi:&#xa0;10.1001/jama.2015.1346</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.1346</ArticleId><ArticleId IdType="pubmed">25668027</ArticleId></ArticleIdList></Reference><Reference><Citation>S. Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue. P. Board on the Health of Select and M. Institute of, The National Academies Collection . Reports funded by national institutes of health, beyond myalgic encephalomyelitis/Chronic fatigue syndrome: redefining an illness, national academies press (US). Washington (DC: National Academy of Sciences; (2015).</Citation></Reference><Reference><Citation>Bateman L, Darakjy SS, Klimas NG, Peterson DL, Levine SM, Allen A, et al. . Chronic fatigue syndrome and co-morbid and consequent conditions: evidence from a multi-site clinical epidemiology study. Fatigue: Biomedicine Health Behav. (2015) 3:1&#x2013;15. doi:&#xa0;10.1080/21641846.2014.978109</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2014.978109</ArticleId></ArticleIdList></Reference><Reference><Citation>Valdez AR, Hancock EE, Adebayo S, Kiernicki DJ, Proskauer D, Attewell JR, et al. . Demographics, and costs of ME/CFS using large scale medical claims data and machine learning. Front Pediatr. (2018) 6:412. doi:&#xa0;10.3389/fped.2018.00412</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00412</ArticleId><ArticleId IdType="pmc">PMC6331450</ArticleId><ArticleId IdType="pubmed">30671425</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Katz BZ, Sunnquist M, Torres C, Cotler J, Bhatia S. The prevalence of pediatric myalgic encephalomyelitis/chronic fatigue syndrome in a community&#x2212;Based sample. Child Youth Care Forum. (2020) 49:563&#x2013;79. doi:&#xa0;10.1007/s10566-019-09543-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10566-019-09543-3</ArticleId><ArticleId IdType="pmc">PMC8186295</ArticleId><ArticleId IdType="pubmed">34113066</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul LC, Lacerda EM, Pheby D, Campion P, Molokhia M, Fayyaz S, et al. . Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Med. (2011) 9:91. doi:&#xa0;10.1186/1741-7015-9-91</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-9-91</ArticleId><ArticleId IdType="pmc">PMC3170215</ArticleId><ArticleId IdType="pubmed">21794183</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakken IJ, Tveito K, Gunnes N, Ghaderi S, Stoltenberg C, Trogstad L, et al. . Two age peaks in the incidence of chronic fatigue syndrome/myalgic encephalomyelitis: a population-based registry study from Norway 2008-2012. BMC Med. (2014) 12:167. doi:&#xa0;10.1186/PREACCEPT-1843684980131041</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/PREACCEPT-1843684980131041</ArticleId><ArticleId IdType="pmc">PMC4189623</ArticleId><ArticleId IdType="pubmed">25274261</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim E-J, Son C-G. Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Trans Med. (2020) 18:289. doi:&#xa0;10.1186/s12967-020-02455-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02455-0</ArticleId><ArticleId IdType="pmc">PMC7391812</ArticleId><ArticleId IdType="pubmed">32727489</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, et al. . A community-based study of chronic fatigue syndrome. Arch Intern Med. (1999) 159:2129&#x2013;37. doi:&#xa0;10.1001/archinte.159.18.2129</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.159.18.2129</ArticleId><ArticleId IdType="pubmed">10527290</ArticleId></ArticleIdList></Reference><Reference><Citation>Pendergrast T, Brown A, Sunnquist M, Jantke R, Newton JL, Strand EB, et al. . Housebound versus nonhousebound patients with myalgic encephalomyelitis and chronic fatigue syndrome. Chronic Illn. (2016) 12:292&#x2013;307. doi:&#xa0;10.1177/1742395316644770</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1742395316644770</ArticleId><ArticleId IdType="pmc">PMC5464362</ArticleId><ArticleId IdType="pubmed">27127189</ArticleId></ArticleIdList></Reference><Reference><Citation>NICE . Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management (NICE guideline [NG206]). (2021).</Citation></Reference><Reference><Citation>Rowe PC, Underhill RA, Friedman KJ, Gurwitt A, Medow MS, Schwartz MS, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: A primer. Front Pediatr. (2017) 5:121. doi:&#xa0;10.3389/fped.2017.00121</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2017.00121</ArticleId><ArticleId IdType="pmc">PMC5474682</ArticleId><ArticleId IdType="pubmed">28674681</ArticleId></ArticleIdList></Reference><Reference><Citation>Centers for Disease Control and Prevention . Myalgic encephalomyelitis/chronic fatigue syndrome. U.S. Department of Health &amp; Human Services. (2023).</Citation></Reference><Reference><Citation>Bhui KS, Dinos S, Ashby D, Nazroo J, Wessely S, White PD. Chronic fatigue syndrome in an ethnically diverse population: the influence of psychosocial adversity and physical inactivity. BMC Med. (2011) 9:26. doi:&#xa0;10.1186/1741-7015-9-26</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1741-7015-9-26</ArticleId><ArticleId IdType="pmc">PMC3072345</ArticleId><ArticleId IdType="pubmed">21418640</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Jain AK, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome. J Chronic Fatigue Syndrome. (2003) 11:7&#x2013;115. doi:&#xa0;10.1300/J092v11n01_02</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v11n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Carruthers BM, Sande MIvde, Meirleir KLDe, Klimas NG, Broderick G, Mitchell T, et al. . Myalgic encephalomyelitis: international consensus criteria. J Intern Med. (2011) 270:327&#x2013;38. doi:&#xa0;10.1111/j.1365-2796.2011.02428.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02428.x</ArticleId><ArticleId IdType="pmc">PMC3427890</ArticleId><ArticleId IdType="pubmed">21777306</ArticleId></ArticleIdList></Reference><Reference><Citation>Keech A, Sandler CX, Vollmer-Conna U, Cvejic E, Lloyd AR, Barry BK. Capturing the post-exertional exacerbation of fatigue following physical and cognitive challenge in patients with chronic fatigue syndrome. J Psychosomatic Res. (2015) 79:537&#x2013;49. doi:&#xa0;10.1016/j.jpsychores.2015.08.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2015.08.008</ArticleId><ArticleId IdType="pubmed">26359713</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Benton MC, Valentine L, Johnson A, Torres-Harding S. The economic impact of ME/CFS: individual and societal costs. Dyn Med. (2008) 7:6. doi:&#xa0;10.1186/1476-5918-7-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1476-5918-7-6</ArticleId><ArticleId IdType="pmc">PMC2324078</ArticleId><ArticleId IdType="pubmed">18397528</ArticleId></ArticleIdList></Reference><Reference><Citation>The Optimum Health Clinic (OHC) . Counting the cost: chronic fatigue syndrome/myalgic encephalomyelitis. (2017).</Citation></Reference><Reference><Citation>Hickie I, Lloyd A, Hadzi-Pavlovic D, Parker G, Bird K, Wakefield D. Can the chronic fatigue syndrome be defined by distinct clinical features? Psychol Med. (1995) 25:925&#x2013;35. doi:&#xa0;10.1017/S0033291700037417</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291700037417</ArticleId><ArticleId IdType="pubmed">8588011</ArticleId></ArticleIdList></Reference><Reference><Citation>Edwards JC, McGrath S, Baldwin A, Livingstone M, Kewley A. The biological challenge of myalgic encephalomyelitis/chronic fatigue syndrome: a solvable problem. Fatigue. (2016) 4:63&#x2013;9. doi:&#xa0;10.1080/21641846.2016.1160598</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2016.1160598</ArticleId><ArticleId IdType="pmc">PMC4867862</ArticleId><ArticleId IdType="pubmed">27226928</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study International Chronic Fatigue Syndrome Study Group. Ann Intern Med. (1994) 121:953&#x2013;9. doi:&#xa0;10.7326/0003-4819-121-12-199412150-00009</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-121-12-199412150-00009</ArticleId><ArticleId IdType="pubmed">7978722</ArticleId></ArticleIdList></Reference><Reference><Citation>Bateman L, Bested AC, Bonilla HF, Chheda BV, Chu L, Curtin JM, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc. (2021) 96:2861&#x2013;78. doi:&#xa0;10.1016/j.mayocp.2021.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2021.07.004</ArticleId><ArticleId IdType="pubmed">34454716</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang CJ, Hung LY, Kogelnik AM, Kaufman D, Aiyar RS, Chu AM, et al. . A comprehensive examination of severely ill ME/CFS patients. Healthcare (Basel). 9. (2021). doi:&#xa0;10.3390/healthcare9101290</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9101290</ArticleId><ArticleId IdType="pmc">PMC8535418</ArticleId><ArticleId IdType="pubmed">34682970</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong TL, Weitzer DJ, Long COVID. and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)-A systemic review and comparison of clinical presentation and symptomatology. Medicina (Kaunas). (2021) 57. doi:&#xa0;10.3390/medicina57050418</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Bested AC, Marshall LM. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians. Rev Environ Health. (2015) 30:223&#x2013;49. doi:&#xa0;10.1515/reveh-2015-0026</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/reveh-2015-0026</ArticleId><ArticleId IdType="pubmed">26613325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramsay MA. Myalgic encephalomyelitis: A baffling syndrome with a tragic aftermath. ME Assoc. (1981).</Citation><ArticleIdList><ArticleId IdType="pubmed">6913030</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med (Lond). (2005) 55:20&#x2013;31. doi:&#xa0;10.1093/occmed/kqi013</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/occmed/kqi013</ArticleId><ArticleId IdType="pubmed">15699087</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;., Tronstad KJ, Mella O. Pathomechanisms and possible interventions in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Clin Invest 131. (2021). doi:&#xa0;10.1172/JCI150377</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI150377</ArticleId><ArticleId IdType="pmc">PMC8279575</ArticleId><ArticleId IdType="pubmed">34263741</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, et al. . Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Evidence for an autoimmune disease. Autoimmun Rev. (2018) 17:601&#x2013;9. doi:&#xa0;10.1016/j.autrev.2018.01.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Brittain E, Muirhead N, Finlay AY, Vyas J. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): major impact on lives of both patients and family members. Medicina (Kaunas) 57. (2021). doi:&#xa0;10.3390/medicina57010043</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57010043</ArticleId><ArticleId IdType="pmc">PMC7825605</ArticleId><ArticleId IdType="pubmed">33430175</ArticleId></ArticleIdList></Reference><Reference><Citation>Kingdon CC, Bowman EW, Curran H, Nacul L, Lacerda EM. Functional status and well-being in people with myalgic encephalomyelitis/chronic fatigue syndrome compared with people with multiple sclerosis and healthy controls. Pharmacoecon Open. (2018) 2:381&#x2013;92. doi:&#xa0;10.1007/s41669-018-0071-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41669-018-0071-6</ArticleId><ArticleId IdType="pmc">PMC6249197</ArticleId><ArticleId IdType="pubmed">29536371</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul LC, Lacerda EM, Campion P, Pheby D, M.d.L. Drachler JC, Poland F, et al. . Molokhia, The functional status and well being of people with myalgic encephalomyelitis/chronic fatigue syndrome and their carers. BMC Public Health. (2011) 11:402. doi:&#xa0;10.1186/1471-2458-11-402</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2458-11-402</ArticleId><ArticleId IdType="pmc">PMC3123211</ArticleId><ArticleId IdType="pubmed">21619607</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#xfa;&#xf1;ez M, Nunez E, Del Val JL, J. fernandez-huerta C, Alegre M, Roig D, et al. . Health-related quality of life in chronic fatigue syndrome versus rheumatoid arthritis as control group. J Chronic Fatigue Syndrome. (2008) 14:31&#x2013;43. doi:&#xa0;10.1300/J092v14n02_04</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v14n02_04</ArticleId></ArticleIdList></Reference><Reference><Citation>Falk Hvidberg M, Brinth LS, Olesen AV, Petersen KD, Ehlers L. The health-related quality of life for patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). PloS One. (2015) 10:e0132421. doi:&#xa0;10.1371/journal.pone.0132421</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0132421</ArticleId><ArticleId IdType="pmc">PMC4492975</ArticleId><ArticleId IdType="pubmed">26147503</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein E. Assessment and treatment of patients with ME/CFS: Clinical guidelines for psychiatrists. Hentet. (2005) 11:13.</Citation></Reference><Reference><Citation>Roberts E, Wessely S, Chalder T, Chang C-K, Hotopf M. Mortality of people with chronic fatigue syndrome: a retrospective cohort study in England and Wales from the South London and Maudsley NHS Foundation Trust Biomedical Research Centre (SLaM BRC) Clinical Record Interactive Search (CRIS) Register. Lancet. (2016) 387:1638&#x2013;43. doi:&#xa0;10.1016/S0140-6736(15)01223-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(15)01223-4</ArticleId><ArticleId IdType="pubmed">26873808</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox DL. Management of CFS: development and evaluation of a service. Br J Ther Rehabil. (1998) 5:205&#x2013;9. doi:&#xa0;10.12968/bjtr.1998.5.4.14088</Citation><ArticleIdList><ArticleId IdType="doi">10.12968/bjtr.1998.5.4.14088</ArticleId></ArticleIdList></Reference><Reference><Citation>Speight N. Severe ME in children. Healthcare (Basel) 8. (2020). doi:&#xa0;10.3390/healthcare8030211</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8030211</ArticleId><ArticleId IdType="pmc">PMC7551866</ArticleId><ArticleId IdType="pubmed">32674263</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams LR, Isaacson-Barash C. Three cases of severe ME/CFS in adults. Healthcare (Basel) 9. (2021). doi:&#xa0;10.3390/healthcare9020215</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare9020215</ArticleId><ArticleId IdType="pmc">PMC7920463</ArticleId><ArticleId IdType="pubmed">33669438</ArticleId></ArticleIdList></Reference><Reference><Citation>US Food and Drug Administration . The voice of the patient. In: A series of reports from the U.S. Food and Drug Administration&#x2019;s (FDA&#x2019;s) patient-focused drug development initiative. Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) U.S. Food and Drug Administration (FDA) (2013).</Citation></Reference><Reference><Citation>Vink M, Vink-Niese F. Work rehabilitation and medical retirement for myalgic encephalomyelitis/chronic fatigue syndrome patients. A review and appraisal of diagnostic strategies. Diagnostics (Basel). (2019) 9. doi:&#xa0;10.3390/diagnostics9040124</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9040124</ArticleId><ArticleId IdType="pmc">PMC6963831</ArticleId><ArticleId IdType="pubmed">31547009</ArticleId></ArticleIdList></Reference><Reference><Citation>Vyas J, Muirhead N, Singh R, Ephgrave R, Finlay AY. Impact of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) on the quality of life of people with ME/CFS and their partners and family members: an online cross-sectional survey. BMJ Open. (2022) 12:e058128. doi:&#xa0;10.1136/bmjopen-2021-058128</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2021-058128</ArticleId><ArticleId IdType="pmc">PMC9062824</ArticleId><ArticleId IdType="pubmed">35501074</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Manual of the international statistical classification of diseases, injuries, and causes of death based on the recommendations of the eighth revision conference. Geneva: World Health Organization; (1969). p. 173.</Citation></Reference><Reference><Citation>Nakatomi Y, Kuratsune H, Watanabe Y. [Neuroinflammation in the brain of patients with myalgic encephalomyelitis/chronic fatigue syndrome]. Brain Nerve. (2018) 70:19&#x2013;25. doi:&#xa0;10.11477/mf.1416200945</Citation><ArticleIdList><ArticleId IdType="doi">10.11477/mf.1416200945</ArticleId><ArticleId IdType="pubmed">29348371</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, et al. . Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an &#xb9;&#xb9;C-(R)-PK11195 PET study. J Nucl Med. (2014) 55:945&#x2013;50. doi:&#xa0;10.2967/jnumed.113.131045</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.113.131045</ArticleId><ArticleId IdType="pubmed">24665088</ArticleId></ArticleIdList></Reference><Reference><Citation>Mueller C, Lin JC, Sheriff S, Maudsley AA, Younger JW. Evidence of widespread metabolite abnormalities in Myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav. (2020) 14:562&#x2013;72. doi:&#xa0;10.1007/s11682-018-0029-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-018-0029-4</ArticleId><ArticleId IdType="pmc">PMC6612467</ArticleId><ArticleId IdType="pubmed">30617782</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeineh MM, Kang J, Atlas SW, Raman MM, Reiss AL, Norris JL, et al. . Right arcuate fasciculus abnormality in chronic fatigue syndrome. Radiology. (2015) 274:517&#x2013;26. doi:&#xa0;10.1148/radiol.14141079</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.14141079</ArticleId><ArticleId IdType="pubmed">25353054</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D, Cheney PR, Peterson DL, Henry B, Wormsley SB, Geiger A, et al. . A chronic illness characterised by fatigue, neurologic and immunologic disorders, and active human herpesvirus type 6 infection. Ann Intern Med. (1992) 116:103&#x2013;13. doi:&#xa0;10.7326/0003-4819-116-2-103</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-116-2-103</ArticleId><ArticleId IdType="pubmed">1309285</ArticleId></ArticleIdList></Reference><Reference><Citation>Barnden LR, Shan ZY, Staines DR, Marshall-Gradisnik S, Finegan K, Ireland T, et al. . Hyperintense sensorimotor T1 spin echo MRI is associated with brainstem abnormality in chronic fatigue syndrome. NeuroImage Clin. (2018) 20:102&#x2013;9. doi:&#xa0;10.1016/j.nicl.2018.07.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2018.07.011</ArticleId><ArticleId IdType="pmc">PMC6309570</ArticleId><ArticleId IdType="pubmed">30497131</ArticleId></ArticleIdList></Reference><Reference><Citation>Cockshell SJ, Mathias JL. Cognitive functioning in chronic fatigue syndrome: a meta-analysis. psychol Med. (2010) 40:1253&#x2013;67. doi:&#xa0;10.1017/S0033291709992054</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291709992054</ArticleId><ArticleId IdType="pubmed">20047703</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza ME. Myalgic encephalomyelitis/chronic fatigue syndrome: the human herpesviruses are back! Biomolecules. (2021) 11. doi:&#xa0;10.3390/biom11020185</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11020185</ArticleId><ArticleId IdType="pmc">PMC7912523</ArticleId><ArticleId IdType="pubmed">33572802</ArticleId></ArticleIdList></Reference><Reference><Citation>Pheby DFH, Friedman KJ, Murovska M, Zalewski P. Turning a corner in ME/CFS research. Medicina (Kaunas) 57. (2021). doi:&#xa0;10.3390/medicina57101012</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57101012</ArticleId><ArticleId IdType="pmc">PMC8541042</ArticleId><ArticleId IdType="pubmed">34684049</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Brown A, Clyne E, Bartgis L, Evans M, Brown M. Contrasting case definitions for chronic fatigue syndrome, Myalgic Encephalomyelitis/chronic fatigue syndrome and myalgic encephalomyelitis. Eval Health Prof. (2012) 35:280&#x2013;304. doi:&#xa0;10.1177/0163278711424281</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0163278711424281</ArticleId><ArticleId IdType="pmc">PMC3658447</ArticleId><ArticleId IdType="pubmed">22158691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell DS. The doctor&#x2019;s guide to chronic fatigue syndrome: understanding, treating, and living with Cfids. (Boston, Massachusetts: Da Capo Press; ) (1994).</Citation></Reference><Reference><Citation>Dibble JJ, McGrath SJ, Ponting CP. Genetic risk factors of ME/CFS: a critical review. Hum Mol Genet 29. (2020) 29, R117&#x2013;r124. doi:&#xa0;10.1093/hmg/ddaa169</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddaa169</ArticleId><ArticleId IdType="pmc">PMC7530519</ArticleId><ArticleId IdType="pubmed">32744306</ArticleId></ArticleIdList></Reference><Reference><Citation>Newberry F, Hsieh SY, Wileman T, Carding SR. Does the microbiome and virome contribute to myalgic encephalomyelitis/chronic fatigue syndrome? Clin Sci (Lond). (2018) 132:523&#x2013;42. doi:&#xa0;10.1042/CS20171330</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/CS20171330</ArticleId><ArticleId IdType="pmc">PMC5843715</ArticleId><ArticleId IdType="pubmed">29523751</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth K, Scheibenbogen C. A Unifying Hypothesis of the Pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Recognitions from the finding of autoantibodies against &#xdf;2-adrenergic receptors. Autoimmun Rev. (2020) 19:102527. doi:&#xa0;10.1016/j.autrev.2020.102527</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2020.102527</ArticleId><ArticleId IdType="pubmed">32247028</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, O&#x2019;Boyle S, Palla L, Nacul FE, Mudie K, Kingdon CC, et al. . How myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) progresses: the natural history of ME/CFS. Front Neurol. (2020) 11:826doi:&#xa0;10.3389/fneur.2020.00826</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00826</ArticleId><ArticleId IdType="pmc">PMC7431524</ArticleId><ArticleId IdType="pubmed">32849252</ArticleId></ArticleIdList></Reference><Reference><Citation>Toogood PL, Clauw DJ, Phadke S, Hoffman D. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from? Pharmacol Res. (2021) 165:105465. doi:&#xa0;10.1016/j.phrs.2021.105465</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phrs.2021.105465</ArticleId><ArticleId IdType="pubmed">33529750</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu L, Valencia IJ, Garvert DW, Montoya JG. Onset patterns and course of myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. (2019) 7:12. doi:&#xa0;10.3389/fped.2019.00012</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00012</ArticleId><ArticleId IdType="pmc">PMC6370741</ArticleId><ArticleId IdType="pubmed">30805319</ArticleId></ArticleIdList></Reference><Reference><Citation>Salit IE. Precipitating factors for the chronic fatigue syndrome. J Psychiatr Res. (1997) 31:59&#x2013;65. doi:&#xa0;10.1016/S0022-3956(96)00050-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3956(96)00050-7</ArticleId><ArticleId IdType="pubmed">9201648</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate W, Walker M, Sweetman E, Helliwell A, Peppercorn K, Edgar C, et al. . Molecular mechanisms of neuroinflammation in ME/CFS and long COVID to sustain disease and promote relapses. Front Neurol. (2022) 13:877772. doi:&#xa0;10.3389/fneur.2022.877772</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.877772</ArticleId><ArticleId IdType="pmc">PMC9174654</ArticleId><ArticleId IdType="pubmed">35693009</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimas NG, Broderick G, Fletcher MA. Biomarkers for chronic fatigue. Brain Behav Immun. (2012) 26:1202&#x2013;10. doi:&#xa0;10.1016/j.bbi.2012.06.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2012.06.006</ArticleId><ArticleId IdType="pmc">PMC5373648</ArticleId><ArticleId IdType="pubmed">22732129</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh CM, Zainal NZ, Middleton SJ, Paykel ES. A family history study of chronic fatigue syndrome. Psychiatr Genet. (2001) 11:123&#x2013;8. doi:&#xa0;10.1097/00041444-200109000-00003</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00041444-200109000-00003</ArticleId><ArticleId IdType="pubmed">11702053</ArticleId></ArticleIdList></Reference><Reference><Citation>Albright F, Light K, Light A, Bateman L, Cannon-Albright LA. Evidence for a heritable predisposition to Chronic Fatigue Syndrome. BMC Neurol. (2011) 11:62. doi:&#xa0;10.1186/1471-2377-11-62</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2377-11-62</ArticleId><ArticleId IdType="pmc">PMC3128000</ArticleId><ArticleId IdType="pubmed">21619629</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D, Herrell R, Ashton S, Belcourt M, Schmaling K, Sullivan P, et al. . A twin study of chronic fatigue. Psychosom Med. (2001) 63:936&#x2013;43. doi:&#xa0;10.1097/00006842-200111000-00012</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006842-200111000-00012</ArticleId><ArticleId IdType="pubmed">11719632</ArticleId></ArticleIdList></Reference><Reference><Citation>Underhill R, O&#x2019;Gorman R. Prevalence of chronic fatigue syndrome and chronic fatigue within families of CFS patients. J Chronic Fatigue Syndrome. (2006) 13:3&#x2013;13. doi:&#xa0;10.1300/J092v13n01_02</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v13n01_02</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez M, Jaundoo R, Hilton K, Del Alamo A, Gemayel K, Klimas NG, et al. . Genetic predisposition for immune system, hormone, and metabolic dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome: A pilot study. Front Pediatr. (2019) 7:206.doi:&#xa0;10.3389/fped.2019.00206</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00206</ArticleId><ArticleId IdType="pmc">PMC6542994</ArticleId><ArticleId IdType="pubmed">31179255</ArticleId></ArticleIdList></Reference><Reference><Citation>Maher B. Personal genomes: The case of the missing heritability. Nature. (2008) 456:18&#x2013;21. doi:&#xa0;10.1038/456018a</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/456018a</ArticleId><ArticleId IdType="pubmed">18987709</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakhani CM, Tierney BT, Manrai AK, Yang J, Visscher PM, Patel CJ. Repurposing large health insurance claims data to estimate genetic and environmental contributions in 560 phenotypes. Nat Genet. (2019) 51:327&#x2013;34. doi:&#xa0;10.1038/s41588-018-0313-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0313-7</ArticleId><ArticleId IdType="pmc">PMC6358510</ArticleId><ArticleId IdType="pubmed">30643253</ArticleId></ArticleIdList></Reference><Reference><Citation>Canela-Xandri O, Rawlik K, Tenesa A. An atlas of genetic associations in UK Biobank. Nat Genet. (2018) 50:1593&#x2013;9. doi:&#xa0;10.1038/s41588-018-0248-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-018-0248-z</ArticleId><ArticleId IdType="pmc">PMC6707814</ArticleId><ArticleId IdType="pubmed">30349118</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan PF, Eveng&#xe5;rd B, Jacks A, Pedersen NL. Twin analyses of chronic fatigue in a Swedish national sample. Psychol Med. (2005) 35:1327&#x2013;36. doi:&#xa0;10.1017/S0033291705005222</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291705005222</ArticleId><ArticleId IdType="pubmed">16168155</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlo-Stella N, Badulli C, De Silvestri A, Bazzichi L, Martinetti M, Lorusso L, et al. . A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles. Clin Exp Rheumatol. (2006) 24:179&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">16762155</ArticleId></ArticleIdList></Reference><Reference><Citation>Vangeel E, Van Den Eede F, Hompes T, Izzi B, Del Favero J, Moorkens G, et al. . Chronic fatigue syndrome and DNA hypomethylation of the glucocorticoid receptor gene promoter 1F region: associations with HPA axis hypofunction and childhood trauma. Psychosomatic Med 77. (2015). doi:&#xa0;10.1097/PSY.0000000000000224</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000224</ArticleId><ArticleId IdType="pubmed">26230484</ArticleId></ArticleIdList></Reference><Reference><Citation>Kashi AA, Davis RW, Phair RD. The IDO metabolic trap hypothesis for the etiology of ME/CFS. Diagnostics (Basel) 9. (2019). doi:&#xa0;10.3390/diagnostics9030082</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030082</ArticleId><ArticleId IdType="pmc">PMC6787624</ArticleId><ArticleId IdType="pubmed">31357483</ArticleId></ArticleIdList></Reference><Reference><Citation>Metz R, Duhadaway JB, Kamasani U, Laury-Kleintop L, Muller AJ, Prendergast GC. Novel tryptophan catabolic enzyme IDO2 is the preferred biochemical target of the antitumor indoleamine 2,3-dioxygenase inhibitory compound D-1-methyl-tryptophan. Cancer Res. (2007) 67:7082&#x2013;7. doi:&#xa0;10.1158/0008-5472.CAN-07-1872</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-07-1872</ArticleId><ArticleId IdType="pubmed">17671174</ArticleId></ArticleIdList></Reference><Reference><Citation>Sommerfeldt L, Portilla H, Jacobsen L, Gjerstad J, Wyller VB. Polymorphisms of adrenergic cardiovascular control genes are associated with adolescent chronic fatigue syndrome. Acta Paediatrica. (2011) 100:293&#x2013;8. doi:&#xa0;10.1111/j.1651-2227.2010.02072.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1651-2227.2010.02072.x</ArticleId><ArticleId IdType="pubmed">21059181</ArticleId></ArticleIdList></Reference><Reference><Citation>Eisenach JH, Wittwer ED. &#x3b2;-Adrenoceptor gene variation and intermediate physiological traits: prediction of distant phenotype. Exp Physiol. (2010) 95:757&#x2013;64. doi:&#xa0;10.1113/expphysiol.2009.048330</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/expphysiol.2009.048330</ArticleId><ArticleId IdType="pmc">PMC3919627</ArticleId><ArticleId IdType="pubmed">20382665</ArticleId></ArticleIdList></Reference><Reference><Citation>Wittwer ED, Liu Z, Warner ND, Schroeder DR, Nadeau AM, Allen AR, et al. . Beta-1 and beta-2 adrenergic receptor polymorphism and association with cardiovascular response to orthostatic screening. Autonomic Neurosci. (2011) 164:89&#x2013;95. doi:&#xa0;10.1016/j.autneu.2011.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autneu.2011.07.004</ArticleId><ArticleId IdType="pmc">PMC3167015</ArticleId><ArticleId IdType="pubmed">21807569</ArticleId></ArticleIdList></Reference><Reference><Citation>Snyder EM, Beck KC, Dietz NM, Eisenach JH, Joyner MJ, Turner ST, et al. . Arg16Gly polymorphism of the beta2-adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans. J Physiol. (2006) 571:121&#x2013;30. doi:&#xa0;10.1113/jphysiol.2005.098558</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/jphysiol.2005.098558</ArticleId><ArticleId IdType="pmc">PMC1805638</ArticleId><ArticleId IdType="pubmed">16339181</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanigawa Y, Li J, Justesen JM, Horn H, Aguirre M, DeBoever C, et al. . Components of genetic associations across 2,138 phenotypes in the UK Biobank highlight adipocyte biology. Nat Commun. (2019) 10:4064. doi:&#xa0;10.1038/s41467-019-11953-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-11953-9</ArticleId><ArticleId IdType="pmc">PMC6731283</ArticleId><ArticleId IdType="pubmed">31492854</ArticleId></ArticleIdList></Reference><Reference><Citation>Li YR, Li J, Zhao SD, Bradfield JP, Mentch FD, Maggadottir SM, et al. . Meta-analysis of shared genetic architecture across ten pediatric autoimmune diseases. Nat Med. (2015) 21:1018&#x2013;27. doi:&#xa0;10.1038/nm.3933</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.3933</ArticleId><ArticleId IdType="pmc">PMC4863040</ArticleId><ArticleId IdType="pubmed">26301688</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;, Risa K, Lunde S, Alme K, Rekeland IG, Sapkota D, et al. . B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment. PloS One. (2015) 10:e0129898. doi:&#xa0;10.1371/journal.pone.0129898</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0129898</ArticleId><ArticleId IdType="pmc">PMC4488509</ArticleId><ArticleId IdType="pubmed">26132314</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg J, Gottfries CG, Elfaitouri A, Rizwan M, Ros&#xe9;n A. Infection elicited autoimmunity and myalgic encephalomyelitis/chronic fatigue syndrome: an explanatory model. Front Immunol. (2018) 9:229. doi:&#xa0;10.3389/fimmu.2018.00229</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00229</ArticleId><ArticleId IdType="pmc">PMC5818468</ArticleId><ArticleId IdType="pubmed">29497420</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer D, C.A. VR, Bitarello BD, C.B. DY, Nunes K. A genomic perspective on HLA evolution. Immunogenetics. (2018) 70:5&#x2013;27. doi:&#xa0;10.1007/s00251-017-1017-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00251-017-1017-3</ArticleId><ArticleId IdType="pmc">PMC5748415</ArticleId><ArticleId IdType="pubmed">28687858</ArticleId></ArticleIdList></Reference><Reference><Citation>Yasukochi Y, Satta Y. A human-specific allelic group of the MHC DRB1 gene in primates. J Physiol Anthropol. (2014) 33:14. doi:&#xa0;10.1186/1880-6805-33-14</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1880-6805-33-14</ArticleId><ArticleId IdType="pmc">PMC4072476</ArticleId><ArticleId IdType="pubmed">24928070</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J, Fritz EL, Kerr JR, Cleare AJ, Wessely S, Mattey DL. Association of chronic fatigue syndrome with human leucocyte antigen class II alleles. J Clin Pathol. (2005) 58:860&#x2013;3. doi:&#xa0;10.1136/jcp.2004.022681</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2004.022681</ArticleId><ArticleId IdType="pmc">PMC1770867</ArticleId><ArticleId IdType="pubmed">16049290</ArticleId></ArticleIdList></Reference><Reference><Citation>Lande A, Fluge &#xd8;, Strand EB, Fl&#xe5;m ST, Sosa DD, Mella O, et al. . Human Leukocyte Antigen alleles associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Sci Rep. (2020) 10:5267. doi:&#xa0;10.1038/s41598-020-62157-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-62157-x</ArticleId><ArticleId IdType="pmc">PMC7093502</ArticleId><ArticleId IdType="pubmed">32210306</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Pablos M, Paiva B, Montero-Mateo R, Garcia N, Zabaleta A. Epstein-barr virus and the origin of myalgic encephalomyelitis or chronic fatigue syndrome. Front Immunol. (2021) 12:656797. doi:&#xa0;10.3389/fimmu.2021.656797</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.656797</ArticleId><ArticleId IdType="pmc">PMC8634673</ArticleId><ArticleId IdType="pubmed">34867935</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoeman EM, van der Westhuisen FH, Erasmus E, van Dyk E, Knowles CV, Al-Ali S, et al. . Clinically proven mtDNA mutations are not common in those with chronic fatigue syndrome. BMC Med Genet. (2017) 18:29. doi:&#xa0;10.1186/s12881-017-0387-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12881-017-0387-6</ArticleId><ArticleId IdType="pmc">PMC5356238</ArticleId><ArticleId IdType="pubmed">28302057</ArticleId></ArticleIdList></Reference><Reference><Citation>Billing-Ross P, Germain A, Ye K, Keinan A, Gu Z, Hanson MR. Mitochondrial DNA variants correlate with symptoms in myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med. (2016) 14:19. doi:&#xa0;10.1186/s12967-016-0771-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-016-0771-6</ArticleId><ArticleId IdType="pmc">PMC4719218</ArticleId><ArticleId IdType="pubmed">26791940</ArticleId></ArticleIdList></Reference><Reference><Citation>Venter M, Tomas C, Pienaar IS, Strassheim V, Erasmus E, Ng WF, et al. . MtDNA population variation in Myalgic encephalomyelitis/Chronic fatigue syndrome in two populations: a study of mildly deleterious variants. Sci Rep. (2019) 9:2914. doi:&#xa0;10.1038/s41598-019-39060-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-39060-1</ArticleId><ArticleId IdType="pmc">PMC6393470</ArticleId><ArticleId IdType="pubmed">30814539</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Hernandez OD, Shoenfeld Y. Infection, vaccination, and autoantibodies in chronic fatigue syndrome, cause or coincidence? Ann N Y Acad Sci. (2009) 1173:600&#x2013;9. doi:&#xa0;10.1111/j.1749-6632.2009.04799.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2009.04799.x</ArticleId><ArticleId IdType="pubmed">19758205</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett SV, Alleva LM, Korossy-Horwood R, Clark IA. Chronic fatigue syndrome&#x2013;a neuroimmunological model. Med Hypotheses. (2011) 77:77&#x2013;83. doi:&#xa0;10.1016/j.mehy.2011.03.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2011.03.030</ArticleId><ArticleId IdType="pubmed">21474251</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacerda EM, Geraghty K, Kingdon CC, Palla L, Nacul L. A logistic regression analysis of risk factors in ME/CFS pathogenesis. BMC Neurol. (2019) 19:275. doi:&#xa0;10.1186/s12883-019-1468-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12883-019-1468-2</ArticleId><ArticleId IdType="pmc">PMC6839177</ArticleId><ArticleId IdType="pubmed">31699051</ArticleId></ArticleIdList></Reference><Reference><Citation>Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet. (2006) 367:346&#x2013;55. doi:&#xa0;10.1016/S0140-6736(06)68073-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(06)68073-2</ArticleId><ArticleId IdType="pubmed">16443043</ArticleId></ArticleIdList></Reference><Reference><Citation>Naess H, Sundal E, Myhr KM, Nyland HI. Postinfectious and chronic fatigue syndromes: clinical experience from a tertiary-referral centre in Norway. In Vivo. (2010) 24:185&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">20363992</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. . Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med. (2018) 16:268. doi:&#xa0;10.1186/s12967-018-1644-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1644-y</ArticleId><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. (2005) 23:683&#x2013;747. doi:&#xa0;10.1146/annurev.immunol.23.021704.115707</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.23.021704.115707</ArticleId><ArticleId IdType="pubmed">15771584</ArticleId></ArticleIdList></Reference><Reference><Citation>Wekerle H. Epstein-Barr virus sparks brain autoimmunity in multiple sclerosis. Nature. (2022) 603:230&#x2013;2. doi:&#xa0;10.1038/d41586-022-00382-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-022-00382-2</ArticleId><ArticleId IdType="pubmed">35169323</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Kogelnik AM, Bhangoo M, Lunn MR, Flamand L, Merrihew LE, et al. . Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. J Med Virol (2013) 85:2101&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">23959519</ArticleId></ArticleIdList></Reference><Reference><Citation>Katz BZ, Shiraishi Y, Mears CJ, Binns HJ, Taylor R. Chronic fatigue syndrome after infectious mononucleosis in adolescents. Pediatrics. (2009) 124:189&#x2013;93. doi:&#xa0;10.1542/peds.2008-1879</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2008-1879</ArticleId><ArticleId IdType="pmc">PMC2756827</ArticleId><ArticleId IdType="pubmed">19564299</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia JK, Chia AY. Chronic fatigue syndrome is associated with chronic enterovirus infection of the stomach. J Clin Pathol (2008) 61:43&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17872383</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr JR, Gough J, Richards SC, Main J, Enlander D, McCreary M, et al. . Antibody to parvovirus B19 nonstructural protein is associated with chronic arthralgia in patients with chronic fatigue syndrome/myalgic encephalomyelitis. J Gen Virol (2010) 91:893&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20007355</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobson SK, Daly JS, Thorne GM, McIntosh K. Chronic parvovirus B19 infection resulting in chronic fatigue syndrome: case history andf review. Clin Infect Dis (1997) 24:1048&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">9195056</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia J, Chia A, Voeller M, Lee T, Chang R. Acute enterovirus infection followed by myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and viral persistence. J Clin Pathol. (2010) 63:165&#x2013;8. doi:&#xa0;10.1136/jcp.2009.070466</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2009.070466</ArticleId><ArticleId IdType="pubmed">19828908</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia JK. The role of enterovirus in chronic fatigue syndrome. J Clin Pathol (2005) 58:1126&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1770761</ArticleId><ArticleId IdType="pubmed">16254097</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. . Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. Bmj. (2006) 333:575. doi:&#xa0;10.1136/bmj.38933.585764.AE</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.38933.585764.AE</ArticleId><ArticleId IdType="pmc">PMC1569956</ArticleId><ArticleId IdType="pubmed">16950834</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: Post-viral syndrome post COVID-19. Med Hypotheses (2020) 144:110055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Bateman L. Will COVID-19 Lead to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome? Front Med (Lausanne) (2020) 7:606824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia JK, Chia LY. Chronic Chlamydia pneumoniae infection: a treatable cause of chronic fatigue syndrome. Clin Infect Dis (1999) 29:452&#x2013;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">10476765</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L, Gough J, Christmas D, Mattey DL, Richards SC, Main J, et al. . Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis. J Clin Pathol. (2010) 63:156&#x2013;64. doi:&#xa0;10.1136/jcp.2009.072561</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2009.072561</ArticleId><ArticleId IdType="pmc">PMC2921262</ArticleId><ArticleId IdType="pubmed">19955554</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol (2006) 37 Suppl 1:S39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">17276367</ArticleId></ArticleIdList></Reference><Reference><Citation>Wray B, Gaughf C, Chandler F, Jr., Berry S, Latham J, Wood L, et al. . Detection of Epstein-Barr virus and cytomegalovirus in patients with chronic fatigue. Ann Allergy (1993) 71:223&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">8396863</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones JF, Ray CG, Minnich LL, Hicks MJ, Kibler R, Lucas DO. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Ann Intern Med (1985) 102:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">2578266</ArticleId></ArticleIdList></Reference><Reference><Citation>Sejvar JJ, Curns AT, Welburg L, Jones JF, Lundgren LM, Capuron L, et al. . Neurocognitive and functional outcomes in persons recovering from West Nile virus illness. J Neuropsychol (2008) 2:477&#x2013;99.</Citation><ArticleIdList><ArticleId IdType="pubmed">19824176</ArticleId></ArticleIdList></Reference><Reference><Citation>Eveng&#xe5;rd B, Gr&#xe4;ns H, Wahlund E, Nord CE. Increased number of Candida albicans in the faecal microflora of chronic fatigue syndrome patients during the acute phase of illness. Scand J Gastroenterol (2007) 42:1514&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">17886123</ArticleId></ArticleIdList></Reference><Reference><Citation>Moldofsky H, Patcai J. Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study. BMC Neurol (2011) 11:37.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3071317</ArticleId><ArticleId IdType="pubmed">21435231</ArticleId></ArticleIdList></Reference><Reference><Citation>Epstein L, Wong KK, Kallen AJ, Uyeki TM. Post-Ebola Signs and Symptoms in U. S. Survivors. N Engl J Med (2015) 373:2484&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">26672870</ArticleId></ArticleIdList></Reference><Reference><Citation>Seet RC, Quek AM, Lim EC. Post-infectious fatigue syndrome in dengue infection. J Clin Virol (2007) 38:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">17137834</ArticleId></ArticleIdList></Reference><Reference><Citation>Salit IE. Sporadic postinfectious neuromyasthenia. Cmaj (1985) 133:659&#x2013;63.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1346266</ArticleId><ArticleId IdType="pubmed">4042036</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf8;rch K, Hanevik K, Rivenes AC, B&#xf8;dtker JE, N&#xe6;ss H, Stubhaug B, et al. . Chronic fatigue syndrome 5 years after giardiasis: differential diagnoses, characteristics and natural course. BMC Gastroenterol (2013) 13:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3598369</ArticleId><ArticleId IdType="pubmed">23399438</ArticleId></ArticleIdList></Reference><Reference><Citation>Beqaj SH, Lerner AM, Fitzgerald JT. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome. J Clin Pathol (2008) 61:623&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">18037660</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH, Wing YK, Yu MW, Leung CM, Ma RC, Kong AP, et al. . Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med (2009) 169:2142&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigal LH. Summary of the first 100 patients seen at a lyme disease referral center. Am J Med (1990) 88:577&#x2013;81.</Citation><ArticleIdList><ArticleId IdType="pubmed">2346158</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Z, Hollmann C, Kalanidhi S, Grothey A, Keating S, Mena-Palomo I, et al. . Increased circulating fibronectin, depletion of natural IgM and heightened EBV, HSV-1 reactivation in ME/CFS and long COVID. medRxiv. (2023). doi:&#xa0;10.1101/2023.06.23.23291827</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.06.23.23291827</ArticleId></ArticleIdList></Reference><Reference><Citation>Banko A, Miljanovic D, Cirkovic A. Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field. Int J Infect Dis. (2023) 130:108&#x2013;25. doi:&#xa0;10.1016/j.ijid.2023.01.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2023.01.036</ArticleId><ArticleId IdType="pmc">PMC9889115</ArticleId><ArticleId IdType="pubmed">36736577</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagemeier SR, Barlow EA, Kleman AA, Kenney SC. The Epstein-Barr virus BRRF1 protein, Na, induces lytic infection in a TRAF2- and p53-dependent manner. J Virol. (2011) 85:4318&#x2013;29. doi:&#xa0;10.1128/JVI.01856-10</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01856-10</ArticleId><ArticleId IdType="pmc">PMC3126225</ArticleId><ArticleId IdType="pubmed">21325409</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin P, Williams MV, Klimas NG, Fletcher MA, Barnes Z, Ariza ME. Myalgic encephalomyelitis/chronic fatigue syndrome and gulf war illness patients exhibit increased humoral responses to the herpesviruses-encoded dUTPase: Implications in disease pathophysiology. J Med Virol. (2017) 89:1636&#x2013;45. doi:&#xa0;10.1002/jmv.24810</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24810</ArticleId><ArticleId IdType="pmc">PMC5513753</ArticleId><ArticleId IdType="pubmed">28303641</ArticleId></ArticleIdList></Reference><Reference><Citation>Lerner AM, Ariza ME, Williams M, Jason L, Beqaj S, Fitzgerald JT, et al. . Antibody to Epstein-Barr virus deoxyuridine triphosphate nucleotidohydrolase and deoxyribonucleotide polymerase in a chronic fatigue syndrome subset. PloS One. (2012) 7:e47891. doi:&#xa0;10.1371/journal.pone.0047891</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0047891</ArticleId><ArticleId IdType="pmc">PMC3498272</ArticleId><ArticleId IdType="pubmed">23155374</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza ME, Rivailler P, Glaser R, Chen M, Williams MV. Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells. PloS One. (2013) 8:e69827. doi:&#xa0;10.1371/journal.pone.0069827</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0069827</ArticleId><ArticleId IdType="pmc">PMC3718799</ArticleId><ArticleId IdType="pubmed">23894549</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariza ME, Glaser R, Williams MV. Human herpesviruses-encoded dUTPases: a family of proteins that modulate dendritic cell function and innate immunity. Front Microbiol. (2014) 5:504. doi:&#xa0;10.3389/fmicb.2014.00504</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2014.00504</ArticleId><ArticleId IdType="pmc">PMC4176148</ArticleId><ArticleId IdType="pubmed">25309527</ArticleId></ArticleIdList></Reference><Reference><Citation>Murata T, Okuno Y, Sato Y, Watanabe T, Kimura H. Oncogenesis of CAEBV revealed: Intragenic deletions in the viral genome and leaky expression of lytic genes. Rev Med Virol. (2020) 30:e2095. doi:&#xa0;10.1002/rmv.2095</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2095</ArticleId><ArticleId IdType="pubmed">31845495</ArticleId></ArticleIdList></Reference><Reference><Citation>Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, et al. . Defective Epstein-Barr virus in chronic active infection and haematological Malignancy. Nat Microbiol. (2019) 4:404&#x2013;13. doi:&#xa0;10.1038/s41564-018-0334-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0334-0</ArticleId><ArticleId IdType="pubmed">30664667</ArticleId></ArticleIdList></Reference><Reference><Citation>Laichalk LL, Thorley-Lawson DA. Terminal differentiation into plasma cells initiates the replicative cycle of Epstein-Barr virus in vivo. J Virol. (2005) 79:1296&#x2013;307. doi:&#xa0;10.1128/JVI.79.2.1296-1307.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.79.2.1296-1307.2005</ArticleId><ArticleId IdType="pmc">PMC538585</ArticleId><ArticleId IdType="pubmed">15613356</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams Ph DM, Cox B, Lafuse Ph DW, Ariza ME. Epstein-barr virus dUTPase induces neuroinflammatory mediators: implications for myalgic encephalomyelitis/chronic fatigue syndrome. Clin Ther. (2019) 41:848&#x2013;63. doi:&#xa0;10.1016/j.clinthera.2019.04.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.04.009</ArticleId><ArticleId IdType="pmc">PMC6525645</ArticleId><ArticleId IdType="pubmed">31040055</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D, Ashley RL, Pearlman T, Kith P, Komaroff AL. Viral serologies in patients with chronic fatigue and chronic fatigue syndrome. J Med Virol. (1996) 50:25&#x2013;30. doi:&#xa0;10.1002/(ISSN)1096-9071</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(ISSN)1096-9071</ArticleId><ArticleId IdType="pubmed">8890037</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchwald D, Sullivan JL, Komaroff AL. Frequency of &#x2018;chronic active Epstein-Barr virus infection&#x2019; in a general medical practice. Jama. (1987) 257:2303&#x2013;7. doi:&#xa0;10.1001/jama.257.17.2303</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.257.17.2303</ArticleId><ArticleId IdType="pubmed">3033338</ArticleId></ArticleIdList></Reference><Reference><Citation>DuBois RE, Seeley JK, Brus I, Sakamoto K, Ballow M, Harada S, et al. . Chronic mononucleosis syndrome. South Med J. (1984) 77:1376&#x2013;82. doi:&#xa0;10.1097/00007611-198411000-00007</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00007611-198411000-00007</ArticleId><ArticleId IdType="pubmed">6093268</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobi M, Morag A, Ravid Z, Chowers I, Feldman-Weiss V, Michaeli Y, et al. . Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet. (1982) 1:61&#x2013;4. doi:&#xa0;10.1016/S0140-6736(82)90210-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(82)90210-0</ArticleId><ArticleId IdType="pubmed">6119490</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes GP, Kaplan JE, Stewart JA, Hunt B, Pinsky PF, Schonberger LB. A cluster of patients with a chronic mononucleosis-like syndrome. Is Epstein-Barr Virus cause? JAMA. (1987) 257:2297&#x2013;302. doi:&#xa0;10.1001/jama.257.17.2297</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.257.17.2297</ArticleId><ArticleId IdType="pubmed">3033337</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellinger WC, Smith TF, Van Scoy RE, Spitzer PG, Forgacs P, Edson RS. Chronic fatigue syndrome and the diagnostic utility of antibody to Epstein-Barr virus early antigen. Jama. (1988) 260:971&#x2013;3. doi:&#xa0;10.1001/jama.260.7.971</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.260.7.971</ArticleId><ArticleId IdType="pubmed">2840523</ArticleId></ArticleIdList></Reference><Reference><Citation>Straus SE, Dale JK, Tobi M, Lawley T, Preble O, Blaese RM, et al. . Acyclovir treatment of the chronic fatigue syndrome Lack of efficacy in a placebo-controlled trial. . N Engl J Med. (1988) 319:1692&#x2013;8. doi:&#xa0;10.1056/NEJM198812293192602</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM198812293192602</ArticleId><ArticleId IdType="pubmed">2849717</ArticleId></ArticleIdList></Reference><Reference><Citation>Gold D, Bowden R, Sixbey J, Riggs R, Katon WJ, Ashley R, et al. . Chronic fatigue. A prospective clinical and virologic study. Jama. (1990) 264:48&#x2013;53. doi:&#xa0;10.1001/jama.264.1.48</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.264.1.48</ArticleId><ArticleId IdType="pubmed">2162397</ArticleId></ArticleIdList></Reference><Reference><Citation>Levine PH, Jacobson S, Pocinki AG, Cheney P, Peterson D, Connelly RR, et al. . Clinical, epidemiologic, and virologic studies in four clusters of the chronic fatigue syndrome. Arch Intern Med. (1992) 152:1611&#x2013;6. doi:&#xa0;10.1001/archinte.152.8.1611</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.152.8.1611</ArticleId><ArticleId IdType="pubmed">1323246</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron B, Flamand L, Juwana H, Middeldorp J, Naing Z, Rawlinson W, et al. . Serological and virological investigation of the role of the herpesviruses EBV, CMV and HHV-6 in post-infective fatigue syndrome. J Med Virol. (2010) 82:1684&#x2013;8. doi:&#xa0;10.1002/jmv.21873</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.21873</ArticleId><ArticleId IdType="pubmed">20827765</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M, Eckey M, Sotzny F, Hahn E, Bauer S, Grabowski P, et al. . Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray. PloS One. (2017) 12:e0179124. doi:&#xa0;10.1371/journal.pone.0179124</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179124</ArticleId><ArticleId IdType="pmc">PMC5467847</ArticleId><ArticleId IdType="pubmed">28604802</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg J, Rizwan M, B&#xf6;hlin-Wiener A, Elfaitouri A, Julin P, Zachrisson O, et al. . Antibodies to human herpesviruses in myalgic encephalomyelitis/chronic fatigue syndrome patients. Front Immunol. (2019) 10:1946. doi:&#xa0;10.3389/fimmu.2019.01946</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.01946</ArticleId><ArticleId IdType="pmc">PMC6702656</ArticleId><ArticleId IdType="pubmed">31475007</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto NE, Straus SE. Chronic fatigue syndrome and herpesviruses: the fading evidence. Herpes. (2000) 7:46&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pubmed">11867001</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe4;rtner BC, Fischinger JM, Roemer K, Mak M, Fleurent B, Mueller-Lantzsch N. Evaluation of a recombinant line blot for diagnosis of Epstein-Barr Virus compared with ELISA, using immunofluorescence as reference method. J Virol Methods. (2001) 93:89&#x2013;96. doi:&#xa0;10.1016/S0166-0934(00)00301-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0166-0934(00)00301-3</ArticleId><ArticleId IdType="pubmed">11311347</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahmaz N, Soutar A, Cherrie JW. Chronic fatigue and organophosphate pesticides in sheep farming: a retrospective study amongst people reporting to a UK pharmacovigilance scheme. Ann Occup Hyg. (2003) 47:261&#x2013;7. doi:&#xa0;10.1093/annhyg/meg042</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/annhyg/meg042</ArticleId><ArticleId IdType="pubmed">12765866</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan PO. Chronic fatigue syndrome as a delayed reaction to chronic low-dose organophosphate exposure. J Nutr Environ Med. (1996) 6:341&#x2013;50. doi:&#xa0;10.3109/13590849609007262</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/13590849609007262</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacini S, Fiore MG, Magherini S, Morucci G, Branca JJ, Gulisano M, et al. . Could cadmium be responsible for some of the neurological signs and symptoms of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Med Hypotheses. (2012) 79:403&#x2013;7. doi:&#xa0;10.1016/j.mehy.2012.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2012.06.007</ArticleId><ArticleId IdType="pubmed">22795611</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez E, Arce C, Oset-Gasque MJ, Ca&#xf1;adas S, Gonz&#xe1;lez MP. Cadmium induces reactive oxygen species generation and lipid peroxidation in cortical neurons in culture. Free Radic Biol Med. (2006) 40:940&#x2013;51. doi:&#xa0;10.1016/j.freeradbiomed.2005.10.062</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2005.10.062</ArticleId><ArticleId IdType="pubmed">16540389</ArticleId></ArticleIdList></Reference><Reference><Citation>de Lange FP, Kalkman JS, Bleijenberg G, Hagoort P, van der Meer JWM, Toni I. Gray matter volume reduction in the chronic fatigue syndrome. NeuroImage. (2005) 26:777&#x2013;81. doi:&#xa0;10.1016/j.neuroimage.2005.02.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroimage.2005.02.037</ArticleId><ArticleId IdType="pubmed">15955487</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart RP, Rose CS, Hamer RM. Neuropsychological effects of occupational exposure to cadmium. J Clin Exp Neuropsychol. (1989) 11:933&#x2013;43. doi:&#xa0;10.1080/01688638908400946</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/01688638908400946</ArticleId><ArticleId IdType="pubmed">2592532</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswal B, Kunwar P, Natelson BH. Cerebral blood flow is reduced in chronic fatigue syndrome as assessed by arterial spin labeling. J Neurol Sci. (2011) 301:9&#x2013;11. doi:&#xa0;10.1016/j.jns.2010.11.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2010.11.018</ArticleId><ArticleId IdType="pmc">PMC3139492</ArticleId><ArticleId IdType="pubmed">21167506</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshiuchi K, Farkas J, Natelson BH. Patients with chronic fatigue syndrome have reduced absolute cortical blood flow. Clin Physiol Funct Imaging. (2006) 26:83&#x2013;6. doi:&#xa0;10.1111/j.1475-097X.2006.00649.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1475-097X.2006.00649.x</ArticleId><ArticleId IdType="pubmed">16494597</ArticleId></ArticleIdList></Reference><Reference><Citation>Pacini S, Punzi T, Morucci G, Gulisano M, Ruggiero M. A paradox of cadmium: a carcinogen that impairs the capability of human breast cancer cells to induce angiogenesis. J Environ Pathol Toxicol Oncol. (2009) 28:85&#x2013;8. doi:&#xa0;10.1615/JEnvironPatholToxicolOncol.v28.i1</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/JEnvironPatholToxicolOncol.v28.i1</ArticleId><ArticleId IdType="pubmed">19392658</ArticleId></ArticleIdList></Reference><Reference><Citation>Stejskal VD, Danersund A, Lindvall A, Hudecek R, Nordman V, Yaqob A, et al. . Metal-specific lymphocytes: biomarkers of sensitivity in man. Neuro Endocrinol Lett. (1999) 20:289&#x2013;98.</Citation><ArticleIdList><ArticleId IdType="pubmed">11460087</ArticleId></ArticleIdList></Reference><Reference><Citation>Valentine-Thon E, M&#xfc;ller K, Guzzi G, Kreisel S, Ohnsorge P, Sandkamp M. LTT-MELISA is clinically relevant for detecting and monitoring metal sensitivity. Neuro Endocrinol Lett. (2006) 27 Suppl 1:17&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">17261998</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherardi RK, Cr&#xe9;peaux G, Authier F-J. Myalgia and chronic fatigue syndrome following immunization: macrophagic myofasciitis and animal studies support linkage to aluminum adjuvant persistency and diffusion in the immune system. Autoimmun Rev. (2019) 18:691&#x2013;705. doi:&#xa0;10.1016/j.autrev.2019.05.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2019.05.006</ArticleId><ArticleId IdType="pubmed">31059838</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh KM, Marra FH, Stiver HG. Influenza vaccination: is it appropriate in chronic fatigue syndrome? Am J Respir Med. (2002) 1:3&#x2013;9. doi:&#xa0;10.1007/BF03257157</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03257157</ArticleId><ArticleId IdType="pubmed">14720070</ArticleId></ArticleIdList></Reference><Reference><Citation>Manysheva K, Sherman M, Zhukova N, Kopishinskaia S. Myalgic encephalomyelitis/chronic fatigue syndrome: first described complication after gam-COVID-vac vaccine. Psychiatr Danub. (2022) 34:189&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">36170726</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherardi RK. [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome]. Rev Neurol (Paris). (2003) 159:162&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12660567</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoenfeld Y, Agmon-Levin N. &#x2018;ASIA&#x2019; - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun. (2011) 36:4&#x2013;8. doi:&#xa0;10.1016/j.jaut.2010.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2010.07.003</ArticleId><ArticleId IdType="pubmed">20708902</ArticleId></ArticleIdList></Reference><Reference><Citation>Gherardi RK, Coquet M, Cherin P, Belec L, Moretto P, Dreyfus PA, et al. . Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminum hydroxide in muscle. Brain. (2001) 124:1821&#x2013;31. doi:&#xa0;10.1093/brain/124.9.1821</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/124.9.1821</ArticleId><ArticleId IdType="pubmed">11522584</ArticleId></ArticleIdList></Reference><Reference><Citation>Feiring B, Laake I, Bakken IJ, Greve-Isdahl M, Wyller VB, H&#xe5;berg SE, et al. . HPV vaccination and risk of chronic fatigue syndrome/myalgic encephalomyelitis: A nationwide register-based study from Norway. Vaccine. (2017) 35:4203&#x2013;12. doi:&#xa0;10.1016/j.vaccine.2017.06.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.06.031</ArticleId><ArticleId IdType="pubmed">28648542</ArticleId></ArticleIdList></Reference><Reference><Citation>Prinsen H, de Vries IJM, Torensma R, Pots JM, Mulder SF, van Herpen CML, et al. . Humoral and cellular immune responses after influenza vaccination in patients with chronic fatigue syndrome. BMC Immunol. (2012) 13:71. doi:&#xa0;10.1186/1471-2172-13-71</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2172-13-71</ArticleId><ArticleId IdType="pmc">PMC3534525</ArticleId><ArticleId IdType="pubmed">23244635</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh KM, Danforth DG, Hall RT, Fleming JA, Stiver HG. Double-blind, randomised study of the effects of influenza vaccination on the specific antibody response and clinical course of patients with chronic fatigue syndrome. Can J Infect Dis. (2000) 11:267&#x2013;73. doi:&#xa0;10.1155/2000/602862</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2000/602862</ArticleId><ArticleId IdType="pmc">PMC2094778</ArticleId><ArticleId IdType="pubmed">18159300</ArticleId></ArticleIdList></Reference><Reference><Citation>Golomb BA, Koslik HJ, Redd AJ. Fluoroquinolone-induced serious, persistent, multisymptom adverse effects. BMJ Case Rep 2015. (2015). doi:&#xa0;10.1136/bcr-2015-209821</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2015-209821</ArticleId><ArticleId IdType="pmc">PMC4600819</ArticleId><ArticleId IdType="pubmed">26438672</ArticleId></ArticleIdList></Reference><Reference><Citation>Balfour JA, Wiseman LR. Moxifloxacin. Drugs. (1999) 57:363&#x2013;73. doi:&#xa0;10.2165/00003495-199957030-00007</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/00003495-199957030-00007</ArticleId><ArticleId IdType="pubmed">10193688</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipsky BA, Dorr MB, Magner DJ, Talbot GH. Safety profile of sparfloxacin, a new fluoroquinolone antibiotic. Clin Ther. (1999) 21:148&#x2013;59. doi:&#xa0;10.1016/S0149-2918(00)88275-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0149-2918(00)88275-2</ArticleId><ArticleId IdType="pubmed">10090432</ArticleId></ArticleIdList></Reference><Reference><Citation>Wimer SM, Schoonover L, Garrison MW. Levofloxacin: a therapeutic review. Clin Ther. (1998) 20:1049&#x2013;70. doi:&#xa0;10.1016/S0149-2918(98)80104-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0149-2918(98)80104-5</ArticleId><ArticleId IdType="pubmed">9916602</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaleagasioglu F, Olcay E. Fluoroquinolone-induced tendinopathy: etiology and preventive measures. Tohoku J Exp Med. (2012) 226:251&#x2013;8. doi:&#xa0;10.1620/tjem.226.251</Citation><ArticleIdList><ArticleId IdType="doi">10.1620/tjem.226.251</ArticleId><ArticleId IdType="pubmed">22452935</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai WC, Yang YM. Fluoroquinolone-associated tendinopathy. Chang Gung Med J. (2011) 34:461&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22035890</ArticleId></ArticleIdList></Reference><Reference><Citation>Sendzik J, Shakibaei M, Sch&#xe4;fer-Korting M, Lode H, Stahlmann R. Synergistic effects of dexamethasone and quinolones on human-derived tendon cells. Int J Antimicrob Agents. (2010) 35:366&#x2013;74. doi:&#xa0;10.1016/j.ijantimicag.2009.10.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2009.10.009</ArticleId><ArticleId IdType="pubmed">20034766</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim GK. The risk of fluoroquinolone-induced tendinopathy and tendon rupture: what does the clinician need to know? J Clin Aesthet Dermatol. (2010) 3:49&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2921747</ArticleId><ArticleId IdType="pubmed">20725547</ArticleId></ArticleIdList></Reference><Reference><Citation>Lowes DA, Wallace C, Murphy MP, Webster NR, Galley HF. The mitochondria targeted antioxidant MitoQ protects against fluoroquinolone-induced oxidative stress and mitochondrial membrane damage in human Achilles tendon cells. Free Radic Res. (2009) 43:323&#x2013;8. doi:&#xa0;10.1080/10715760902736275</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10715760902736275</ArticleId><ArticleId IdType="pubmed">19235604</ArticleId></ArticleIdList></Reference><Reference><Citation>Keel M, Trentz O. Pathophysiology of polytrauma. Injury. (2005) 36:691&#x2013;709. doi:&#xa0;10.1016/j.injury.2004.12.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.injury.2004.12.037</ArticleId><ArticleId IdType="pubmed">15910820</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Berk M, Galecki P, Maes M. The emerging role of autoimmunity in myalgic encephalomyelitis/chronic fatigue syndrome (ME/cfs). Mol Neurobiol. (2014) 49:741&#x2013;56. doi:&#xa0;10.1007/s12035-013-8553-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-013-8553-0</ArticleId><ArticleId IdType="pubmed">24068616</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanculescu D, Sep&#xfa;lveda N, Lim CL, Bergquist J. Lessons from heat stroke for understanding myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol. (2021) 12:789784. doi:&#xa0;10.3389/fneur.2021.789784</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.789784</ArticleId><ArticleId IdType="pmc">PMC8710546</ArticleId><ArticleId IdType="pubmed">34966354</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;, Mella O, Bruland O, Risa K, Dyrstad SE, Alme K, et al. . Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome. JCI Insight. (2016) 1:e89376. doi:&#xa0;10.1172/jci.insight.89376</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.89376</ArticleId><ArticleId IdType="pmc">PMC5161229</ArticleId><ArticleId IdType="pubmed">28018972</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoel F, Hoel A, Pettersen IK, Rekeland IG, Risa K, Alme K, et al. . A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome. JCI Insight 6. (2021). doi:&#xa0;10.1172/jci.insight.149217</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.149217</ArticleId><ArticleId IdType="pmc">PMC8409979</ArticleId><ArticleId IdType="pubmed">34423789</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Ruppert D, Levine SM, Hanson MR. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol Biosyst. (2017) 13:371&#x2013;9. doi:&#xa0;10.1039/C6MB00600K</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C6MB00600K</ArticleId><ArticleId IdType="pmc">PMC5365380</ArticleId><ArticleId IdType="pubmed">28059425</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong CW, McGregor NR, Lewis DP, Butt HL, Gooley PR. Metabolic profiling reveals anomalous energy metabolism and oxidative stress pathways in chronic fatigue syndrome patients. Metabolomics. (2015) 11:1626&#x2013;39. doi:&#xa0;10.1007/s11306-015-0816-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-015-0816-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ. Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radic Biol Med. (2005) 39:584&#x2013;9. doi:&#xa0;10.1016/j.freeradbiomed.2005.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2005.04.020</ArticleId><ArticleId IdType="pubmed">16085177</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinsvik EK, Hausken T, Fluge &#xd8;, Mella O, Gilja OH. Gastric dysmotility and gastrointestinal symptoms in myalgic encephalomyelitis/chronic fatigue syndrome. Scandinavian J Gastroenterol. (2023) 58:718&#x2013;25. doi:&#xa0;10.1080/00365521.2023.2173533</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/00365521.2023.2173533</ArticleId><ArticleId IdType="pubmed">36728717</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakhan SE, Kirchgessner A. Gut inflammation in chronic fatigue syndrome. Nutr Metab (Lond). (2010) 7:79. doi:&#xa0;10.1186/1743-7075-7-79</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-7075-7-79</ArticleId><ArticleId IdType="pmc">PMC2964729</ArticleId><ArticleId IdType="pubmed">20939923</ArticleId></ArticleIdList></Reference><Reference><Citation>Giloteaux L, Goodrich JK, Walters WA, Levine SM, Ley RE, Hanson MR. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. (2016) 4:30. doi:&#xa0;10.1186/s40168-016-0171-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-016-0171-4</ArticleId><ArticleId IdType="pmc">PMC4918027</ArticleId><ArticleId IdType="pubmed">27338587</ArticleId></ArticleIdList></Reference><Reference><Citation>Lupo GFD, Rocchetti G, Lucini L, Lorusso L, Manara E, Bertelli M, et al. . Potential role of microbiome in Chronic Fatigue Syndrome/Myalgic Encephalomyelits (CFS/ME). Sci Rep. (2021) 11:7043. doi:&#xa0;10.1038/s41598-021-86425-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-86425-6</ArticleId><ArticleId IdType="pmc">PMC8007739</ArticleId><ArticleId IdType="pubmed">33782445</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A, Marshall T. Myalgic encephalomyelitis/chronic fatigue syndrome in the era of the human microbiome: persistent pathogens drive chronic symptoms by interfering with host metabolism, gene expression, and immunity. Front Pediatr. (2018) 6:373. doi:&#xa0;10.3389/fped.2018.00373</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00373</ArticleId><ArticleId IdType="pmc">PMC6288442</ArticleId><ArticleId IdType="pubmed">30564562</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D, Williams BL, Mishra N, Che X, Lee B, Bateman L, et al. . Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. (2017) 5:44. doi:&#xa0;10.1186/s40168-017-0261-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0261-y</ArticleId><ArticleId IdType="pmc">PMC5405467</ArticleId><ArticleId IdType="pubmed">28441964</ArticleId></ArticleIdList></Reference><Reference><Citation>Machiels K, Joossens M, Sabino J, De Preter V, Arijs I, Eeckhaut V, et al. . A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis. Gut. (2014) 63:1275&#x2013;83. doi:&#xa0;10.1136/gutjnl-2013-304833</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2013-304833</ArticleId><ArticleId IdType="pubmed">24021287</ArticleId></ArticleIdList></Reference><Reference><Citation>Segain JP, Raingeard de la Bl&#xe9;ti&#xe8;re D, Bourreille A, Leray V, Gervois N, Rosales C, et al. . Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn&#x2019;s disease. Gut. (2000) 47:397&#x2013;403. doi:&#xa0;10.1136/gut.47.3.397</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gut.47.3.397</ArticleId><ArticleId IdType="pmc">PMC1728045</ArticleId><ArticleId IdType="pubmed">10940278</ArticleId></ArticleIdList></Reference><Reference><Citation>R&#xed;os-Covi&#xe1;n D, Ruas-Madiedo P, Margolles A, Gueimonde M, de Los Reyes-Gavil&#xe1;n CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol. (2016) 7:185. doi:&#xa0;10.3389/fmicb.2016.00185</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2016.00185</ArticleId><ArticleId IdType="pmc">PMC4756104</ArticleId><ArticleId IdType="pubmed">26925050</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong CW, McGregor NR, Lewis DP, Butt HL, Gooley PR. The association of fecal microbiota and fecal, blood serum and urine metabolites in myalgic encephalomyelitis/chronic fatigue syndrome. Metabolomics. (2017) 13:1&#x2013;13. doi:&#xa0;10.1007/s11306-016-1145-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11306-016-1145-z</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizzatti G, Lopetuso LR, Gibiino G, Binda C, Gasbarrini A. Proteobacteria: A common factor in human diseases. BioMed Res Int. (2017) 2017:9351507. doi:&#xa0;10.1155/2017/9351507</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/9351507</ArticleId><ArticleId IdType="pmc">PMC5688358</ArticleId><ArticleId IdType="pubmed">29230419</ArticleId></ArticleIdList></Reference><Reference><Citation>Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil. (2012) 24:521&#x2013;30.e248. doi:&#xa0;10.1111/j.1365-2982.2012.01891.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2982.2012.01891.x</ArticleId><ArticleId IdType="pmc">PMC3975596</ArticleId><ArticleId IdType="pubmed">22339879</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff AL, Lipkin WI. Insights from myalgic encephalomyelitis/chronic fatigue syndrome may help unravel the pathogenesis of postacute COVID-19 syndrome. Trends Mol Med. (2021) 27:895&#x2013;906. doi:&#xa0;10.1016/j.molmed.2021.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molmed.2021.06.002</ArticleId><ArticleId IdType="pmc">PMC8180841</ArticleId><ArticleId IdType="pubmed">34175230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ercoli G, Fernandes VE, Chung WY, Wanford JJ, Thomson S, Bayliss CD, et al. . Intracellular replication of Streptococcus pneumoniae inside splenic macrophages serves as a reservoir for septicaemia. Nat Microbiol. (2018) 3:600&#x2013;10. doi:&#xa0;10.1038/s41564-018-0147-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-018-0147-1</ArticleId><ArticleId IdType="pmc">PMC6207342</ArticleId><ArticleId IdType="pubmed">29662129</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldelli V, Scaldaferri F, Putignani L, Del Chierico F. The role of enterobacteriaceae in gut microbiota dysbiosis in inflammatory bowel diseases. Microorganisms 9. (2021). doi:&#xa0;10.3390/microorganisms9040697</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9040697</ArticleId><ArticleId IdType="pmc">PMC8066304</ArticleId><ArticleId IdType="pubmed">33801755</ArticleId></ArticleIdList></Reference><Reference><Citation>Scales BS, Dickson RP, Huffnagle GB. A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs. J Leukoc Biol. (2016) 100:943&#x2013;50. doi:&#xa0;10.1189/jlb.3MR0316-106R</Citation><ArticleIdList><ArticleId IdType="doi">10.1189/jlb.3MR0316-106R</ArticleId><ArticleId IdType="pmc">PMC5069096</ArticleId><ArticleId IdType="pubmed">27365534</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Mihaylova I, Leunis JC. Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): indication for the involvement of gram-negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. J Affect Disord. (2007) 99:237&#x2013;40. doi:&#xa0;10.1016/j.jad.2006.08.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2006.08.021</ArticleId><ArticleId IdType="pubmed">17007934</ArticleId></ArticleIdList></Reference><Reference><Citation>Page MJ, Kell DB, Pretorius E. The role of lipopolysaccharide-induced cell signalling in chronic inflammation. Chronic Stress (Thousand Oaks). (2022) 6:24705470221076390. doi:&#xa0;10.1177/24705470221076390</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/24705470221076390</ArticleId><ArticleId IdType="pmc">PMC8829728</ArticleId><ArticleId IdType="pubmed">35155966</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y, Kagan JC. A cross-disciplinary perspective on the innate immune responses to bacterial lipopolysaccharide. Mol Cell. (2014) 54:212&#x2013;23. doi:&#xa0;10.1016/j.molcel.2014.03.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.03.012</ArticleId><ArticleId IdType="pmc">PMC4096783</ArticleId><ArticleId IdType="pubmed">24766885</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#x142;&#xf3;ciennikowska A, Hromada-Judycka A, Borz&#x119;cka K, Kwiatkowska K. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. (2015) 72:557&#x2013;81. doi:&#xa0;10.1007/s00018-014-1762-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00018-014-1762-5</ArticleId><ArticleId IdType="pmc">PMC4293489</ArticleId><ArticleId IdType="pubmed">25332099</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford NJ, Sacino AN, Brooks M, Ceballos-Diaz C, Ladd TB, Howard JK, et al. . Studies of lipopolysaccharide effects on the induction of &#x3b1;-synuclein pathology by exogenous fibrils in transgenic mice. Mol Neurodegener. (2015) 10:32. doi:&#xa0;10.1186/s13024-015-0029-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-015-0029-4</ArticleId><ArticleId IdType="pmc">PMC4520273</ArticleId><ArticleId IdType="pubmed">26223783</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Pretorius E. On the translocation of bacteria and their lipopolysaccharides between blood and peripheral locations in chronic, inflammatory diseases: the central roles of LPS and LPS-induced cell death. Integr Biol (Camb). (2015) 7:1339&#x2013;77. doi:&#xa0;10.1039/c5ib00158g</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c5ib00158g</ArticleId><ArticleId IdType="pubmed">26345428</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Bing G. Lipopolysaccharide animal models for Parkinson&#x2019;s disease. Parkinsons Dis. (2011) 2011:327089. doi:&#xa0;10.4061/2011/327089</Citation><ArticleIdList><ArticleId IdType="doi">10.4061/2011/327089</ArticleId><ArticleId IdType="pmc">PMC3096023</ArticleId><ArticleId IdType="pubmed">21603177</ArticleId></ArticleIdList></Reference><Reference><Citation>Zielen S, Trischler J, Schubert R. Lipopolysaccharide challenge: immunological effects and safety in humans. Expert Rev Clin Immunol. (2015) 11:409&#x2013;18. doi:&#xa0;10.1586/1744666X.2015.1012158</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/1744666X.2015.1012158</ArticleId><ArticleId IdType="pubmed">25655761</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, Jung S, Brackmann F, Richter-Kraus M, Trollmann R. Hypoxia potentiates LPS-mediated cytotoxicity of BV2 microglial cells in vitro by synergistic effects on glial cytokine and nitric oxide system. Neuropediatrics. (2015) 46:321&#x2013;8. doi:&#xa0;10.1055/s-00000041</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/s-00000041</ArticleId><ArticleId IdType="pubmed">26356486</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, et al. . Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol. (1999) 162:3749&#x2013;52. doi:&#xa0;10.4049/jimmunol.162.7.3749</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.162.7.3749</ArticleId><ArticleId IdType="pubmed">10201887</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimoto Y, Shimoyama A, Suda Y, Fukase K. Synthesis and immunomodulatory activities of Helicobacter pylori lipophilic terminus of lipopolysaccharide including lipid A. Carbohydr Res. (2012) 356:37&#x2013;43. doi:&#xa0;10.1016/j.carres.2012.03.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carres.2012.03.013</ArticleId><ArticleId IdType="pubmed">22486825</ArticleId></ArticleIdList></Reference><Reference><Citation>Medzhitov R. Origin and physiological roles of inflammation. Nature. (2008) 454:428&#x2013;35. doi:&#xa0;10.1038/nature07201</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07201</ArticleId><ArticleId IdType="pubmed">18650913</ArticleId></ArticleIdList></Reference><Reference><Citation>Rossol M, Heine H, Meusch U, Quandt D, Klein C, Sweet MJ, et al. . LPS-induced cytokine production in human monocytes and macrophages. Crit Rev Immunol. (2011) 31:379&#x2013;446. doi:&#xa0;10.1615/CritRevImmunol.v31.i5</Citation><ArticleIdList><ArticleId IdType="doi">10.1615/CritRevImmunol.v31.i5</ArticleId><ArticleId IdType="pubmed">22142165</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage CD, Lopez-Castejon G, Denes A, Brough D. NLRP3-inflammasome activating DAMPs stimulate an inflammatory response in glia in the absence of priming which contributes to brain inflammation after injury. Front Immunol. (2012) 3:288. doi:&#xa0;10.3389/fimmu.2012.00288</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2012.00288</ArticleId><ArticleId IdType="pmc">PMC3444764</ArticleId><ArticleId IdType="pubmed">23024646</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Coucke F, Leunis JC. Normalization of the increased translocation of endotoxin from gram negative enterobacteria (leaky gut) is accompanied by a remission of chronic fatigue syndrome. Neuro Endocrinol Lett. (2007) 28:739&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">18063928</ArticleId></ArticleIdList></Reference><Reference><Citation>Paez-Espino D, Eloe-Fadrosh EA, Pavlopoulos GA, Thomas AD, Huntemann M, Mikhailova N, et al. . Uncovering earth&#x2019;s virome. Nature. (2016) 536:425&#x2013;30. doi:&#xa0;10.1038/nature19094</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature19094</ArticleId><ArticleId IdType="pubmed">27533034</ArticleId></ArticleIdList></Reference><Reference><Citation>De Sordi L, Louren&#xe7;o M, Debarbieux L. &#x201c;I will survive&#x201d;: A tale of bacteriophage-bacteria coevolution in the gut. Gut Microbes. (2019) 10:92&#x2013;9. doi:&#xa0;10.1080/19490976.2018.1474322</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2018.1474322</ArticleId><ArticleId IdType="pmc">PMC6363074</ArticleId><ArticleId IdType="pubmed">29913091</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner J, Maksimovic J, Farries G, Sim WH, Bishop RF, Cameron DJ, et al. . Bacteriophages in gut samples from pediatric Crohn&#x2019;s disease patients: metagenomic analysis using 454 pyrosequencing. Inflammation Bowel Dis. (2013) 19:1598&#x2013;608. doi:&#xa0;10.1097/MIB.0b013e318292477c</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MIB.0b013e318292477c</ArticleId><ArticleId IdType="pubmed">23749273</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Brocal V, Garc&#xed;a-L&#xf3;pez R, V&#xe1;zquez-Castellanos JF, Nos P, Beltr&#xe1;n B, Latorre A, et al. . Study of the viral and microbial communities associated with Crohn&#x2019;s disease: a metagenomic approach. Clin Transl Gastroenterol. (2013) 4:e36. doi:&#xa0;10.1038/ctg.2013.9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ctg.2013.9</ArticleId><ArticleId IdType="pmc">PMC3696940</ArticleId><ArticleId IdType="pubmed">23760301</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Jovel J, Halloran B, Wine E, Patterson J, Ford G, et al. . Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria. Inflammation Bowel Dis. (2015) 21:1419&#x2013;27. doi:&#xa0;10.1097/MIB.0000000000000344</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MIB.0000000000000344</ArticleId><ArticleId IdType="pmc">PMC4450971</ArticleId><ArticleId IdType="pubmed">25939040</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Montoya JG, Klimas NG, Levine S, Felsenstein D, Bateman L, et al. . Distinct plasma immune signatures in ME/CFS are present early in the course of illness. Sci Adv 1. (2015). doi:&#xa0;10.1126/sciadv.1400121</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.1400121</ArticleId><ArticleId IdType="pmc">PMC4465185</ArticleId><ArticleId IdType="pubmed">26079000</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, de Barros B, Kingdon CC, Cliff JM, Clark TG, Mudie K, et al. . Evidence of clinical pathology abnormalities in people with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) from an analytic cross-sectional study. Diagnostics (Basel) 9. (2019). doi:&#xa0;10.3390/diagnostics9020041</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9020041</ArticleId><ArticleId IdType="pmc">PMC6627354</ArticleId><ArticleId IdType="pubmed">30974900</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorusso L, Mikhaylova SV, Capelli E, Ferrari D, Ngonga GK, Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun Rev. (2009) 8:287&#x2013;91. doi:&#xa0;10.1016/j.autrev.2008.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2008.08.003</ArticleId><ArticleId IdType="pubmed">18801465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M, Gottschalk G, Peterson DL, Knox KK, Schultz AF, Eddy ML, et al. . Cytokine network analysis of cerebrospinal fluid in myalgic encephalomyelitis/chronic fatigue syndrome. Mol Psychiatry. (2016) 21:261&#x2013;9. doi:&#xa0;10.1038/mp.2015.29</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.29</ArticleId><ArticleId IdType="pubmed">25824300</ArticleId></ArticleIdList></Reference><Reference><Citation>Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. Brain Behav Immun. (2010) 24:1209&#x2013;17. doi:&#xa0;10.1016/j.bbi.2010.04.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2010.04.012</ArticleId><ArticleId IdType="pmc">PMC2939140</ArticleId><ArticleId IdType="pubmed">20447453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuratsune H. [Overview of chronic fatigue syndrome focusing on prevalence and diagnostic criteria]. Nihon Rinsho. (2007) 65:983&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pubmed">17561686</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, et al. . Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci U.S.A. (2017) 114:E7150&#x2013;e7158. doi:&#xa0;10.1073/pnas.1710519114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710519114</ArticleId><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Moudgil KD, Choubey D. Cytokines in autoimmunity: role in induction, regulation, and treatment. J Interferon Cytokine Res. (2011) 31:695&#x2013;703. doi:&#xa0;10.1089/jir.2011.0065</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jir.2011.0065</ArticleId><ArticleId IdType="pmc">PMC3189547</ArticleId><ArticleId IdType="pubmed">21942420</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinney EF, Smith KG. T cell exhaustion and immune-mediated disease-the potential for therapeutic exhaustion. Curr Opin Immunol. (2016) 43:74&#x2013;80. doi:&#xa0;10.1016/j.coi.2016.09.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coi.2016.09.005</ArticleId><ArticleId IdType="pubmed">27744240</ArticleId></ArticleIdList></Reference><Reference><Citation>Sen DR, Kaminski J, Barnitz RA, Kurachi M, Gerdemann U, Yates KB, et al. . The epigenetic landscape of T cell exhaustion. Science. (2016) 354:1165&#x2013;9. doi:&#xa0;10.1126/science.aae0491</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aae0491</ArticleId><ArticleId IdType="pmc">PMC5497589</ArticleId><ArticleId IdType="pubmed">27789799</ArticleId></ArticleIdList></Reference><Reference><Citation>Blundell S, Ray KK, Buckland M, White PD. Chronic fatigue syndrome and circulating cytokines: A systematic review. Brain Behav Immun. (2015) 50:186&#x2013;95. doi:&#xa0;10.1016/j.bbi.2015.07.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.07.004</ArticleId><ArticleId IdType="pubmed">26148446</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarello CA. Biologic basis for interleukin-1 in disease. Blood (1996) 87:2095&#x2013;147.</Citation><ArticleIdList><ArticleId IdType="pubmed">8630372</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarello CA. Anti-inflammatory agents: Present and future. Cell (2010) 140:935&#x2013;50.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3752337</ArticleId><ArticleId IdType="pubmed">20303881</ArticleId></ArticleIdList></Reference><Reference><Citation>Almehed K, d'Elia HF, Bokarewa M, Carlsten H. Role of resistin as a marker of inflammation in systemic lupus erythematosus. Arthritis Res Ther (2008) 10:R15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2374439</ArticleId><ArticleId IdType="pubmed">18234104</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Yang Z. Resistin's, obesity and insulin resistance: the continuing disconnect between rodents and humans. J Endocrinol Invest (2016) 39:607&#x2013;15.</Citation><ArticleIdList><ArticleId IdType="pubmed">26662574</ArticleId></ArticleIdList></Reference><Reference><Citation>Idriss HT, Naismith JH. TNF alpha and the TNF receptor superfamily: structure-function relationship(s). Microsc Res Tech (2000) 50:184&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">10891884</ArticleId></ArticleIdList></Reference><Reference><Citation>Landi A, Broadhurst D, Vernon SD, Tyrrell DL, Houghton M. Reductions in circulating levels of IL-16, IL-7 and VEGF-a in myalgic encephalomyelitis/chronic fatigue syndrome. Cytokine (2016) 78:27&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">26615570</ArticleId></ArticleIdList></Reference><Reference><Citation>Massagu&#xe9; J. TGF&#x3b2; signalling in context. Nat Rev Mol Cell Biol (2012) 13:616&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4027049</ArticleId><ArticleId IdType="pubmed">22992590</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyamoto H, Saura R, Harada T, Doita M, Mizuno K. The role of cyclooxygenase-2 and inflammatory cytokines in pain induction of herniated lumbar intervertebral disc. Kobe J Med Sci (2000) 46:13&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">11193500</ArticleId></ArticleIdList></Reference><Reference><Citation>Procaccini C, Jirillo E, Matarese G. Leptin as an immunomodulator. Mol Aspects Med (2012) 33:35&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">22040697</ArticleId></ArticleIdList></Reference><Reference><Citation>Procaccini C, La Rocca C, Carbone F, De Rosa V, Galgani M, Matarese G. Leptin as immune mediator: Interaction between neuroendocrine and immune system. Dev Comp Immunol (2017) 66:120&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">27288847</ArticleId></ArticleIdList></Reference><Reference><Citation>Simons M, Gordon E, Claesson-Welsh L. Mechanisms and regulation of endothelial VEGF receptor signalling. Nat Rev Mol Cell Biol (2016) 17:611&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">27461391</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol (2014) 6:a016295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4176007</ArticleId><ArticleId IdType="pubmed">25190079</ArticleId></ArticleIdList></Reference><Reference><Citation>Muri J, Kopf M. Redox regulation of immunometabolism. Nat Rev Immunol. (2021) 21:363&#x2013;81. doi:&#xa0;10.1038/s41577-020-00478-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-00478-8</ArticleId><ArticleId IdType="pubmed">33340021</ArticleId></ArticleIdList></Reference><Reference><Citation>Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB. Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal. (2014) 20:1126&#x2013;67. doi:&#xa0;10.1089/ars.2012.5149</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2012.5149</ArticleId><ArticleId IdType="pmc">PMC3929010</ArticleId><ArticleId IdType="pubmed">23991888</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas SK. Does the interdependence between oxidative stress and inflammation explain the antioxidant paradox? Oxid Med Cell Longev. (2016) 2016:5698931. doi:&#xa0;10.1155/2016/5698931</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/5698931</ArticleId><ArticleId IdType="pmc">PMC4736408</ArticleId><ArticleId IdType="pubmed">26881031</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul BD, Lemle MD, Komaroff AL, Snyder SH. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc Natl Acad Sci U.S.A. (2021) 118. doi:&#xa0;10.1073/pnas.2024358118</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J, Nees A, Paul L, De Kooning M, Ickmans K, Meeus M, et al. . Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: a systematic literature review. Exerc Immunol Rev. (2014) 20:94&#x2013;116.</Citation><ArticleIdList><ArticleId IdType="pubmed">24974723</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, et al. . Immunological abnormalities as potential biomarkers in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. J Transl Med. (2011) 9:81. doi:&#xa0;10.1186/1479-5876-9-81</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-9-81</ArticleId><ArticleId IdType="pmc">PMC3120691</ArticleId><ArticleId IdType="pubmed">21619669</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano AH, Maya J, Giloteaux L, Peterson DL, Maynard M, Gottschalk CG, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J Clin Invest. (2020) 130:1491&#x2013;505. doi:&#xa0;10.1172/JCI132185</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI132185</ArticleId><ArticleId IdType="pmc">PMC7269566</ArticleId><ArticleId IdType="pubmed">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes Rivera M, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA. Myalgic encephalomyelitis/chronic fatigue syndrome: A comprehensive review. Diagnostics (Basel). (2019) 9. doi:&#xa0;10.3390/diagnostics9030091</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030091</ArticleId><ArticleId IdType="pmc">PMC6787585</ArticleId><ArticleId IdType="pubmed">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Kell DB, Pretorius E. The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications. Biochem J. (2022) 479:1653&#x2013;708. doi:&#xa0;10.1042/BCJ20220154</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BCJ20220154</ArticleId><ArticleId IdType="pmc">PMC9484810</ArticleId><ArticleId IdType="pubmed">36043493</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Increased plasma peroxides as a marker of oxidative stress in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Med. Sci. Monit. (2011) 17:Sc11&#x2013;5</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3539515</ArticleId><ArticleId IdType="pubmed">21455120</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyle CH, Kader KN. Mechanisms of H2O2-induced oxidative stress in endothelial cells exposed to physiologic shear stress. Asaio J (2007) 53:17&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">17237644</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurup RK, Kurup PA. Hypothalamic digoxin, cerebral chemical dominance and myalgic encephalomyelitis. Int J Neurosci (2003) 113:683&#x2013;701.</Citation><ArticleIdList><ArticleId IdType="pubmed">12745627</ArticleId></ArticleIdList></Reference><Reference><Citation>Indo HP, Yen HC, Nakanishi I, Matsumoto K, Tamura M, Nagano Y, et al. . A mitochondrial superoxide theory for oxidative stress diseases and aging. J Clin Biochem Nutr (2015) 56:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4306659</ArticleId><ArticleId IdType="pubmed">25834301</ArticleId></ArticleIdList></Reference><Reference><Citation>Younus H. Therapeutic potentials of superoxide dismutase. Int J Health Sci (Qassim) (2018) 12:88&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5969776</ArticleId><ArticleId IdType="pubmed">29896077</ArticleId></ArticleIdList></Reference><Reference><Citation>Brkic S, Tomic S, Maric D, Novakov Mikic A, Turkulov V. Lipid peroxidation is elevated in female patients with chronic fatigue syndrome. Med Sci Monit (2010) 16:Cr628&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pubmed">21119582</ArticleId></ArticleIdList></Reference><Reference><Citation>Keenoy BM, Moorkens G, Vertommen J, De Leeuw I. Antioxidant status and lipoprotein peroxidation in chronic fatigue syndrome. Life Sci (2001) 68:2037&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">11388705</ArticleId></ArticleIdList></Reference><Reference><Citation>Vecchiet J, Cipollone F, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T, et al. . Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett (2003) 335:151&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">12531455</ArticleId></ArticleIdList></Reference><Reference><Citation>Gawe&#x142; S, Wardas M, Niedworok E, Wardas P. [Malondialdehyde (MDA) as a lipid peroxidation marker]. Wiad Lek (2004) 57:453&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">15765761</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes Y, Retornaz F. Understanding neuromuscular disorders in chronic fatigue syndrome. F1000Res. (2019) 8. doi:&#xa0;10.12688/f1000research</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research</ArticleId><ArticleId IdType="pmc">PMC6883394</ArticleId><ArticleId IdType="pubmed">31814961</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenouillet E, Vigouroux A, Steinberg JG, Chagvardieff A, Retornaz F, Guieu R, et al. . Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients. J Transl Med (2016) 14:251.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5006431</ArticleId><ArticleId IdType="pubmed">27580693</ArticleId></ArticleIdList></Reference><Reference><Citation>Catal&#xe1;n V, Fr&#xfc;hbeck G, G&#xf3;mez-Ambrosi J. Chapter 8 - inflammatory and oxidative stress markers in skeletal muscle of obese subjects. In: del Moral AM, Aguilera Garc&#xed;a CM, editors. Obesity. Academic Press; (2018).</Citation></Reference><Reference><Citation>Germain A, Ruppert D, Levine SM, Hanson MR. Prospective biomarkers from plasma metabolomics of myalgic encephalomyelitis/chronic fatigue syndrome implicate redox imbalance in disease symptomatology. Metabolites. (2018) 8. doi:&#xa0;10.3390/metabo8040090</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo8040090</ArticleId><ArticleId IdType="pmc">PMC6315598</ArticleId><ArticleId IdType="pubmed">30563204</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiabrando D, Vinchi F, Fiorito V, Mercurio S, Tolosano E. Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes. Front Pharmacol (2014) 5:61.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3986552</ArticleId><ArticleId IdType="pubmed">24782769</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogun AS, Adeyinka A. Biochemistry, transferrin. In: StatPearls. Treasure Island (FL: StatPearls Publishing; (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">30422523</ArticleId></ArticleIdList></Reference><Reference><Citation>Regland B, Andersson M, Abrahamsson L, Bagby J, Dyrehag LE, Gottfries CG. Increased concentrations of homocysteine in the cerebrospinal fluid in patients with fibromyalgia and chronic fatigue syndrome. Scand J Rheumatol (1997) 26:301&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">9310111</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss N. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function. Curr Drug Metab (2005) 6:27&#x2013;36.</Citation><ArticleIdList><ArticleId IdType="pubmed">15720205</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Berk M, Klein H, Walder K, Galecki P, Maes M. Nitrosative stress, hypernitrosylation, and autoimmune responses to nitrosylated proteins: New pathways in neuroprogressive disorders including depression and chronic fatigue syndrome. Mol Neurobiol (2017) 54:4271&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">27339878</ArticleId></ArticleIdList></Reference><Reference><Citation>Pall ML. Levels of nitric oxide synthase product citrulline are elevated in sera of chronic fatigue syndrome patients. J Chronic Fatigue Syndrome (2002) 10:37&#x2013;41.</Citation></Reference><Reference><Citation>Lubos E, Handy DE, Loscalzo J. Role of oxidative stress and nitric oxide in atherothrombosis. Front Biosci (2008) 13:5323&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2617738</ArticleId><ArticleId IdType="pubmed">18508590</ArticleId></ArticleIdList></Reference><Reference><Citation>Poznyak AV, Nikiforov NG, Markin AM, Kashirskikh DA, Myasoedova VA, Gerasimova EV, et al. . Overview of OxLDL and its impact on cardiovascular health: Focus on atherosclerosis. Front Pharmacol (2021) 11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836017</ArticleId><ArticleId IdType="pubmed">33510639</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, Huth TK, Hardcastle SL, Fuller K, Kaur M, Johnston S, et al. . Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis. Int Immunol (2014) 26:233&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">24343819</ArticleId></ArticleIdList></Reference><Reference><Citation>Laforge M, Elbim C, Fr&#xe8;re C, H&#xe9;madi M, Massaad C, Nuss P, et al. . Tissue damage from neutrophil-induced oxidative stress in COVID-19. Nat Rev Immunol (2020) 20:515&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7388427</ArticleId><ArticleId IdType="pubmed">32728221</ArticleId></ArticleIdList></Reference><Reference><Citation>Middleton EA, He XY, Denorme F, Campbell RA, Ng D, Salvatore SP, et al. . Neutrophil extracellular traps contribute to immunothrombosis in COVID-19 acute respiratory distress syndrome. Blood (2020) 136:1169&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7472714</ArticleId><ArticleId IdType="pubmed">32597954</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo Y, Yalavarthi S, Shi H, Gockman K, Zuo M, Madison JA, et al. . Neutrophil extracellular traps in COVID-19. JCI Insight (2020) 5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308057</ArticleId><ArticleId IdType="pubmed">32329756</ArticleId></ArticleIdList></Reference><Reference><Citation>Veenith T, Martin H, Le Breuilly M, Whitehouse T, Gao-Smith F, Duggal N, et al. . High generation of reactive oxygen species from neutrophils in patients with severe COVID-19. Sci Rep (2022) 12:10484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9212205</ArticleId><ArticleId IdType="pubmed">35729319</ArticleId></ArticleIdList></Reference><Reference><Citation>Shungu DC, Weiduschat N, Murrough JW, Mao X, Pillemer S, Dyke JP, et al. . Increased ventricular lactate in chronic fatigue syndrome. III. Relationships to cortical glutathione and clinical symptoms implicate oxidative stress in disorder pathophysiology. NMR BioMed. (2012) 25:1073&#x2013;87. doi:&#xa0;10.1002/nbm.2772</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.2772</ArticleId><ArticleId IdType="pmc">PMC3896084</ArticleId><ArticleId IdType="pubmed">22281935</ArticleId></ArticleIdList></Reference><Reference><Citation>Song J, Kang SM, Lee WT, Park KA, Lee KM, Lee JE. Glutathione protects brain endothelial cells from hydrogen peroxide-induced oxidative stress by increasing nrf2 expression. Exp Neurobiol (2014) 23:93&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3984961</ArticleId><ArticleId IdType="pubmed">24737944</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon DH, Cha HJ, Lee H, Hong SH, Park C, Park SH, et al. . Protective effect of glutathione against oxidative stress-induced cytotoxicity in RAW 264.7 macrophages through activating the nuclear factor erythroid 2-related factor-2/Heme oxygenase-1 pathway. . Antioxidants (Basel) (2019) 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6523540</ArticleId><ArticleId IdType="pubmed">30939721</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G, Khan F, Hill A, Underwood C, Belch JJ. Biochemical and vascular aspects of pediatric chronic fatigue syndrome. Arch Pediatr Adolesc Med (2010) 164:817&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">20819963</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawashima A, Sekizawa A, Koide K, Hasegawa J, Satoh K, Arakaki T, et al. . Vitamin c induces the reduction of oxidative stress and paradoxically stimulates the apoptotic gene expression in extravillous trophoblasts derived from first-trimester tissue. Reprod Sci (2015) 22:783&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565473</ArticleId><ArticleId IdType="pubmed">25519716</ArticleId></ArticleIdList></Reference><Reference><Citation>Miwa K, Fujita M. Fluctuation of serum vitamin e (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome. Heart Vessels (2010) 25:319&#x2013;23.</Citation><ArticleIdList><ArticleId IdType="pubmed">20676841</ArticleId></ArticleIdList></Reference><Reference><Citation>Surai PF. Natural antioxidants in avian nutrition and reproduction. Nottingham University Press Nottingham; (2002).</Citation></Reference><Reference><Citation>Miwa K, Fujita M. Increased oxidative stress suggested by low serum vitamin e concentrations in patients with chronic fatigue syndrome. Int J Cardiol (2009) 136:238&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">18684522</ArticleId></ArticleIdList></Reference><Reference><Citation>Tucker JM, Townsend DM. Alpha-tocopherol: roles in prevention and therapy of human disease. BioMed Pharmacother (2005) 59:380&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6361124</ArticleId><ArticleId IdType="pubmed">16081238</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki T, Miyakoshi H, Usuda Y, Herberman RB. Low NK syndrome and its relationship to chronic fatigue syndrome. Clin Immunol Immunopathol (1993) 69:253&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">8242898</ArticleId></ArticleIdList></Reference><Reference><Citation>Fra A, Yoboue ED, Sitia R. Cysteines as redox molecular switches and targets of disease. Front Mol Neurosci (2017) 10:167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5459893</ArticleId><ArticleId IdType="pubmed">28634440</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E, Ryan M, Edgar C, MacKay A, Vallings R, Tate W. Changes in the transcriptome of circulating immune cells of a New Zealand cohort with myalgic encephalomyelitis/chronic fatigue syndrome. Int J Immunopathol Pharmacol. (2019) 33:2058738418820402. doi:&#xa0;10.1177/2058738418820402</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/2058738418820402</ArticleId><ArticleId IdType="pmc">PMC6350121</ArticleId><ArticleId IdType="pubmed">30791746</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng D, Xu D, Murakoshi N, Tajiri K, Qin R, Yonebayashi S, et al. . Nicotinamide phosphoribosyltransferase (Nampt)/Nicotinamide adenine dinucleotide (NAD) axis suppresses atrial fibrillation by modulating the calcium handling pathway. Int J Mol Sci (2020) 21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7370160</ArticleId><ArticleId IdType="pubmed">32629939</ArticleId></ArticleIdList></Reference><Reference><Citation>Tedeschi PM, Bansal N, Kerrigan JE, Abali EE, Scotto KW, Bertino JR. NAD+ kinase as a therapeutic target in cancer. Clin Cancer Res (2016) 22:5189&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">27582489</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez A, Guillam&#xf3; E, Roig T, Bl&#xe1;zquez A, Alegre J, Berm&#xfa;dez J, et al. . Nitric oxide metabolite production during exercise in chronic fatigue syndrome: a case-control study. J Womens Health (Larchmt). (2010) 19:1073&#x2013;7. doi:&#xa0;10.1089/jwh.2008.1255</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/jwh.2008.1255</ArticleId><ArticleId IdType="pubmed">20469961</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Torres I, Manzano-Pech L, Rubio-Ru&#xed;z ME, Soto ME, Guarner-Lans V. Nitrosative stress and its association with cardiometabolic disorders. Molecules. (2020) 25:2555. doi:&#xa0;10.3390/molecules25112555</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25112555</ArticleId><ArticleId IdType="pmc">PMC7321091</ArticleId><ArticleId IdType="pubmed">32486343</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes Y, Steinberg JG, Olivier M, Brerro-Saby C, Condo J, Ravailhe S, et al. . The mechanisms of the widespread production of phosphorylated HSP25 after fatiguing muscle stimulation. J Exp Biol. (2013) 216:3620&#x2013;6. doi:&#xa0;10.1242/jeb.088898</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jeb.088898</ArticleId><ArticleId IdType="pubmed">23788701</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitham M, Fortes MB. Heat shock protein 72: release and biological significance during exercise. Front Biosci. (2008) 13:1328&#x2013;39. doi:&#xa0;10.2741/2765</Citation><ArticleIdList><ArticleId IdType="doi">10.2741/2765</ArticleId><ArticleId IdType="pubmed">17981633</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble E. Heat shock proteins and their induction with exercise. Exercise and stress response: the role of stress proteins. Barcelona: Boca Raton. (2002), 43&#x2013;78. doi:&#xa0;10.1201/CRCEXEPHYSIO</Citation><ArticleIdList><ArticleId IdType="doi">10.1201/CRCEXEPHYSIO</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes Y, Steinberg JG, Delliaux S, Br&#xe9;geon F. Chronic fatigue syndrome combines increased exercise-induced oxidative stress and reduced cytokine and Hsp responses. J Intern Med. (2009) 266:196&#x2013;206. doi:&#xa0;10.1111/j.1365-2796.2009.02079.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2009.02079.x</ArticleId><ArticleId IdType="pubmed">19457057</ArticleId></ArticleIdList></Reference><Reference><Citation>Jammes Y, Steinberg JG, Delliaux S. Chronic fatigue syndrome: acute infection and history of physical activity affect resting levels and response to exercise of plasma oxidant/antioxidant status and heat shock proteins. J Intern Med. (2012) 272:74&#x2013;84. doi:&#xa0;10.1111/j.1365-2796.2011.02488.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2011.02488.x</ArticleId><ArticleId IdType="pubmed">22112145</ArticleId></ArticleIdList></Reference><Reference><Citation>Gerwyn M, Maes M. Mechanisms explaining muscle fatigue and muscle pain in patients with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a review of recent findings. Curr Rheumatol Rep. (2017) 19:1. doi:&#xa0;10.1007/s11926-017-0628-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-017-0628-x</ArticleId><ArticleId IdType="pubmed">28116577</ArticleId></ArticleIdList></Reference><Reference><Citation>Blauensteiner J, Bertinat R, Le&#xf3;n LE, Riederer M, Sep&#xfa;lveda N, Westermeier F. Altered endothelial dysfunction-related miRs in plasma from ME/CFS patients. Sci Rep. (2021) 11:10604. doi:&#xa0;10.1038/s41598-021-89834-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-89834-9</ArticleId><ArticleId IdType="pmc">PMC8134566</ArticleId><ArticleId IdType="pubmed">34011981</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherbakov N, Szklarski M, Hartwig J, Sotzny F, Lorenz S, Meyer A, et al. . Peripheral endothelial dysfunction in myalgic encephalomyelitis/chronic fatigue syndrome. ESC Heart Fail. (2020) 7:1064&#x2013;71. doi:&#xa0;10.1002/ehf2.12633</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ehf2.12633</ArticleId><ArticleId IdType="pmc">PMC7261521</ArticleId><ArticleId IdType="pubmed">32154656</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton DJ, Kennedy G, Chan KK, Lang CC, Belch JJ, Khan F. Large and small artery endothelial dysfunction in chronic fatigue syndrome. Int J Cardiol. (2012) 154:335&#x2013;6. doi:&#xa0;10.1016/j.ijcard.2011.10.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijcard.2011.10.030</ArticleId><ArticleId IdType="pubmed">22078396</ArticleId></ArticleIdList></Reference><Reference><Citation>Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nat Rev Immunol. (2007) 7:803&#x2013;15. doi:&#xa0;10.1038/nri2171</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2171</ArticleId><ArticleId IdType="pubmed">17893694</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai B, Yang Y, Wang Q, Li M, Tian C, Liu Y, et al. . NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis. (2020) 11:776. doi:&#xa0;10.1038/s41419-020-02985-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-020-02985-x</ArticleId><ArticleId IdType="pmc">PMC7501262</ArticleId><ArticleId IdType="pubmed">32948742</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton J, Okonkwo O, Sutcliffe K, Seth A, Shin J, Jones D. Symptoms of autonomic dysfunction in chronic fatigue syndrome. QJM: Int J Med. (2007) 100:519&#x2013;26. doi:&#xa0;10.1093/qjmed/hcm057</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcm057</ArticleId><ArticleId IdType="pubmed">17617647</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf8;rland K, Sandvik MK, Rekeland IG, Ribu L, Sm&#xe5;stuen MC, Mella O, et al. . Reduced endothelial function in myalgic encephalomyelitis/chronic fatigue syndrome-results from open-label cyclophosphamide intervention study. Front Med (Lausanne). (2021) 8:642710. doi:&#xa0;10.3389/fmed.2021.642710</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.642710</ArticleId><ArticleId IdType="pmc">PMC8019750</ArticleId><ArticleId IdType="pubmed">33829023</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C-A, Bauer S, Ho Y-C, Sotzny F, Chang J-G, Scheibenbogen C. The expression signature of very long non-coding RNA in myalgic encephalomyelitis/chronic fatigue syndrome. J Trans Med. (2018) 16:231. doi:&#xa0;10.1186/s12967-018-1600-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-018-1600-x</ArticleId><ArticleId IdType="pmc">PMC6098652</ArticleId><ArticleId IdType="pubmed">30119681</ArticleId></ArticleIdList></Reference><Reference><Citation>Nunes JM, Kruger A, Proal A, Kell DB, Pretorius E. The occurrence of hyperactivated platelets and fibrinaloid microclots in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Pharm (Basel) 15. (2022). doi:&#xa0;10.21203/rs.3.rs-1727226/v2</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-1727226/v2</ArticleId><ArticleId IdType="pmc">PMC9413879</ArticleId><ArticleId IdType="pubmed">36015078</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L, Koczera P, Zechendorf E, Schuerholz T. The endothelial glycocalyx: new diagnostic and therapeutic approaches in sepsis. BioMed Res Int. (2016) 2016:3758278. doi:&#xa0;10.1155/2016/3758278</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/3758278</ArticleId><ArticleId IdType="pmc">PMC5028820</ArticleId><ArticleId IdType="pubmed">27699168</ArticleId></ArticleIdList></Reference><Reference><Citation>Santulli G. MicroRNAs and endothelial (Dys) function. J Cell Physiol. (2016) 231:1638&#x2013;44. doi:&#xa0;10.1002/jcp.v231.8</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.v231.8</ArticleId><ArticleId IdType="pmc">PMC4871250</ArticleId><ArticleId IdType="pubmed">26627535</ArticleId></ArticleIdList></Reference><Reference><Citation>Kauppinen A, Suuronen T, Ojala J, Kaarniranta K, Salminen A. Antagonistic crosstalk between NF-&#x3ba;B and SIRT1 in the regulation of inflammation and metabolic disorders. Cell Signal. (2013) 25:1939&#x2013;48. doi:&#xa0;10.1016/j.cellsig.2013.06.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cellsig.2013.06.007</ArticleId><ArticleId IdType="pubmed">23770291</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattagajasingh I, Kim CS, Naqvi A, Yamamori T, Hoffman TA, Jung SB, et al. . SIRT1 promotes endothelium-dependent vascular relaxation by activating endothelial nitric oxide synthase. Proc Natl Acad Sci U.S.A. (2007) 104:14855&#x2013;60. doi:&#xa0;10.1073/pnas.0704329104</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0704329104</ArticleId><ArticleId IdType="pmc">PMC1976244</ArticleId><ArticleId IdType="pubmed">17785417</ArticleId></ArticleIdList></Reference><Reference><Citation>Farah C, Michel LYM, Balligand JL. Nitric oxide signalling in cardiovascular health and disease. Nat Rev Cardiol. (2018) 15:292&#x2013;316. doi:&#xa0;10.1038/nrcardio.2017.224</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrcardio.2017.224</ArticleId><ArticleId IdType="pubmed">29388567</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan W, Fang R, Wu X, Liu J, Feng M, Dai G, et al. . Shear-sensitive microRNA-34a modulates flow-dependent regulation of endothelial inflammation. J Cell Sci (2015) 128:70&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pubmed">25395581</ArticleId></ArticleIdList></Reference><Reference><Citation>Gou L, Zhao L, Song W, Wang L, Liu J, Zhang H, et al. . Inhibition of miR-92a suppresses oxidative stress and improves endothelial function by upregulating heme oxygenase-1 in db/db mice. Antioxid Redox Signal (2018) 28:358&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">28683566</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Li P, Gao L, Zhang J, Yang Z, Bledsoe G, et al. . Kallistatin reduces vascular senescence and aging by regulating microRNA-34a-SIRT1 pathway. Aging Cell (2017) 16:837&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5506400</ArticleId><ArticleId IdType="pubmed">28544111</ArticleId></ArticleIdList></Reference><Reference><Citation>Murugaiyan G, da Cunha AP, Ajay AK, Joller N, Garo LP, Kumaradevan S, et al. . MicroRNA-21 promotes Th17 differentiation and mediates experimental autoimmune encephalomyelitis. J Clin Invest (2015) 125:1069&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4362225</ArticleId><ArticleId IdType="pubmed">25642768</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouas R, Fayyad-Kazan H, El Zein N, Lewalle P, Roth&#xe9; F, Simion A, et al. . Human natural treg microRNA signature: role of microRNA-31 and microRNA-21 in FOXP3 expression. Eur J Immunol (2009) 39:1608&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">19408243</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F, Zhou F. Inhibition of microRNA-92a ameliorates lipopolysaccharide-induced endothelial barrier dysfunction by targeting ITGA5 through the PI3K/Akt signaling pathway in human pulmonary microvascular endothelial cells. Int Immunopharmacol (2020) 78:106060.</Citation><ArticleIdList><ArticleId IdType="pubmed">31841757</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang HH, Chen Y, Gao CY, Cui ZT, Yao JM. Protective effects of MicroRNA-126 on human cardiac microvascular endothelial cells against Hypoxia/Reoxygenation-induced injury and inflammatory response by activating PI3K/Akt/eNOS signaling pathway. Cell Physiol Biochem (2017) 42:506&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pubmed">28578351</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Liu J, Qu D, Wang L, Luo JY, Lau CW, et al. . Inhibition of miR-200c restores endothelial function in diabetic mice through suppression of COX-2. Diabetes (2016) 65:1196&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">26822089</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Y, Li P, Bledsoe G, Yang ZR, Chao L, Chao J. Kallistatin inhibits TGF-&#x3b2;-induced endothelial-mesenchymal transition by differential regulation of microRNA-21 and eNOS expression. Exp Cell Res (2015) 337:103&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4560618</ArticleId><ArticleId IdType="pubmed">26156753</ArticleId></ArticleIdList></Reference><Reference><Citation>Hart M, Walch-R&#xfc;ckheim B, Friedmann KS, Rheinheimer S, T&#xe4;nzer T, Glombitza B, et al. . miR-34a: a new player in the regulation of t cell function by modulation of NF-&#x3ba;B signaling. Cell Death Dis (2019) 10:46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6362007</ArticleId><ArticleId IdType="pubmed">30718475</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson MJ, Bahl JS, Buckley JD, Thomson RL, Davison K. Evidence of altered cardiac autonomic regulation in myalgic encephalomyelitis/chronic fatigue syndrome: A systematic review and meta-analysis. Med (Baltimore). (2019) 98:e17600. doi:&#xa0;10.1097/MD.0000000000017600</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000017600</ArticleId><ArticleId IdType="pmc">PMC6824690</ArticleId><ArticleId IdType="pubmed">31651868</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeus M, Goubert D, De Backer F, Struyf F, Hermans L, Coppieters I, et al. . Heart rate variability in patients with fibromyalgia and patients with chronic fatigue syndrome: A systematic review. Semin Arthritis Rheumatism. (2013) 43:279&#x2013;87. doi:&#xa0;10.1016/j.semarthrit.2013.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2013.03.004</ArticleId><ArticleId IdType="pubmed">23838093</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#x142;omko J, Est&#xe9;vez-L&#xf3;pez F, Kujawski S, Zawadka-Kunikowska M, Tafil-Klawe M, Klawe JJ, et al. . Autonomic phenotypes in chronic fatigue syndrome (CFS) are associated with illness severity: A cluster analysis. J Clin Med. (2020) 9. doi:&#xa0;10.3390/jcm9082531</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9082531</ArticleId><ArticleId IdType="pmc">PMC7464864</ArticleId><ArticleId IdType="pubmed">32764516</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Mart&#xed;nez L-A, Mora T, Vargas A, Fuentes-Iniestra M, Mart&#xed;nez-Lav&#xed;n M. Sympathetic nervous system dysfunction in fibromyalgia, chronic fatigue syndrome, irritable bowel syndrome, and interstitial cystitis: a review of case-control studies. JCR: J Clin Rheumatol (2014) 20:146&#x2013;50. doi:&#xa0;10.1097/RHU.0000000000000089</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RHU.0000000000000089</ArticleId><ArticleId IdType="pubmed">24662556</ArticleId></ArticleIdList></Reference><Reference><Citation>Orjatsalo M, Alakuijala A, Partinen M. Autonomic nervous system functioning related to nocturnal sleep in patients with chronic fatigue syndrome compared to tired controls. J Clin Sleep Med (2018) 14:163&#x2013;71. doi:&#xa0;10.5664/jcsm.6924</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.6924</ArticleId><ArticleId IdType="pmc">PMC5786834</ArticleId><ArticleId IdType="pubmed">29246267</ArticleId></ArticleIdList></Reference><Reference><Citation>Sisto SA, Tapp W, Drastal S, Bergen M, DeMasi I, Cordero D, et al. . Vagal tone is reduced during paced breathing in patients with the chronic fatigue syndrome. Clin Autonomic Res. (1995) 5:139&#x2013;43. doi:&#xa0;10.1007/BF01826195</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01826195</ArticleId><ArticleId IdType="pubmed">7549414</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones DEJ, Hollingsworth KG, Taylor R, Blamire AM, Newton JL. Abnormalities in pH handling by peripheral muscle and potential regulation by the autonomic nervous system in chronic fatigue syndrome. J Internal Med. (2010) 267:394&#x2013;401. doi:&#xa0;10.1111/j.1365-2796.2009.02160.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2009.02160.x</ArticleId><ArticleId IdType="pubmed">20433583</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart JM. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterised by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res. (2000) 48:218&#x2013;26. doi:&#xa0;10.1203/00006450-200008000-00016</Citation><ArticleIdList><ArticleId IdType="doi">10.1203/00006450-200008000-00016</ArticleId><ArticleId IdType="pubmed">10926298</ArticleId></ArticleIdList></Reference><Reference><Citation>Beaumont A, Burton AR, Lemon J, Bennett BK, Lloyd A, Vollmer-Conna U. Reduced cardiac vagal modulation impacts on cognitive performance in chronic fatigue syndrome. PloS One. (2012) 7:e49518. doi:&#xa0;10.1371/journal.pone.0049518</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049518</ArticleId><ArticleId IdType="pmc">PMC3498107</ArticleId><ArticleId IdType="pubmed">23166694</ArticleId></ArticleIdList></Reference><Reference><Citation>Wyller VB, Saul JP, Wall&#xf8;e L, Thaulow E. Sympathetic cardiovascular control during orthostatic stress and isometric exercise in adolescent chronic fatigue syndrome. Eur J Appl Physiol. (2008) 102:623&#x2013;32. doi:&#xa0;10.1007/s00421-007-0634-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00421-007-0634-1</ArticleId><ArticleId IdType="pubmed">18066580</ArticleId></ArticleIdList></Reference><Reference><Citation>De Becker P, Dendale P, De Meirleir K, Campine I, Vandenborne K, Hagers Y. Autonomic testing in patients with chronic fatigue syndrome. Am J Med. (1998) 105:22S&#x2013;6S. doi:&#xa0;10.1016/S0002-9343(98)00168-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(98)00168-5</ArticleId><ArticleId IdType="pubmed">9790478</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimes KA, Lievesley K, Chalder T. Stress vulnerability in adolescents with chronic fatigue syndrome: experimental study investigating heart rate variability and skin conductance responses. J Child Psychol Psychiatry. (2017) 58:851&#x2013;8. doi:&#xa0;10.1111/jcpp.12711</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcpp.12711</ArticleId><ArticleId IdType="pubmed">28276066</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Cauwenbergh D, Nijs J, Kos D, Van Weijnen L, Struyf F, Meeus M. Malfunctioning of the autonomic nervous system in patients with chronic fatigue syndrome: a systematic literature review. Eur J Clin Invest. (2014) 44:516&#x2013;26. doi:&#xa0;10.1111/eci.12256</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.12256</ArticleId><ArticleId IdType="pubmed">24601948</ArticleId></ArticleIdList></Reference><Reference><Citation>Frith J, Zalewski P, Klawe JJ, Pairman J, Bitner A, Tafil-Klawe M, et al. . Impaired blood pressure variability in chronic fatigue syndrome&#x2014;a potential biomarker. QJM: Int J Med. (2012) 105:831&#x2013;8. doi:&#xa0;10.1093/qjmed/hcs085</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcs085</ArticleId><ArticleId IdType="pubmed">22670061</ArticleId></ArticleIdList></Reference><Reference><Citation>Burton AR, Rahman K, Kadota Y, Lloyd A, Vollmer-Conna U. Reduced heart rate variability predicts poor sleep quality in a case&#x2013;control study of chronic fatigue syndrome. Exp Brain Res. (2010) 204:71&#x2013;8. doi:&#xa0;10.1007/s00221-010-2296-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-010-2296-1</ArticleId><ArticleId IdType="pubmed">20502886</ArticleId></ArticleIdList></Reference><Reference><Citation>Yataco A, Talo H, Rowe P, Kass DA, Berger RD, Calkins H. Comparison of heart rate variability in patients with chronic fatigue syndrome and controls. Clin Autonomic Res. (1997) 7:293&#x2013;7. doi:&#xa0;10.1007/BF02267720</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF02267720</ArticleId><ArticleId IdType="pubmed">9430800</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaur J, Krishnan AC, Senador D, Alvarez A, Hanna HW, O&#x2019;Leary DS. Altered arterial baroreflex-muscle metaboreflex interaction in heart failure. Am J Physiol Heart Circ Physiol (2018). doi:&#xa0;10.1152/ajpheart.00338.2018</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpheart.00338.2018</ArticleId><ArticleId IdType="pmc">PMC6297818</ArticleId><ArticleId IdType="pubmed">30074841</ArticleId></ArticleIdList></Reference><Reference><Citation>Ylikorkala O, Dawood MY. New concepts in dysmenorrhea. Am J Obstetrics Gynecology. (1978) 130:833&#x2013;47. doi:&#xa0;10.1016/0002-9378(78)90019-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0002-9378(78)90019-4</ArticleId><ArticleId IdType="pubmed">25021</ArticleId></ArticleIdList></Reference><Reference><Citation>Mullins RJ, Malias MA, Hudgens RW. Isoproterenol inhibits the increase in microvascular membrane permeability produced by bradykinin. J Trauma. (1989) 29:1053&#x2013;63. doi:&#xa0;10.1097/00005373-198908000-00002</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005373-198908000-00002</ArticleId><ArticleId IdType="pubmed">2760947</ArticleId></ArticleIdList></Reference><Reference><Citation>Szab&#xf3; G, Magyar Z. Effect of histamine and bradykinin on lymph and tissue fluid composition in the rabbit hindlimb: evidence for two compartments in tissue fluid. Acta Physiol Acad Sci Hung. (1982) 59:15&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pubmed">7180507</ArticleId></ArticleIdList></Reference><Reference><Citation>Berg D, Berg LH, Couvaras J, Harrison H. Chronic fatigue syndrome and/or fibromyalgia as a variation of antiphospholipid antibody syndrome: an explanatory model and approach to laboratory diagnosis. Blood Coagul Fibrinolysis. (1999) 10:435&#x2013;8. doi:&#xa0;10.1097/00001721-199910000-00006</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001721-199910000-00006</ArticleId><ArticleId IdType="pubmed">10695770</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannan KL, Berg DE, Baumzweiger W, Harrison HH, Berg LH, Ramirez R, et al. . Activation of the coagulation system in Gulf War Illness: a potential pathophysiologic link with chronic fatigue syndrome. A Lab approach to diagnosis. Blood Coagul Fibrinolysis (2000) 11:673&#x2013;8. doi:&#xa0;10.1097/00001721-200010000-00013</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001721-200010000-00013</ArticleId><ArticleId IdType="pubmed">11085289</ArticleId></ArticleIdList></Reference><Reference><Citation>Brewer JH, Berg D. Hypercoaguable state associated with active human herpesvirus-6 (HHV-6) viremia in patients with chronic fatigue syndrome. J Chronic Fatigue Syndrome. (2001) 8:111&#x2013;6. doi:&#xa0;10.1300/J092v08n03_10</Citation><ArticleIdList><ArticleId IdType="doi">10.1300/J092v08n03_10</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy G, Norris G, Spence V, McLaren M, Belch JJ. Is chronic fatigue syndrome associated with platelet activation? Blood Coagul Fibrinolysis (2006) 17:89&#x2013;92. doi:&#xa0;10.1097/01.mbc.0000214705.80997.73</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.mbc.0000214705.80997.73</ArticleId><ArticleId IdType="pubmed">16479189</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E, Mbotwe S, Bester J, Robinson CJ, Kell DB. Acute induction of anomalous and amyloidogenic blood clotting by molecular amplification of highlysubstoichiometric levels of bacterial lipopolysaccharide. J R Soc Interface (2016) 13. doi:&#xa0;10.1101/053538</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/053538</ArticleId><ArticleId IdType="pmc">PMC5046953</ArticleId><ArticleId IdType="pubmed">27605168</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson BH, Weaver SA, Tseng CL, Ottenweller JE. Spinal fluid abnormalities in patients with chronic fatigue syndrome. Clin Diagn Lab Immunol (2005) 12:52&#x2013;5. doi:&#xa0;10.1128/CDLI.12.1.52-55.2005</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CDLI.12.1.52-55.2005</ArticleId><ArticleId IdType="pmc">PMC540195</ArticleId><ArticleId IdType="pubmed">15642984</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfera A, Osorio C, Zapata Mart&#xed;n Del Campo CM, Pereida S, Maurer S, Maldonado JC, et al. . Endothelial senescence and chronic fatigue syndrome, a COVID-19 based hypothesis. Front Cell Neurosci (2021) 15:673217. doi:&#xa0;10.3389/fncel.2021.673217</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.673217</ArticleId><ArticleId IdType="pmc">PMC8267916</ArticleId><ArticleId IdType="pubmed">34248502</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa DC, Tannock C, Brostoff J. Brainstem perfusion is impaired in chronic fatigue syndrome. Qjm. (1995) 88:767&#x2013;73.</Citation><ArticleIdList><ArticleId IdType="pubmed">8542261</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli U, Chierichetti F, Tavio M, Simonelli C, Bianchin G, Zanco P, et al. . Brain positron emission tomography (PET) in chronic fatigue syndrome: preliminary data. Am J Med (1998) 105. doi:&#xa0;10.1016/S0002-9343(98)00179-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9343(98)00179-X</ArticleId><ArticleId IdType="pubmed">9790483</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuratsune H, Yamaguti K, Lindh G, Eveng&#xe5;rd B, Hagberg G, Matsumura K, et al. . Brain regions involved in fatigue sensation: reduced acetylcarnitine uptake into the brain. Neuroimage. (2002) 17:1256&#x2013;65. doi:&#xa0;10.1006/nimg.2002.1260</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/nimg.2002.1260</ArticleId><ArticleId IdType="pubmed">12414265</ArticleId></ArticleIdList></Reference><Reference><Citation>Wirth KJ, Scheibenbogen C. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). J Transl Med (2021) 19:162. doi:&#xa0;10.1186/s12967-021-02833-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-021-02833-2</ArticleId><ArticleId IdType="pmc">PMC8058748</ArticleId><ArticleId IdType="pubmed">33882940</ArticleId></ArticleIdList></Reference><Reference><Citation>van Campen C, Verheugt FWA, Rowe PC, Visser FC. Cerebral blood flow is reduced in ME/CFS during head-up tilt testing even in the absence of hypotension or tachycardia: A quantitative, controlled study using Doppler echography. Clin Neurophysiol Pract (2020) 5:50&#x2013;8. doi:&#xa0;10.1016/j.cnp.2020.01.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cnp.2020.01.003</ArticleId><ArticleId IdType="pmc">PMC7044650</ArticleId><ArticleId IdType="pubmed">32140630</ArticleId></ArticleIdList></Reference><Reference><Citation>Brag&#xe9;e B, Michos A, Drum B, Fahlgren M, Szulkin R, Bertilson BC. Signs of intracranial hypertension, hypermobility, and craniocervical obstructions in patients with myalgic encephalomyelitis/chronic fatigue syndrome. Front Neurol (2020) 11:828. doi:&#xa0;10.3389/fneur.2020.00828</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.00828</ArticleId><ArticleId IdType="pmc">PMC7485557</ArticleId><ArticleId IdType="pubmed">32982905</ArticleId></ArticleIdList></Reference><Reference><Citation>Hulens M, Rasschaert R, Vansant G, Stalmans I, Bruyninckx F, Dankaerts W. The link between idiopathic intracranial hypertension, fibromyalgia, and chronic fatigue syndrome: exploration of a shared pathophysiology. J Pain Res (2018) 11:3129&#x2013;40. doi:&#xa0;10.2147/JPR</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR</ArticleId><ArticleId IdType="pmc">PMC6292399</ArticleId><ArticleId IdType="pubmed">30573989</ArticleId></ArticleIdList></Reference><Reference><Citation>Tohidpour A, Morgun AV, Boitsova EB, Malinovskaya NA, Martynova GP, Khilazheva ED, et al. . Neuroinflammation and infection: molecular mechanisms associated with dysfunction of neurovascular unit. Front Cell Infect Microbiol (2017) 7:276. doi:&#xa0;10.1146/annurev.nutr.26.061505.111258</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.nutr.26.061505.111258</ArticleId><ArticleId IdType="pmc">PMC5476750</ArticleId><ArticleId IdType="pubmed">28676848</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. (2017) 542:177&#x2013;85. doi:&#xa0;10.1038/nature21363</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21363</ArticleId><ArticleId IdType="pubmed">28179656</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahill GF, Jr.. Fuel metabolism in starvation. Annu Rev Nutr (2006) 26:1&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pubmed">16848698</ArticleId></ArticleIdList></Reference><Reference><Citation>van Hall G. The physiological regulation of skeletal muscle fatty acid supply and oxidation during moderate-intensity exercise. Sports Med (2015) 45 Suppl 1:S23&#x2013;32. doi:&#xa0;10.1007/s40279-015-0394-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40279-015-0394-8</ArticleId><ArticleId IdType="pmc">PMC4672010</ArticleId><ArticleId IdType="pubmed">26553490</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagenmakers AJ. Muscle amino acid metabolism at rest and during exercise: role in human physiology and metabolism. Exerc Sport Sci Rev (1998) 26:287&#x2013;314. doi:&#xa0;10.1249/00003677-199800260-00013</Citation><ArticleIdList><ArticleId IdType="doi">10.1249/00003677-199800260-00013</ArticleId><ArticleId IdType="pubmed">9696993</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhill S, Booth NE, McLaren-Howard J. Chronic fatigue syndrome and mitochondrial dysfunction. Int J Clin Exp Med (2009) 2:1&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680051</ArticleId><ArticleId IdType="pubmed">19436827</ArticleId></ArticleIdList></Reference><Reference><Citation>Holden S, Maksoud R, Eaton-Fitch N, Cabanas H, Staines D, Marshall-Gradisnik S. A systematic review of mitochondrial abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome/systemic exertion intolerance disease. J Transl Med (2020) 18:290. doi:&#xa0;10.1186/s12967-020-02452-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02452-3</ArticleId><ArticleId IdType="pmc">PMC7392668</ArticleId><ArticleId IdType="pubmed">32727475</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth NE, Myhill S, McLaren-Howard J. Mitochondrial dysfunction and the pathophysiology of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). Int J Clin Exp Med (2012) 5:208&#x2013;20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3403556</ArticleId><ArticleId IdType="pubmed">22837795</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Cordero MD, S&#xe1;ez-Francas N, Jimenez-Gutierrez C, Aguilar- Montilla FJ, Aliste L, et al. . Could mitochondrial dysfunction be a differentiating marker between chronic fatigue syndrome and fibromyalgia? Antioxid Redox Signal (2013) 19:1855&#x2013;60. doi:&#xa0;10.1089/ars.2013.5346</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2013.5346</ArticleId><ArticleId IdType="pubmed">23600892</ArticleId></ArticleIdList></Reference><Reference><Citation>Myhill S, Booth NE, McLaren-Howard J. Targeting mitochondrial dysfunction in the treatment of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-a clinical audit. Int J Clin Exp Med (2013) 6:1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3515971</ArticleId><ArticleId IdType="pubmed">23236553</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Maes M. Mitochondrial dysfunctions in myalgic encephalomyelitis/ chronic fatigue syndrome explained by activated immuno-inflammatory, oxidative and nitrosative stress pathways. Metab Brain Dis (2014) 29:19&#x2013;36. doi:&#xa0;10.1007/s11011-013-9435-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-013-9435-x</ArticleId><ArticleId IdType="pubmed">24557875</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Annesley SJ, Fisher PR. Pathological mechanisms underlying myalgic encephalomyelitis/chronic fatigue syndrome. Diagnostics (Basel). (2019) 9. doi:&#xa0;10.20944/preprints201907.0196.v1</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints201907.0196.v1</ArticleId><ArticleId IdType="pmc">PMC6787592</ArticleId><ArticleId IdType="pubmed">31330791</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Twisk FNM, Ringel K. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression. Psychother Psychosomatics. (2012) 81:286&#x2013;95. doi:&#xa0;10.1159/000336803</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000336803</ArticleId><ArticleId IdType="pubmed">22832503</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadatomi D, Nakashioya K, Mamiya S, Honda S, Kameyama Y, Yamamura Y, et al. . Mitochondrial function is required for extracellular ATP-induced NLRP3= inflammasome activation. J Biochem (2017) 161:503&#x2013;12. doi:&#xa0;10.1093/jb/mvw098</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jb/mvw098</ArticleId><ArticleId IdType="pubmed">28096454</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills EL, Kelly B, O&#x2019;Neill LAJ. Mitochondria are the powerhouses of immunity. Nat Immunol (2017) 18:488&#x2013;98. doi:&#xa0;10.1038/ni.3704</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3704</ArticleId><ArticleId IdType="pubmed">28418387</ArticleId></ArticleIdList></Reference><Reference><Citation>Breda CNS, Davanzo GG, Basso PJ, Saraiva C&#xe2;mara NO, Moraes-Vieira PMM. Mitochondria as central hub of the immune system. Redox Biol (2019) 26:101255. doi:&#xa0;10.1016/j.redox.2019.101255</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.redox.2019.101255</ArticleId><ArticleId IdType="pmc">PMC6598836</ArticleId><ArticleId IdType="pubmed">31247505</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinberg SE, Sena LA, Chandel NS. Mitochondria in the regulation of innate and adaptive immunity. Immunity. (2015) 42:406&#x2013;17. doi:&#xa0;10.1016/j.immuni.2015.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2015.02.002</ArticleId><ArticleId IdType="pmc">PMC4365295</ArticleId><ArticleId IdType="pubmed">25786173</ArticleId></ArticleIdList></Reference><Reference><Citation>Murphy MP. How mitochondria produce reactive oxygen species. Biochem J (2009) 417:1&#x2013;13. doi:&#xa0;10.1042/BJ20081386</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20081386</ArticleId><ArticleId IdType="pmc">PMC2605959</ArticleId><ArticleId IdType="pubmed">19061483</ArticleId></ArticleIdList></Reference><Reference><Citation>Abate G, Vezzoli M, Sandri M, Rungratanawanich W, Memo M, Uberti D. Mitochondria and cellular redox state on the route from ageing to Alzheimer&#x2019;s disease. Mech Ageing Dev (2020) 192:111385. doi:&#xa0;10.1016/j.mad.2020.111385</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mad.2020.111385</ArticleId><ArticleId IdType="pubmed">33129798</ArticleId></ArticleIdList></Reference><Reference><Citation>Behan WM, More IA, Behan PO. Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol. (1991) 83:61&#x2013;5. doi:&#xa0;10.1007/BF00294431</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00294431</ArticleId><ArticleId IdType="pubmed">1792865</ArticleId></ArticleIdList></Reference><Reference><Citation>Plioplys AV, Plioplys S. Electron-microscopic investigation of muscle mitochondria in chronic fatigue syndrome. Neuropsychobiology. (1995) 32:175&#x2013;81. doi:&#xa0;10.1159/000119233</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000119233</ArticleId><ArticleId IdType="pubmed">8587699</ArticleId></ArticleIdList></Reference><Reference><Citation>Lawson N, Hsieh CH, March D, Wang X. Elevated energy production in chronic fatigue syndrome patients. J Nat Sci. (2016) 2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5065105</ArticleId><ArticleId IdType="pubmed">27747291</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Brown A, Strassheim V, Elson JL, Newton J, Manning P. Cellular bioenergetics is impaired in patients with chronic fatigue syndrome. PloS One. (2017) 12:e0186802. doi:&#xa0;10.1371/journal.pone.0186802</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0186802</ArticleId><ArticleId IdType="pmc">PMC5655451</ArticleId><ArticleId IdType="pubmed">29065167</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Annesley SJ, Allan CY, Sanislav O, Lidbury BA, Lewis DP, et al. . An isolated complex V inefficiency and dysregulated mitochondrial function in immortalised lymphocytes from ME/CFS patients. Int J Mol Sci 21. (2020). doi:&#xa0;10.20944/preprints201909.0043.v2</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints201909.0043.v2</ArticleId><ArticleId IdType="pmc">PMC7036826</ArticleId><ArticleId IdType="pubmed">32041178</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweetman E, Kleffmann T, Edgar C, de Lange M, Vallings R, Tate W. A SWATH-MS analysis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome peripheral blood mononuclear cell proteomes reveals mitochondrial dysfunction. J Transl Med. (2020) 18:365. doi:&#xa0;10.1186/s12967-020-02533-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02533-3</ArticleId><ArticleId IdType="pmc">PMC7512220</ArticleId><ArticleId IdType="pubmed">32972442</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Elson JL, Strassheim V, Newton JL, Walker M. The effect of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) severity on cellular bioenergetic function. PloS One. (2020) 15:e0231136. doi:&#xa0;10.1371/journal.pone.0231136</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0231136</ArticleId><ArticleId IdType="pmc">PMC7147788</ArticleId><ArticleId IdType="pubmed">32275686</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen T, Staines D, Johnston S, Marshall-Gradisnik S. Reduced glycolytic reserve in isolated natural killer cells from Myalgic encephalomyelitis/chronic fatigue syndrome patients: A preliminary investigation. Asian Pac J Allergy Immunol. (2019) 37:102&#x2013;8. doi:&#xa0;10.12932/AP-011117-0188. PMID: 29981562</Citation><ArticleIdList><ArticleId IdType="doi">10.12932/AP-011117-0188</ArticleId><ArticleId IdType="pubmed">29981562</ArticleId></ArticleIdList></Reference><Reference><Citation>Rutherford G, Manning P, Newton JL. Understanding muscle dysfunction in chronic fatigue syndrome. J Aging Res. (2016) 2016:2497348. doi:&#xa0;10.1155/2016/2497348</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/2497348</ArticleId><ArticleId IdType="pmc">PMC4779819</ArticleId><ArticleId IdType="pubmed">26998359</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Twisk FN. Why myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) may kill you: disorders in the inflammatory and oxidative and nitrosative stress (IO&amp;NS) pathways may explain cardiovascular disorders in ME/CFS. Neuro Endocrinol Lett. (2009) 30:677&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">20038921</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartee L, Anderson C. Mt Hood Community College Biology 101: An overview of cellular respiration, Open Oregon Educational Resources. (2016).</Citation></Reference><Reference><Citation>van Campen CLM, Rowe PC, Visser FC. Two-day cardiopulmonary exercise testing in females with a severe grade of myalgic encephalomyelitis/chronic fatigue syndrome: comparison with patients with mild and moderate disease. Healthcare (Basel) 8. (2020). doi:&#xa0;10.3390/healthcare8030192</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare8030192</ArticleId><ArticleId IdType="pmc">PMC7551790</ArticleId><ArticleId IdType="pubmed">32629923</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens S, Snell C, Stevens J, Keller B, VanNess JM. Cardiopulmonary exercise test methodology for assessing exertion intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. (2018) 6:242. doi:&#xa0;10.3389/fped.2018.00242</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2018.00242</ArticleId><ArticleId IdType="pmc">PMC6131594</ArticleId><ArticleId IdType="pubmed">30234078</ArticleId></ArticleIdList></Reference><Reference><Citation>Murrough JW, Mao X, Collins KA, Kelly C, Andrade G, Nestadt P, et al. . Increased ventricular lactate in chronic fatigue syndrome measured by 1H MRS imaging at 3.0 T. II: comparison with major depressive disorder. NMR BioMed. (2010) 23:643&#x2013;50. doi:&#xa0;10.1002/nbm.1512</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1512</ArticleId><ArticleId IdType="pubmed">20661876</ArticleId></ArticleIdList></Reference><Reference><Citation>Mathew SJ, Mao X, Keegan KA, Levine SM, Smith EL, Heier LA, et al. . Ventricular cerebrospinal fluid lactate is increased in chronic fatigue syndrome compared with generalised anxiety disorder: an in vivo 3. 0 T (1)H MRS Imaging study. NMR BioMed. (2009) 22:251&#x2013;8. doi:&#xa0;10.1002/nbm.1315</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/nbm.1315</ArticleId><ArticleId IdType="pubmed">18942064</ArticleId></ArticleIdList></Reference><Reference><Citation>Lien K, Johansen B, Veier&#xf8;d MB, Haslestad AS, B&#xf8;hn SK, Melsom MN, et al. . Abnormal blood lactate accumulation during repeated exercise testing in myalgic encephalomyelitis/chronic fatigue syndrome. Physiol Rep. (2019) 7:e14138. doi:&#xa0;10.14814/phy2.14138</Citation><ArticleIdList><ArticleId IdType="doi">10.14814/phy2.14138</ArticleId><ArticleId IdType="pmc">PMC6546966</ArticleId><ArticleId IdType="pubmed">31161646</ArticleId></ArticleIdList></Reference><Reference><Citation>Snell CR, Stevens SR, Davenport TE, Van Ness JM. Discriminative validity of metabolic and workload measurements for identifying people with chronic fatigue syndrome. Phys Ther. (2013) 93:1484&#x2013;92. doi:&#xa0;10.2522/ptj.20110368</Citation><ArticleIdList><ArticleId IdType="doi">10.2522/ptj.20110368</ArticleId><ArticleId IdType="pubmed">23813081</ArticleId></ArticleIdList></Reference><Reference><Citation>Vermeulen RC, Vermeulen van Eck IW. Decreased oxygen extraction during cardiopulmonary exercise test in patients with chronic fatigue syndrome. J Transl Med. (2014) 12:20. doi:&#xa0;10.1186/1479-5876-12-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-12-20</ArticleId><ArticleId IdType="pmc">PMC3903040</ArticleId><ArticleId IdType="pubmed">24456560</ArticleId></ArticleIdList></Reference><Reference><Citation>Fegan KG, Behan PO, Bell EJ. Myalgic encephalomyelitis&#x2013;report of an epidemic. J R Coll Gen Pract. (1983) 33:335&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1972867</ArticleId><ArticleId IdType="pubmed">6310104</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Newton J. Metabolic abnormalities in chronic fatigue syndrome/myalgic encephalomyelitis: a mini-review. Biochem Soc Trans. (2018) 46:547&#x2013;53. doi:&#xa0;10.1042/BST20170503</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BST20170503</ArticleId><ArticleId IdType="pubmed">29666214</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones DE, Hollingsworth KG, Jakovljevic DG, Fattakhova G, Pairman J, Blamire AM, et al. . Loss of capacity to recover from acidosis on repeat exercise in chronic fatigue syndrome: a case-control study. Eur J Clin Invest. (2012) 42:186&#x2013;94. doi:&#xa0;10.1111/j.1365-2362.2011.02567.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2362.2011.02567.x</ArticleId><ArticleId IdType="pubmed">21749371</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaudhuri A, Behan PO. In vivo magnetic resonance spectroscopy in chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids. (2004) 71:181&#x2013;3. doi:&#xa0;10.1016/j.plefa.2004.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plefa.2004.03.009</ArticleId><ArticleId IdType="pubmed">15253888</ArticleId></ArticleIdList></Reference><Reference><Citation>Lengert N, Drossel B. In silico analysis of exercise intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Biophys Chem. (2015) 202:21&#x2013;31. doi:&#xa0;10.1016/j.bpc.2015.03.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2015.03.009</ArticleId><ArticleId IdType="pubmed">25899994</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A, Barupal DK, Levine SM, Hanson MR. Comprehensive circulatory metabolomics in ME/CFS reveals disrupted metabolism of acyl lipids and steroids. Metabolites. (2020) 10. doi:&#xa0;10.3390/metabo10010034</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo10010034</ArticleId><ArticleId IdType="pmc">PMC7023305</ArticleId><ArticleId IdType="pubmed">31947545</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D, Barupal DK, Lee B, Che X, Williams BL, Kahn EJR, et al. . Insights into myalgic encephalomyelitis/chronic fatigue syndrome phenotypes through comprehensive metabolomics. Sci Rep. (2018) 8:10056. doi:&#xa0;10.1038/s41598-018-28477-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28477-9</ArticleId><ArticleId IdType="pmc">PMC6030047</ArticleId><ArticleId IdType="pubmed">29968805</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, et al. . Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci U.S.A. (2016) 113:E5472&#x2013;80. doi:&#xa0;10.1073/pnas.1607571113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607571113</ArticleId><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamano E, Sugimoto M, Hirayama A, Kume S, Yamato M, Jin G, et al. . Index markers of chronic fatigue syndrome with dysfunction of TCA and urea cycles. Sci Rep. (2016) 6:34990. doi:&#xa0;10.1038/srep34990</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep34990</ArticleId><ArticleId IdType="pmc">PMC5057083</ArticleId><ArticleId IdType="pubmed">27725700</ArticleId></ArticleIdList></Reference><Reference><Citation>Niblett SH, King KE, Dunstan RH, Clifton-Bligh P, Hoskin LA, Roberts TK, et al. . Hematologic and urinary excretion anomalies in patients with chronic fatigue syndrome. Exp Biol Med (Maywood). (2007) 232:1041&#x2013;9. doi:&#xa0;10.3181/0702-RM-44</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/0702-RM-44</ArticleId><ArticleId IdType="pubmed">17720950</ArticleId></ArticleIdList></Reference><Reference><Citation>Maloney EM, Boneva RS, Lin JM, Reeves WC. Chronic fatigue syndrome is associated with metabolic syndrome: results from a case-control study in Georgia. Metabolism. (2010) 59:1351&#x2013;7. doi:&#xa0;10.1016/j.metabol.2009.12.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.metabol.2009.12.019</ArticleId><ArticleId IdType="pubmed">20102774</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitami T, Fukuda S, Kato T, Yamaguti K, Nakatomi Y, Yamano E, et al. . Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population. Sci Rep. (2020) 10:19933. doi:&#xa0;10.1038/s41598-020-77105-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-77105-y</ArticleId><ArticleId IdType="pmc">PMC7669873</ArticleId><ArticleId IdType="pubmed">33199820</ArticleId></ArticleIdList></Reference><Reference><Citation>Reuter SE, Evans AM. Long-chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase-I activity. J Internal Med. (2011) 270:76&#x2013;84. doi:&#xa0;10.1111/j.1365-2796.2010.02341.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2796.2010.02341.x</ArticleId><ArticleId IdType="pubmed">21205027</ArticleId></ArticleIdList></Reference><Reference><Citation>Huth TK, Eaton-Fitch N, Staines D, Marshall-Gradisnik S. A systematic review of metabolomic dysregulation in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis/Systemic Exertion Intolerance Disease (CFS/ME/SEID). J Transl Med. (2020) 18:198. doi:&#xa0;10.1186/s12967-020-02356-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02356-2</ArticleId><ArticleId IdType="pmc">PMC7222338</ArticleId><ArticleId IdType="pubmed">32404171</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux RK. Incomplete healing as a cause of aging: the role of mitochondria and the cell danger response. Biol (Basel). (2019) 8. doi:&#xa0;10.3390/biology8020027</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology8020027</ArticleId><ArticleId IdType="pmc">PMC6627909</ArticleId><ArticleId IdType="pubmed">31083530</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux RK. Perspective: Cell danger response Biology-The new science that connects environmental health with mitochondria and the rising tide of chronic illness. Mitochondrion. (2020) 51:40&#x2013;5. doi:&#xa0;10.1016/j.mito.2019.12.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2019.12.005</ArticleId><ArticleId IdType="pubmed">31877376</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux RK. Metabolic features of the cell danger response. Mitochondrion. (2014) 16:7&#x2013;17. doi:&#xa0;10.1016/j.mito.2013.08.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2013.08.006</ArticleId><ArticleId IdType="pubmed">23981537</ArticleId></ArticleIdList></Reference><Reference><Citation>Costa-Mattioli M, Walter P. The integrated stress response: From mechanism to disease. Science. (2020) 368. doi:&#xa0;10.1126/science.aat5314</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aat5314</ArticleId><ArticleId IdType="pmc">PMC8997189</ArticleId><ArticleId IdType="pubmed">32327570</ArticleId></ArticleIdList></Reference><Reference><Citation>Poon DC, Ho YS, Chiu K, Wong HL, Chang RC. Sickness: From the focus on cytokines, prostaglandins, and complement factors to the perspectives of neurons. Neurosci Biobehav Rev. (2015) 57:30&#x2013;45. doi:&#xa0;10.1016/j.neubiorev.2015.07.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2015.07.015</ArticleId><ArticleId IdType="pubmed">26363665</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D, Sanislav O, Allan CY, Annesley SJ, Fisher PR. Cell-based blood biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome. Int J Mol Sci. (2020) 21. doi:&#xa0;10.20944/preprints202002.0029.v1</Citation><ArticleIdList><ArticleId IdType="doi">10.20944/preprints202002.0029.v1</ArticleId><ArticleId IdType="pmc">PMC7037777</ArticleId><ArticleId IdType="pubmed">32046336</ArticleId></ArticleIdList></Reference><Reference><Citation>Pivovarova NB, Andrews SB. Calcium-dependent mitochondrial function and dysfunction in neurons. FEBS J. (2010) 277:3622&#x2013;36. doi:&#xa0;10.1111/j.1742-4658.2010.07754.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1742-4658.2010.07754.x</ArticleId><ArticleId IdType="pmc">PMC3489481</ArticleId><ArticleId IdType="pubmed">20659161</ArticleId></ArticleIdList></Reference><Reference><Citation>Angajala A, Lim S, Phillips JB, Kim JH, Yates C, You Z, et al. . Diverse roles of mitochondria in immune responses: novel insights into immuno-metabolism. Front Immunol. (2018) 9:1605. doi:&#xa0;10.3389/fimmu.2018.01605</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.01605</ArticleId><ArticleId IdType="pmc">PMC6052888</ArticleId><ArticleId IdType="pubmed">30050539</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston SC, Staines DR, Marshall-Gradisnik SM. Epidemiological characteristics of chronic fatigue syndrome/myalgic encephalomyelitis in Australian patients. Clin Epidemiol. (2016) 8:97&#x2013;107. doi:&#xa0;10.2147/CLEP</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/CLEP</ArticleId><ArticleId IdType="pmc">PMC4878662</ArticleId><ArticleId IdType="pubmed">27279748</ArticleId></ArticleIdList></Reference><Reference><Citation>Lattie EG, Antoni MH, Fletcher MA, Penedo F, Czaja S, Lopez C, et al. . Stress management skills, neuroimmune processes and fatigue levels in persons with chronic fatigue syndrome. Brain Behav Immun. (2012) 26:849&#x2013;58. doi:&#xa0;10.1016/j.bbi.2012.02.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2012.02.008</ArticleId><ArticleId IdType="pmc">PMC3572196</ArticleId><ArticleId IdType="pubmed">22417946</ArticleId></ArticleIdList></Reference><Reference><Citation>Balinas C, Eaton-Fitch N, Maksoud R, Staines D, Marshall-Gradisnik S. Impact of life stressors on myalgic encephalomyelitis/chronic fatigue syndrome symptoms: an Australian longitudinal study. Int J Environ Res Public Health. (2021) 18. doi:&#xa0;10.3390/ijerph182010614</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph182010614</ArticleId><ArticleId IdType="pmc">PMC8535742</ArticleId><ArticleId IdType="pubmed">34682360</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomas C, Newton J, Watson S. A review of hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome. ISRN Neurosci. (2013) 2013:784520. doi:&#xa0;10.1155/2013/784520</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/784520</ArticleId><ArticleId IdType="pmc">PMC4045534</ArticleId><ArticleId IdType="pubmed">24959566</ArticleId></ArticleIdList></Reference><Reference><Citation>Tak LM, Cleare AJ, Ormel J, Manoharan A, Kok IC, Wessely S, et al. . Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders. Biol Psychol. (2011) 87:183&#x2013;94. doi:&#xa0;10.1016/j.biopsycho.2011.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopsycho.2011.02.002</ArticleId><ArticleId IdType="pubmed">21315796</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannibal KE, Bishop MD. Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation. Phys Ther. (2014) 94:1816&#x2013;25. doi:&#xa0;10.2522/ptj.20130597</Citation><ArticleIdList><ArticleId IdType="doi">10.2522/ptj.20130597</ArticleId><ArticleId IdType="pmc">PMC4263906</ArticleId><ArticleId IdType="pubmed">25035267</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Harding S, Sorenson M, Jason L, Maher K, Fletcher MA, Reynolds N, et al. . The associations between basal salivary cortisol and illness symptomatology in chronic fatigue syndrome. J Appl Biobehav Res. (2008) 13:157&#x2013;80. doi:&#xa0;10.1111/j.1751-9861.2008.00033.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1751-9861.2008.00033.x</ArticleId><ArticleId IdType="pmc">PMC2730359</ArticleId><ArticleId IdType="pubmed">19701493</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G, Anderson G, Maes M. Hypothalamic-pituitary-adrenal hypofunction in myalgic encephalomyelitis (ME)/chronic fatigue syndrome (CFS) as a consequence of activated immune-inflammatory and oxidative and nitrosative pathways. Mol Neurobiol. (2017) 54:6806&#x2013;19. doi:&#xa0;10.1007/s12035-016-0170-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0170-2</ArticleId><ArticleId IdType="pubmed">27766535</ArticleId></ArticleIdList></Reference><Reference><Citation>De Bellis A, Bellastella G, Pernice V, Cirillo P, Longo M, Maio A, et al. . Hypothalamic-pituitary autoimmunity and related impairment of hormone secretions in chronic fatigue syndrome. J Clin Endocrinol Metab. (2021) 106:e5147&#x2013;55. doi:&#xa0;10.1210/clinem/dgab429</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/clinem/dgab429</ArticleId><ArticleId IdType="pubmed">34254637</ArticleId></ArticleIdList></Reference><Reference><Citation>Berwaerts J, Moorkens G, Abs R. Secretion of growth hormone in patients with chronic fatigue syndrome. Growth Horm IGF Res 8 Suppl B. (1998), 127&#x2013;9. doi:&#xa0;10.1016/S1096-6374(98)80036-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1096-6374(98)80036-1</ArticleId><ArticleId IdType="pubmed">10990147</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J, Ma N, Zhong J, Yu B, Wan J, Zhang W. Age-associated changes in microglia and astrocytes ameliorate blood-brain barrier dysfunction. Mol Ther Nucleic Acids. (2021) 26:970&#x2013;86. doi:&#xa0;10.1016/j.omtn.2021.08.030</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.omtn.2021.08.030</ArticleId><ArticleId IdType="pmc">PMC8561003</ArticleId><ArticleId IdType="pubmed">34760339</ArticleId></ArticleIdList></Reference><Reference><Citation>Akalin A, Kormaksson M, Li S, Garrett-Bakelman FE, Figueroa ME, Melnick A, et al. . methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol. (2012) 13:R87. doi:&#xa0;10.1186/gb-2012-13-10-r87</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/gb-2012-13-10-r87</ArticleId><ArticleId IdType="pmc">PMC3491415</ArticleId><ArticleId IdType="pubmed">23034086</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinan TG. Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function. Life Sci. (1996) 58:1683&#x2013;94. doi:&#xa0;10.1016/0024-3205(96)00066-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(96)00066-5</ArticleId><ArticleId IdType="pubmed">8637392</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira G, Gillies H, Chanda S, Corbett M, Vernon SD, Milani T, et al. . Acute corticotropin-releasing factor receptor type 2 agonism results in sustained symptom improvement in myalgic encephalomyelitis/chronic fatigue syndrome. Front Syst Neurosci. (2021) 15:698240. doi:&#xa0;10.3389/fnsys.2021.698240</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnsys.2021.698240</ArticleId><ArticleId IdType="pmc">PMC8441022</ArticleId><ArticleId IdType="pubmed">34539356</ArticleId></ArticleIdList></Reference><Reference><Citation>
Johnson C. Health rising. (2018). Available at: https://www.healthrising.org [Accessed 17 January 2024].</Citation></Reference><Reference><Citation>Dobryakova E, Genova HM, DeLuca J, Wylie GR. The dopamine imbalance hypothesis of fatigue in multiple sclerosis and other neurological disorders. Front Neurol. (2015) 6:52. doi:&#xa0;10.3389/fneur.2015.00052</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2015.00052</ArticleId><ArticleId IdType="pmc">PMC4357260</ArticleId><ArticleId IdType="pubmed">25814977</ArticleId></ArticleIdList></Reference><Reference><Citation>Janowsky DS, Davis JM. Psychological effects of cholinomimetic agents. In: Davis KL, Berger PA, editors. Brain acetylcholine and neuropsychiatric disease. Springer ; US, Boston, MA: (1979). p. 3&#x2013;14.</Citation></Reference><Reference><Citation>Casanueva FF, Betti R, Cella SG, M&#xfc;ller EE, Mantegazza P. Effect of agonists and antagonists of cholinergic neurotransmission on growth hormone release in the dog. Acta Endocrinol (Copenh). (1983) 103:15&#x2013;20. doi:&#xa0;10.1530/acta.0.1030015</Citation><ArticleIdList><ArticleId IdType="doi">10.1530/acta.0.1030015</ArticleId><ArticleId IdType="pubmed">6305074</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakheit AM, Behan PO, Watson WS, Morton JJ. Abnormal arginine-vasopressin secretion and water metabolism in patients with postviral fatigue syndrome. Acta Neurol Scand. (1993) 87:234&#x2013;8. doi:&#xa0;10.1111/j.1600-0404.1993.tb04108.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.1993.tb04108.x</ArticleId><ArticleId IdType="pubmed">8475696</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakheit AM, Behan PO, Dinan TG, Gray CE, O&#x2019;Keane V. Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. Bmj. (1992) 304:1010&#x2013;2. doi:&#xa0;10.1136/bmj.304.6833.1010</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.304.6833.1010</ArticleId><ArticleId IdType="pmc">PMC1881733</ArticleId><ArticleId IdType="pubmed">1586780</ArticleId></ArticleIdList></Reference><Reference><Citation>Cleare AJ, Bearn J, Allain T, McGregor A, Wessely S, Murray RM, et al. . Contrasting neuroendocrine responses in depression and chronic fatigue syndrome. J Affect Disord. (1995) 34:283&#x2013;9. doi:&#xa0;10.1016/0165-0327(95)00026-J</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0165-0327(95)00026-J</ArticleId><ArticleId IdType="pubmed">8550954</ArticleId></ArticleIdList></Reference><Reference><Citation>Misiak B, &#x141;oniewski I, Marlicz W, Frydecka D, Szulc A, Rudzki L, et al. . The HPA axis dysregulation in severe mental illness: Can we shift the blame to gut microbiota? Prog Neuropsychopharmacol Biol Psychiatry. (2020) 102:109951. doi:&#xa0;10.1016/j.pnpbp.2020.109951</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2020.109951</ArticleId><ArticleId IdType="pubmed">32335265</ArticleId></ArticleIdList></Reference><Reference><Citation>R.a.P. Moss-Morris K. Chronic fatigue syndrome. 1st ed. Milton Park, Abingdon-on-Thames, Oxfordshire, England, UK: Routledge; (2000).</Citation></Reference><Reference><Citation>Bradley AS, Ford B, Bansal AS. Altered functional b cell subset populations in patients with chronic fatigue syndrome compared to healthy controls. Clin Exp Immunol (2013) 172:73&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3719933</ArticleId><ArticleId IdType="pubmed">23480187</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimas NG, Salvato FR, Morgan R, Fletcher MA. Immunologic abnormalities in chronic fatigue syndrome. J Clin Microbiol (1990) 28:1403&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC267940</ArticleId><ArticleId IdType="pubmed">2166084</ArticleId></ArticleIdList></Reference><Reference><Citation>Tirelli U, Marotta G, Improta S, Pinto A. Immunological abnormalities in patients with chronic fatigue syndrome. Scandinavian J Immunol (1994) 40:601&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">7997849</ArticleId></ArticleIdList></Reference><Reference><Citation>Milivojevic M, Che X, Bateman L, Cheng A, Garcia BA, Hornig M, et al. . Plasma proteomic profiling suggests an association between antigen driven clonal b cell expansion and ME/CFS. PloS One (2020) 15:e0236148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7373296</ArticleId><ArticleId IdType="pubmed">32692761</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherukuri A, Cheng PC, Sohn HW, Pierce SK. The CD19/CD21 complex functions to prolong b cell antigen receptor signaling from lipid rafts. Immunity (2001) 14:169&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">11239449</ArticleId></ArticleIdList></Reference><Reference><Citation>Pers JO, Jamin C, Predine-Hug F, Lydyard P, Youinou P. The role of CD5-expressing b cells in health and disease (review). Int J Mol Med (1999) 3:239&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">10028047</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivas JL, Palencia T, Fern&#xe1;ndez G, Garc&#xed;a M. Association of t and NK cell phenotype with the diagnosis of myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS). Front Immunol (2018) 9:1028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5954087</ArticleId><ArticleId IdType="pubmed">29867995</ArticleId></ArticleIdList></Reference><Reference><Citation>Landay AL, Jessop C, Lennette ET, Levy JA. Chronic fatigue syndrome: clinical condition associated with immune activation. Lancet (1991) 338:707&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">1679864</ArticleId></ArticleIdList></Reference><Reference><Citation>Cliff JM, King EC, Lee JS, Sep&#xfa;lveda N, Wolf AS, Kingdon C, et al. . Cellular immune function in myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS). Front Immunol (2019) 10:796.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6477089</ArticleId><ArticleId IdType="pubmed">31057538</ArticleId></ArticleIdList></Reference><Reference><Citation>Barker E, Fujimura SF, Fadem MB, Landay AL, Levy JA. Immunologic abnormalities associated with chronic fatigue syndrome. Clin Infect Dis (1994) 18 Suppl 1:S136&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">8148441</ArticleId></ArticleIdList></Reference><Reference><Citation>Deterre P, Berthelier V, Bauvois B, Dalloul A, Schuber F, Lund F. CD38 in t- and b-cell functions. Chem Immunol (2000) 75:146&#x2013;68.</Citation><ArticleIdList><ArticleId IdType="pubmed">10851783</ArticleId></ArticleIdList></Reference><Reference><Citation>Morra M, Zubiaur M, Terhorst C, Sancho J, Malavasi F. CD38 is functionally dependent on the TCR/CD3 complex in human t cells. FASEB J (1998) 12:581&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">9576485</ArticleId></ArticleIdList></Reference><Reference><Citation>Baecher-Allan C, Wolf E, Hafler DA. MHC class II expression identifies functionally distinct human regulatory t cells. J Immunol (2006) 176:4622&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">16585553</ArticleId></ArticleIdList></Reference><Reference><Citation>Viallard JF, Blanco P, Andr&#xe9; M, Etienne G, Liferman F, Neau D, et al. . CD8+HLA-DR+ t lymphocytes are increased in common variable immunodeficiency patients with impaired memory b-cell differentiation. Clin Immunol (2006) 119:51&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16413828</ArticleId></ArticleIdList></Reference><Reference><Citation>Viallard JF, Bloch-Michel C, Neau-Cransac M, Taupin JL, Garrigue S, Miossec V, et al. . HLA-DR expression on lymphocyte subsets as a marker of disease activity in patients with systemic lupus erythematosus. Clin Exp Immunol (2001) 125:485&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1906149</ArticleId><ArticleId IdType="pubmed">11531958</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardcastle SL, Brenu EW, Johnston S, Nguyen T, Huth T, Wong N, et al. . Characterisation of cell functions and receptors in chronic fatigue Syndrome/Myalgic encephalomyelitis (CFS/ME). BMC Immunol (2015) 16:35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4450981</ArticleId><ArticleId IdType="pubmed">26032326</ArticleId></ArticleIdList></Reference><Reference><Citation>Theorell J, Bileviciute-Ljungar I, Tesi B, Schlums H, Johnsgaard MS, Asadi-Azarbaijani B, et al. . Unperturbed cytotoxic lymphocyte phenotype and function in myalgic Encephalomyelitis/Chronic fatigue syndrome patients. Front Immunol (2017) 8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5483846</ArticleId><ArticleId IdType="pubmed">28694809</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Z, Feng Y, Xu J, Liang J. T-cell exhaustion in immune-mediated inflammatory diseases: New implications for immunotherapy. Front Immunol 13 (2022).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9538155</ArticleId><ArticleId IdType="pubmed">36211414</ArticleId></ArticleIdList></Reference><Reference><Citation>Callender LA, Carroll EC, Bober EA, Akbar AN, Solito E, Henson SM. Mitochondrial mass governs the extent of human t cell senescence. Aging Cell (2020) 19:e13067.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6996952</ArticleId><ArticleId IdType="pubmed">31788930</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornig M. Can the light of immunometabolism cut through "brain fog"? J Clin Invest (2020) 130:1102&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269580</ArticleId><ArticleId IdType="pubmed">32039912</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, van Driel ML, Staines DR, Ashton KJ, Ramos SB, Keane J, et al. . Immunological abnormalities as potential biomarkers in chronic fatigue Syndrome/Myalgic encephalomyelitis. J Transl Med (2011) 9:81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3120691</ArticleId><ArticleId IdType="pubmed">21619669</ArticleId></ArticleIdList></Reference><Reference><Citation>Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, et al. . And t-cell phenotype and function in patients suffering from chronic fatigue syndrome. J Transl Med (2013) 11:68.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3614537</ArticleId><ArticleId IdType="pubmed">23514202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramos S, Brenu E, Broadley S, Kwiatek R, Ng J, Nguyen T, et al. . Natural killer t and &#x3b3;&#x3b4; t cells in multiple sclerosis and chronic fatigue syndrome/myalgic encephalomyelitis: a comparison. Asian Pac J Allergy Immunol (2016) 34:300&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">27001659</ArticleId></ArticleIdList></Reference><Reference><Citation>Grobler C, Maphumulo SC, Grobbelaar LM, Bredenkamp JC, Laubscher GJ, Lourens PJ, et al. . Covid-19: The rollercoaster of Fibrin(Ogen), d-dimer, von willebrand factor, p-selectin and their interactions with endothelial cells, platelets and erythrocytes. Int J Mol Sci (2020) 21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7403995</ArticleId><ArticleId IdType="pubmed">32708334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondlkov&#xe1; K, Vokurkov&#xe1; D, Krejsek J, Borsk&#xe1; L, Fiala Z, Ctirad A. Regulatory t cells (TREG) and their roles in immune system with respect to immunopathological disorders. Acta Med (Hradec Kralove) (2010) 53:73&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">20672742</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, Hardcastle SL, Atkinson GM, van Driel ML, Kreijkamp-Kaspers S, Ashton KJ, et al. . Natural killer cells in patients with severe chronic fatigue syndrome. Auto Immun Highlights (2013) 4:69&#x2013;80.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4389023</ArticleId><ArticleId IdType="pubmed">26000145</ArticleId></ArticleIdList></Reference><Reference><Citation>Caligiuri M, Murray C, Buchwald D, Levine H, Cheney P, Peterson D, et al. . Phenotypic and functional deficiency of natural killer cells in patients with chronic fatigue syndrome. J Immunol (1987) 139:3306&#x2013;13.</Citation><ArticleIdList><ArticleId IdType="pubmed">2824604</ArticleId></ArticleIdList></Reference><Reference><Citation>Fletcher MA, Zeng XR, Maher K, Levis S, Hurwitz B, Antoni M, et al. . Biomarkers in chronic fatigue syndrome: evaluation of natural killer cell function and dipeptidyl peptidase IV/CD26. PloS One (2010) 5:e10817.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2876037</ArticleId><ArticleId IdType="pubmed">20520837</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson BH, Haghighi MH, Ponzio NM. Evidence for the presence of immune dysfunction in chronic fatigue syndrome. Clin Diagn Lab Immunol (2002) 9:747&#x2013;52.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC120010</ArticleId><ArticleId IdType="pubmed">12093668</ArticleId></ArticleIdList></Reference><Reference><Citation>Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. . Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med (2018) 16:268.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6167797</ArticleId><ArticleId IdType="pubmed">30285773</ArticleId></ArticleIdList></Reference><Reference><Citation>Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S. Functions of natural killer cells. Nat Immunol (2008) 9:503&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">18425107</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, van Driel ML, Staines DR, Ashton KJ, Hardcastle SL, Keane J, et al. . Longitudinal investigation of natural killer cells and cytokines in chronic fatigue syndrome/myalgic encephalomyelitis. J Transl Med (2012) 10:88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3464733</ArticleId><ArticleId IdType="pubmed">22571715</ArticleId></ArticleIdList></Reference><Reference><Citation>Eaton-Fitch N, du Preez S, Cabanas H, Staines D, Marshall-Gradisnik S. A systematic review of natural killer cells profile and cytotoxic function in myalgic encephalomyelitis/chronic fatigue syndrome. Syst Rev (2019) 8:279.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6857215</ArticleId><ArticleId IdType="pubmed">31727160</ArticleId></ArticleIdList></Reference><Reference><Citation>Borish L, Schmaling K, DiClementi JD, Streib J, Negri J, Jones JF. Chronic fatigue syndrome: identification of distinct subgroups on the basis of allergy and psychologic variables. J Allergy Clin Immunol (1998) 102:222&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">9723665</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbitt M, Eaton-Fitch N, Staines D, Cabanas H, Marshall-Gradisnik S. A systematic review of cytokines in chronic fatigue syndrome/myalgic encephalomyelitis/systemic exertion intolerance disease (CFS/ME/SEID). BMC Neurol (2019) 19:207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6708220</ArticleId><ArticleId IdType="pubmed">31445522</ArticleId></ArticleIdList></Reference><Reference><Citation>Giloteaux L, O'Neal A, Castro-Marrero J, Levine SM, Hanson MR. Cytokine profiling of extracellular vesicles isolated from plasma in myalgic encephalomyelitis/chronic fatigue syndrome: a pilot study. J Transl Med (2020) 18:387.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7552484</ArticleId><ArticleId IdType="pubmed">33046133</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S, Aggarwal S, See D, Starr A. Cytokine production by adherent and non-adherent mononuclear cells in chronic fatigue syndrome. J Psychiatr Res (1997) 31:149&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">9201656</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T, Yang Y, Wang D, Li C, Qu Y, Guo J, et al. . The clinical value of cytokines in chronic fatigue syndrome. J Trans Med (2019) 17:213.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6599310</ArticleId><ArticleId IdType="pubmed">31253154</ArticleId></ArticleIdList></Reference><Reference><Citation>Brenu EW, Broadley S, Nguyen T, Johnston S, Ramos S, Staines D, et al. . A preliminary comparative assessment of the role of CD8+ t cells in chronic fatigue Syndrome/Myalgic encephalomyelitis and multiple sclerosis. J Immunol Res (2016) 2016:9064529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4736227</ArticleId><ArticleId IdType="pubmed">26881265</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes Rivera M, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M, Lidbury BA. Myalgic Encephalomyelitis/Chronic fatigue syndrome: A comprehensive review. Diagnostics (Basel) 9 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6787585</ArticleId><ArticleId IdType="pubmed">31394725</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano AH, Maya J, Giloteaux L, Peterson DL, Maynard M, Gottschalk CG, et al. . Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered t cell metabolism and cytokine associations. J Clin Invest (2020) 130:1491&#x2013;505.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7269566</ArticleId><ArticleId IdType="pubmed">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Curriu M, Carrillo J, Massanella M, Rigau J, Alegre J, Puig J, et al. . and T-cell phenotype and function in patients suffering from Chronic Fatigue Syndrome. J Transl Med. (2013) 11:68. doi:&#xa0;10.1186/1479-5876-11-68</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-5876-11-68</ArticleId><ArticleId IdType="pmc">PMC3614537</ArticleId><ArticleId IdType="pubmed">23514202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ascherio A, Munger KL. EBV and autoimmunity. Epstein Barr Virus Volume 1: One Herpes Virus: Many Dis. (2015) 390:365&#x2013;85. doi:&#xa0;10.1007/978-3-319-22822-8_15</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-319-22822-8_15</ArticleId><ArticleId IdType="pubmed">26424654</ArticleId></ArticleIdList></Reference><Reference><Citation>Richman S, Morris MC, Broderick G, Craddock TJA, Klimas NG, Fletcher MA. Pharmaceutical interventions in chronic fatigue syndrome: A literature-based commentary. Clin Ther. (2019) 41:798&#x2013;805. doi:&#xa0;10.1016/j.clinthera.2019.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2019.02.011</ArticleId><ArticleId IdType="pmc">PMC6543846</ArticleId><ArticleId IdType="pubmed">30871727</ArticleId></ArticleIdList></Reference><Reference><Citation>Carlo-Stella N, Bozzini S, De Silvestri A, Sbarsi I, Pizzochero C, Lorusso L, et al. . Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome. Int J Immunopathol Pharmacol. (2009) 22:745&#x2013;54. doi:&#xa0;10.1177/039463200902200320</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/039463200902200320</ArticleId><ArticleId IdType="pubmed">19822091</ArticleId></ArticleIdList></Reference><Reference><Citation>Underhill JA, Mahalingam M, Peakman M, Wessely S. Lack of association between HLA genotype and chronic fatigue syndrome. Eur J Immunogenet. (2001) 28:425&#x2013;8. doi:&#xa0;10.1046/j.1365-2370.2001.00235.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2370.2001.00235.x</ArticleId><ArticleId IdType="pubmed">11422420</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochi Y. Genetics of autoimmune diseases: perspectives from genome-wide association studies. Int Immunol. (2016) 28:155&#x2013;61. doi:&#xa0;10.1093/intimm/dxw002</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxw002</ArticleId><ArticleId IdType="pmc">PMC4889885</ArticleId><ArticleId IdType="pubmed">26857735</ArticleId></ArticleIdList></Reference><Reference><Citation>Frederiksen B, Liu E, Romanos J, Steck A, Yin X, Kroehl M, et al. . Investigation of the vitamin D receptor gene (VDR) and its interaction with protein tyrosine phosphatase, non-receptor type 2 gene (PTPN2) on risk of islet autoimmunity and type 1 diabetes: the Diabetes Autoimmunity Study in the Young (DAISY). J Steroid Biochem Mol Biol. (2013) 133:51&#x2013;7. doi:&#xa0;10.1016/j.jsbmb.2012.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsbmb.2012.08.012</ArticleId><ArticleId IdType="pmc">PMC3513655</ArticleId><ArticleId IdType="pubmed">22960018</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigurdsson S, Nordmark G, Garnier S, Grundberg E, Kwan T, Nilsson O, et al. . A risk haplotype of STAT4 for systemic lupus erythematosus is over-expressed, correlates with anti-dsDNA and shows additive effects with two risk alleles of IRF5. Hum Mol Genet. (2008) 17:2868&#x2013;76. doi:&#xa0;10.1093/hmg/ddn184</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddn184</ArticleId><ArticleId IdType="pmc">PMC2525501</ArticleId><ArticleId IdType="pubmed">18579578</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirschfield GM, Liu X, Xu C, Lu Y, Xie G, Lu Y, et al. . Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. New Engl J Med. (2009) 360:2544&#x2013;55. doi:&#xa0;10.1056/NEJMoa0810440</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa0810440</ArticleId><ArticleId IdType="pmc">PMC2857316</ArticleId><ArticleId IdType="pubmed">19458352</ArticleId></ArticleIdList></Reference><Reference><Citation>Ting W-H, Chien M-N, Lo F-S, Wang C-H, Huang C-Y, Lin C-L, et al. . Association of cytotoxic T-lymphocyte-associated protein 4 (CTLA4) gene polymorphisms with autoimmune thyroid disease in children and adults: case-control study. PloS One. (2016) 11:e0154394. doi:&#xa0;10.1371/journal.pone.0154394</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0154394</ArticleId><ArticleId IdType="pmc">PMC4844099</ArticleId><ArticleId IdType="pubmed">27111218</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajeevan MS, Dimulescu I, Murray J, Falkenberg VR, Unger ER. Pathway-focused genetic evaluation of immune and inflammation related genes with chronic fatigue syndrome. Hum Immunol. (2015) 76:553&#x2013;60. doi:&#xa0;10.1016/j.humimm.2015.06.014</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2015.06.014</ArticleId><ArticleId IdType="pubmed">26116897</ArticleId></ArticleIdList></Reference><Reference><Citation>Niller HH, Wolf H, Ay E, Minarovits J. Epigenetic dysregulation of epstein-barr virus latency and development of autoimmune disease. Epigenetic Contributions Autoimmune Dis. (2011) 711, 82&#x2013;102. doi:&#xa0;10.1007/978-1-4419-8216-2_7</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-4419-8216-2_7</ArticleId><ArticleId IdType="pubmed">21627044</ArticleId></ArticleIdList></Reference><Reference><Citation>Manian FA. Simultaneous measurement of antibodies to Epstein-Barr virus, human herpesvirus 6, herpes simplex virus types 1 and 2, and 14 enteroviruses in chronic fatigue syndrome: is there evidence of activation of a nonspecific polyclonal immune response? Clin Infect Dis. (1994) 19:448&#x2013;53. doi:&#xa0;10.1093/clinids/19.3.448</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinids/19.3.448</ArticleId><ArticleId IdType="pubmed">7811864</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M, Eckey M, Sotzny F, Hahn E, Bauer S, Grabowski P, et al. . Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray. PloS One. (2017) 12:e0179124. doi:&#xa0;10.1371/journal.pone.0179124</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0179124</ArticleId><ArticleId IdType="pmc">PMC5467847</ArticleId><ArticleId IdType="pubmed">28604802</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M, Strohschein K, Giannini C, Koelsch U, Bauer S, Doebis C, et al. . Deficient EBV-specific B-and T-cell response in patients with chronic fatigue syndrome. PloS One. (2014) 9:e85387. doi:&#xa0;10.1371/journal.pone.0085387</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0085387</ArticleId><ArticleId IdType="pmc">PMC3893202</ArticleId><ArticleId IdType="pubmed">24454857</ArticleId></ArticleIdList></Reference><Reference><Citation>Kerr JR. Epstein-barr virus induced gene-2 upregulation identifies a particular subtype of chronic fatigue syndrome/myalgic encephalomyelitis. Front Pediatr. (2019) 7:59. doi:&#xa0;10.3389/fped.2019.00059</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2019.00059</ArticleId><ArticleId IdType="pmc">PMC6424879</ArticleId><ArticleId IdType="pubmed">30918887</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishikai M, Tomomatsu S, Hankins RW, Takagi S, Miyachi K, Kosaka S, et al. . Autoantibodies to a 68/48&#x2009;kDa protein in chronic fatigue syndrome and primary fibromyalgia: a possible marker for hypersomnia and cognitive disorders. Rheumatology. (2001) 40:806&#x2013;10. doi:&#xa0;10.1093/rheumatology/40.7.806</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/40.7.806</ArticleId><ArticleId IdType="pubmed">11477286</ArticleId></ArticleIdList></Reference><Reference><Citation>Loebel M, Grabowski P, Heidecke H, Bauer S, Hanitsch LG, Wittke K, et al. . Antibodies to &#x3b2; adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome. Brain Behav Immun. (2016) 52:32&#x2013;9. doi:&#xa0;10.1016/j.bbi.2015.09.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2015.09.013</ArticleId><ArticleId IdType="pubmed">26399744</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S, Kuratsune H, Hidaka Y, Hakariya Y, Tatsumi K-I, Takano T, et al. . Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. Int J Mol Med. (2003) 12:225&#x2013;30. doi:&#xa0;10.3892/ijmm</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm</ArticleId><ArticleId IdType="pubmed">12851722</ArticleId></ArticleIdList></Reference><Reference><Citation>Mikecz AV, Konstantinov K, Buchwald DS, Gerace L, Tan EM. High frequency of autoantibodies to insoluble cellular antigens in patients with chronic fatigue syndrome. Arthritis Rheumatism: Off J Am Coll Rheumatol. (1997) 40:295&#x2013;305. doi:&#xa0;10.1002/art.1780400215</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780400215</ArticleId><ArticleId IdType="pubmed">9041942</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortega-Hernandez OD, Cuccia M, Bozzini S, Bassi N, Moscavitch S, Diaz-Gallo LM, et al. . Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome: are they associated with age at onset and specific symptoms? Ann New York Acad Sci. (2009) 1173:589&#x2013;99. doi:&#xa0;10.1111/j.1749-6632.2009.04802.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2009.04802.x</ArticleId><ArticleId IdType="pubmed">19758204</ArticleId></ArticleIdList></Reference><Reference><Citation>De Be&#xe9;ck KO, Vermeersch P, Verschueren P, Westhovens R, Mari&#xeb;n G, Blockmans D, et al. . Antinuclear antibody detection by automated multiplex immunoassay in untreated patients at the time of diagnosis. Autoimmun Rev. (2012) 12:137&#x2013;43. doi:&#xa0;10.1016/j.autrev.2012.02.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2012.02.013</ArticleId><ArticleId IdType="pubmed">22387973</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein R, Berg P. High incidence of antibodies to 5-hydroxytryptamine, gangliosides and phospholipids in patients with chronic fatigue and fibromyalgia syndrome and their relatives: evidence for a clinical entity of both disorders. Eur J Med Res. (1995) 1:21&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">9392689</ArticleId></ArticleIdList></Reference><Reference><Citation>Hokama Y, Empey-Campora C, Hara C, Higa N, Siu N, Lau R, et al. . Acute phase phospholipids related to the cardiolipin of mitochondria in the sera of patients with chronic fatigue syndrome (CFS), chronic Ciguatera fish poisoning (CCFP), and other diseases attributed to chemicals, Gulf War, and marine toxins. J Clin Lab Anal. (2008) 22:99&#x2013;105. doi:&#xa0;10.1002/jcla.20217</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.20217</ArticleId><ArticleId IdType="pmc">PMC6649096</ArticleId><ArticleId IdType="pubmed">18348309</ArticleId></ArticleIdList></Reference><Reference><Citation>Hokama Y, Campora CE, Hara C, Kuribayashi T, Le Huynh D, Yabusaki K. Anticardiolipin antibodies in the sera of patients with diagnosed chronic fatigue syndrome. J Clin Lab Anal. (2009) 23:210&#x2013;2. doi:&#xa0;10.1002/jcla.20325</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.20325</ArticleId><ArticleId IdType="pmc">PMC6649060</ArticleId><ArticleId IdType="pubmed">19623655</ArticleId></ArticleIdList></Reference><Reference><Citation>Konstantinov K, von Mikecz A, Buchwald D, Jones J, Gerace L, Tan EM. Autoantibodies to nuclear envelope antigens in chronic fatigue syndrome. J Clin Invest. (1996) 98:1888&#x2013;96. doi:&#xa0;10.1172/JCI118990</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI118990</ArticleId><ArticleId IdType="pmc">PMC507629</ArticleId><ArticleId IdType="pubmed">8878441</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabral-Marques O, Marques A, Giil LM, De Vito R, Rademacher J, G&#xfc;nther J, et al. . GPCR-specific autoantibody signatures are associated with physiological and pathological immune homeostasis. Nat Commun. (2018) 9:5224. doi:&#xa0;10.1038/s41467-018-07598-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-018-07598-9</ArticleId><ArticleId IdType="pmc">PMC6283882</ArticleId><ArticleId IdType="pubmed">30523250</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig J, Sotzny F, Bauer S, Heidecke H, Riemekasten G, Dragun D, et al. . IgG stimulated &#x3b2;2 adrenergic receptor activation is attenuated in patients with ME/CFS. Brain Behavior Immun - Health. (2020) 3:100047. doi:&#xa0;10.1016/j.bbih.2020.100047</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100047</ArticleId><ArticleId IdType="pmc">PMC8474590</ArticleId><ArticleId IdType="pubmed">34589837</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Mihaylova I, Kubera M, Leunis J-C, Twisk FNM, Geffard M. IgM-mediated autoimmune responses directed against anchorage epitopes are greater in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) than in major depression. Metab Brain Dis. (2012) 27:415&#x2013;23. doi:&#xa0;10.1007/s11011-012-9316-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-012-9316-8</ArticleId><ArticleId IdType="pubmed">22614823</ArticleId></ArticleIdList></Reference><Reference><Citation>Elfaitouri A, Herrmann B, B&#xf6;lin-Wiener A, Wang Y, Gottfries C-G, Zachrisson O, et al. . Epitopes of microbial and human heat shock protein 60 and their recognition in myalgic encephalomyelitis. PloS One. (2013) 8:e81155. doi:&#xa0;10.1371/journal.pone.0081155</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0081155</ArticleId><ArticleId IdType="pmc">PMC3842916</ArticleId><ArticleId IdType="pubmed">24312270</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernon SD, Reeves WC. Evaluation of autoantibodies to common and neuronal cell antigens in Chronic Fatigue Syndrome. J Autoimmune Dis. (2005) 2:5. doi:&#xa0;10.1186/1740-2557-2-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1740-2557-2-5</ArticleId><ArticleId IdType="pmc">PMC1177983</ArticleId><ArticleId IdType="pubmed">15916704</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M, Mihaylova I, Leunis JC. Chronic fatigue syndrome is accompanied by an IgM-related immune response directed against neopitopes formed by oxidative or nitrosative damage to lipids and proteins. Neuro Endocrinol Lett. (2006) 27:615&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">17159817</ArticleId></ArticleIdList></Reference><Reference><Citation>Fasano A. All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases. F1000Research. (2020) 9. doi:&#xa0;10.12688/f1000research</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research</ArticleId><ArticleId IdType="pmc">PMC6996528</ArticleId><ArticleId IdType="pubmed">32051759</ArticleId></ArticleIdList></Reference><Reference><Citation>Moisini I, Davidson A. BAFF: a local and systemic target in autoimmune diseases. Clin Exp Immunol. (2009) 158:155&#x2013;63. doi:&#xa0;10.1111/j.1365-2249.2009.04007.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2249.2009.04007.x</ArticleId><ArticleId IdType="pmc">PMC2768805</ArticleId><ArticleId IdType="pubmed">19737141</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackay F, Schneider P. Cracking the BAFF code. Nat Rev Immunol. (2009) 9:491&#x2013;502. doi:&#xa0;10.1038/nri2572</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2572</ArticleId><ArticleId IdType="pubmed">19521398</ArticleId></ArticleIdList></Reference><Reference><Citation>Saulep-Easton D, Vincent FB, Quah PS, Wei A, Ting SB, Croce CM, et al. . The BAFF receptor TACI controls IL-10 production by regulatory B cells and CLL B cells. Leukemia. (2016) 30:163&#x2013;72. doi:&#xa0;10.1038/leu.2015.174</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/leu.2015.174</ArticleId><ArticleId IdType="pmc">PMC4606984</ArticleId><ArticleId IdType="pubmed">26139429</ArticleId></ArticleIdList></Reference><Reference><Citation>Hedger MP, de Kretser DM. The activins and their binding protein, follistatin&#x2014;diagnostic and therapeutic targets in inflammatory disease and fibrosis. Cytokine Growth factor Rev. (2013) 24:285&#x2013;95. doi:&#xa0;10.1016/j.cytogfr.2013.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2013.03.003</ArticleId><ArticleId IdType="pubmed">23541927</ArticleId></ArticleIdList></Reference><Reference><Citation>Lidbury BA, Kita B, Lewis DP, Hayward S, Ludlow H, Hedger MP, et al. . Activin B is a novel biomarker for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) diagnosis: a cross sectional study. J Trans Med. (2017) 15:1&#x2013;10. doi:&#xa0;10.1186/s12967-017-1161-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-017-1161-4</ArticleId><ArticleId IdType="pmc">PMC5353946</ArticleId><ArticleId IdType="pubmed">28302133</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox BS, Alharshawi K, Mena-Palomo I, Lafuse WP, Ariza ME. EBV/HHV-6A dUTPases contribute to myalgic encephalomyelitis/chronic fatigue syndrome pathophysiology by enhancing TFH cell differentiation and extrafollicular activities. JCI Insight. (2022) 7. doi:&#xa0;10.1172/jci.insight.158193</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.158193</ArticleId><ArticleId IdType="pmc">PMC9220958</ArticleId><ArticleId IdType="pubmed">35482424</ArticleId></ArticleIdList></Reference><Reference><Citation>Spolski R, Leonard WJ. Interleukin-21: a double-edged sword with therapeutic potential. Nat Rev Drug Discovery. (2014) 13:379&#x2013;95. doi:&#xa0;10.1038/nrd4296</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd4296</ArticleId><ArticleId IdType="pubmed">24751819</ArticleId></ArticleIdList></Reference><Reference><Citation>Crotty S. T follicular helper cell biology: A decade of discovery and diseases. Immunity. (2019) 50:1132&#x2013;48. doi:&#xa0;10.1016/j.immuni.2019.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2019.04.011</ArticleId><ArticleId IdType="pmc">PMC6532429</ArticleId><ArticleId IdType="pubmed">31117010</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Ten Dijke P. Immunoregulation by members of the TGF&#x3b2; superfamily. Nat Rev Immunol. (2016) 16:723&#x2013;40. doi:&#xa0;10.1038/nri.2016.112</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri.2016.112</ArticleId><ArticleId IdType="pubmed">27885276</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang PP, Barral P, Fitch J, Pratama A, Ma CS, Kallies A, et al. . Identification of Bcl-6-dependent follicular helper NKT cells that provide cognate help for B cell responses. Nat Immunol. (2011) 13:35&#x2013;43. doi:&#xa0;10.1038/ni.2166</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2166</ArticleId><ArticleId IdType="pubmed">22120117</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith MB, Haney E, McDonagh M, Pappas M, Daeges M, Wasson N, et al. . Treatment of myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Internal Med. (2015) 162:841&#x2013;50. doi:&#xa0;10.7326/M15-0114</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M15-0114</ArticleId><ArticleId IdType="pubmed">26075755</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, S&#xe1;ez-Franc&#xe0;s N, Santillo D, Alegre J. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis: all roads lead to Rome. Br J Pharmacol. (2017) 174:345&#x2013;69. doi:&#xa0;10.1111/bph.13702</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.13702</ArticleId><ArticleId IdType="pmc">PMC5301046</ArticleId><ArticleId IdType="pubmed">28052319</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim DY, Lee JS, Park SY, Kim SJ, Son CG. Systematic review of randomised controlled trials for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. (2020) 18:7. doi:&#xa0;10.1186/s12967-019-02196-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-019-02196-9</ArticleId><ArticleId IdType="pmc">PMC6943902</ArticleId><ArticleId IdType="pubmed">31906979</ArticleId></ArticleIdList></Reference><Reference><Citation>U.S. ME/CFS clinician coalition, diagnosing and treating myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). (U.S. ME/CFS CLinician Coalition; ) (2020).</Citation></Reference><Reference><Citation>Cullinan J, Pheby DFH, Araja D, Berkis U, Brenna E, de Korwin JD, et al. . Perceptions of european ME/CFS experts concerning knowledge and understanding of ME/CFS among primary care physicians in europe: A report from the european ME/CFS research network (EUROMENE). Medicina (Kaunas). (2021) 57. doi:&#xa0;10.3390/medicina57030208</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57030208</ArticleId><ArticleId IdType="pmc">PMC7996783</ArticleId><ArticleId IdType="pubmed">33652747</ArticleId></ArticleIdList></Reference><Reference><Citation>Hng KN, Geraghty K, Pheby DFH. An audit of UK hospital doctors&#x2019; Knowledge and experience of myalgic encephalomyelitis. Medicina (Kaunas). (2021) 57. doi:&#xa0;10.3390/medicina57090885</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57090885</ArticleId><ArticleId IdType="pmc">PMC8464998</ArticleId><ArticleId IdType="pubmed">34577808</ArticleId></ArticleIdList></Reference><Reference><Citation>McEvedy CP, Beard AW. Concept of benign myalgic encephalomyelitis. Br Med J. (1970) 1:11&#x2013;5. doi:&#xa0;10.1136/bmj.1.5687.11</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.1.5687.11</ArticleId><ArticleId IdType="pmc">PMC1700895</ArticleId><ArticleId IdType="pubmed">5411596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper M. Myalgic encephalomyelitis: a review with emphasis on key findings in biomedical research. J Clin Pathol. (2007) 60:466&#x2013;71. doi:&#xa0;10.1136/jcp.2006.042408</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jcp.2006.042408</ArticleId><ArticleId IdType="pmc">PMC1994528</ArticleId><ArticleId IdType="pubmed">16935967</ArticleId></ArticleIdList></Reference><Reference><Citation>Eveng&#xe5;rd B, Schacterle RS, Komaroff AL. Chronic fatigue syndrome: new insights and old ignorance. J Intern Med. (1999) 246:455&#x2013;69. doi:&#xa0;10.1046/j.1365-2796.1999.00513.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2796.1999.00513.x</ArticleId><ArticleId IdType="pubmed">10583715</ArticleId></ArticleIdList></Reference><Reference><Citation>David AS, Wessely S, Pelosi AJ. Postviral fatigue syndrome: time for a new approach. Br Med J (Clin Res Ed). (1988) 296:696&#x2013;9. doi:&#xa0;10.1136/bmj.296.6623.696</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.296.6623.696</ArticleId><ArticleId IdType="pmc">PMC2545306</ArticleId><ArticleId IdType="pubmed">3128374</ArticleId></ArticleIdList></Reference><Reference><Citation>Stricklin A, Sewell M, Austad C. Objective measurement of personality variables in epidemic neuromyasthenia patients. S Afr Med J. (1990) 77:31&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">2294610</ArticleId></ArticleIdList></Reference><Reference><Citation>American geriatrics society, american geriatrics society 2019 updated AGS beers criteria&#xae; for potentially inappropriate medication use in older adults. J Am Geriatr Soc. (2019) 67:674&#x2013;94. doi:&#xa0;10.1111/jgs.15767</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jgs.15767</ArticleId><ArticleId IdType="pubmed">30693946</ArticleId></ArticleIdList></Reference><Reference><Citation>National Institute for Health and Care Excellence - NICE, Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">35438859</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason LA, Brown M, Brown A, Evans M, Flores S, Grant-Holler E, et al. . Energy conservation/envelope theory interventions to help patients with myalgic encephalomyelitis/chronic fatigue syndrome. Fatigue. (2013) 1:27&#x2013;42. doi:&#xa0;10.1080/21641846.2012.733602</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2012.733602</ArticleId><ArticleId IdType="pmc">PMC3596172</ArticleId><ArticleId IdType="pubmed">23504301</ArticleId></ArticleIdList></Reference><Reference><Citation>Geraghty K, Hann M, Kurtev S. Myalgic encephalomyelitis/chronic fatigue syndrome patients&#x2019; reports of symptom changes following cognitive behavioural therapy, graded exercise therapy and pacing treatments: Analysis of a primary survey compared with secondary surveys. J Health Psychol. (2019) 24:1318&#x2013;33. doi:&#xa0;10.1177/1359105317726152</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1359105317726152</ArticleId><ArticleId IdType="pubmed">28847166</ArticleId></ArticleIdList></Reference><Reference><Citation>Kindlon T. Reporting of harms associated with graded exercise therapy and cognitive behavioural therapy in myalgic encephalomyelitis/chronic fatigue syndrome. Bull IACFS/ME. (2011) 19:59&#x2013;111.</Citation></Reference><Reference><Citation>Psychotherapy for major depressive disorder and generalised anxiety disorder: A health technology assessment. Ont Health Technol Assess Ser. (2017) 17:1&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5709536</ArticleId><ArticleId IdType="pubmed">29213344</ArticleId></ArticleIdList></Reference><Reference><Citation>ME Association . TRIAL BY ERROR: the troubling case of the PACE chronic fatigue syndrome study| investigation by david tuller (Accessed 21 October 2015).</Citation></Reference><Reference><Citation>White PD, Goldsmith KA, Johnson AL, Potts L, Walwyn R, DeCesare JC, et al. . Comparison of adaptive pacing therapy, cognitive behavior therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial. Lancet. (2011) 377:823&#x2013;36. doi:&#xa0;10.1016/S0140-6736(11)60096-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(11)60096-2</ArticleId><ArticleId IdType="pmc">PMC3065633</ArticleId><ArticleId IdType="pubmed">21334061</ArticleId></ArticleIdList></Reference><Reference><Citation>White PD, Goldsmith K, Johnson AL, Chalder T, Sharpe M. Recovery from chronic fatigue syndrome after treatments given in the PACE trial. Psychol Med. (2013) 43:2227&#x2013;35. doi:&#xa0;10.1017/S0033291713000020</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291713000020</ArticleId><ArticleId IdType="pmc">PMC3776285</ArticleId><ArticleId IdType="pubmed">23363640</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilshire CE, Kindlon T. Response: Sharpe, Goldsmith and Chalder fail to restore confidence in the PACE trial findings. BMC Psychol. (2019) 7:19. doi:&#xa0;10.1186/s40359-019-0296-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40359-019-0296-x</ArticleId><ArticleId IdType="pmc">PMC6434781</ArticleId><ArticleId IdType="pubmed">30914065</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilshire CE, Kindlon T, Courtney R, Matthees A, Tuller D, Geraghty K, et al. . Rethinking the treatment of chronic fatigue syndrome-a reanalysis and evaluation of findings from a recent major trial of graded exercise and CBT. BMC Psychol. (2018) 6:6. doi:&#xa0;10.1186/s40359-018-0218-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40359-018-0218-3</ArticleId><ArticleId IdType="pmc">PMC5863477</ArticleId><ArticleId IdType="pubmed">29562932</ArticleId></ArticleIdList></Reference><Reference><Citation>Pheby D, Saffron L. Risk factors for severe ME/CFS. Biol Med. (2009) 1:50&#x2013;74.</Citation></Reference><Reference><Citation>Campbell B. Pacing tutorial. In: ME/CFS and fibromyalgia self-help program. (USA: ME/CFS and Fibromyalgia Self-Help; ) (2020).</Citation></Reference><Reference><Citation>
Visible, visible. (2024). Available at: https://www.makevisible.com
</Citation></Reference><Reference><Citation>Aaron LA, Herrell R, Ashton S, Belcourt M, Schmaling K, Goldberg J, et al. . Comorbid clinical conditions in chronic fatigue: a co-twin control study. J Gen Intern Med. (2001) 16:24&#x2013;31. doi:&#xa0;10.1046/j.1525-1497.2001.03419.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1525-1497.2001.03419.x</ArticleId><ArticleId IdType="pmc">PMC1495162</ArticleId><ArticleId IdType="pubmed">11251747</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson BH. Myalgic encephalomyelitis/chronic fatigue syndrome and fibromyalgia: definitions, similarities, and differences. Clin Ther. (2019) 41:612&#x2013;8. doi:&#xa0;10.1016/j.clinthera.2018.12.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2018.12.016</ArticleId><ArticleId IdType="pmc">PMC6589349</ArticleId><ArticleId IdType="pubmed">30795933</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldenberg DL, Simms RW, Geiger A, Komaroff AL. High frequency of fibromyalgia in patients with chronic fatigue seen in a primary care practice. Arthritis Rheum. (1990) 33:381&#x2013;7. doi:&#xa0;10.1002/art.1780330311</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780330311</ArticleId><ArticleId IdType="pubmed">2317224</ArticleId></ArticleIdList></Reference><Reference><Citation>McKay PG, Walker H, Martin CR, Fleming M. Exploratory study into the relationship between the symptoms of chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) and fibromyalgia (FM) using a quasiexperimental design. BMJ Open. (2021) 11:e041947. doi:&#xa0;10.1136/bmjopen-2020-041947</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-041947</ArticleId><ArticleId IdType="pmc">PMC7853008</ArticleId><ArticleId IdType="pubmed">33526500</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds GK, Lewis DP, Richardson AM, Lidbury BA. Comorbidity of postural orthostatic tachycardia syndrome and chronic fatigue syndrome in an Australian cohort. J Intern Med. (2014) 275:409&#x2013;17. doi:&#xa0;10.1111/joim.12161</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12161</ArticleId><ArticleId IdType="pubmed">24206536</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoad A, Spickett G, Elliott J, Newton J. Postural orthostatic tachycardia syndrome is an under-recognised condition in chronic fatigue syndrome. Qjm. (2008) 101:961&#x2013;5. doi:&#xa0;10.1093/qjmed/hcn123</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/qjmed/hcn123</ArticleId><ArticleId IdType="pubmed">18805903</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones JF, Nicholson A, Nisenbaum R, Papanicolaou DA, Solomon L, Boneva R, et al. . Orthostatic instability in a population-based study of chronic fatigue syndrome. Am J Med. (2005) 118:1415. doi:&#xa0;10.1016/j.amjmed.2005.06.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjmed.2005.06.013</ArticleId><ArticleId IdType="pubmed">16378795</ArticleId></ArticleIdList></Reference><Reference><Citation>Dahan S, Tomljenovic L, Shoenfeld Y. Postural Orthostatic Tachycardia Syndrome (POTS)&#x2013;A novel member of the autoimmune family. Lupus. (2016) 25:339&#x2013;42. doi:&#xa0;10.1177/0961203316629558</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316629558</ArticleId><ArticleId IdType="pubmed">26846691</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanks L, Jason LA, Evans M, Brown A. Cognitive impairments associated with CFS and POTS. Front Physiol. (2013) 4:113. doi:&#xa0;10.3389/fphys.2013.00113</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2013.00113</ArticleId><ArticleId IdType="pmc">PMC3655280</ArticleId><ArticleId IdType="pubmed">23720636</ArticleId></ArticleIdList></Reference><Reference><Citation>Roerink ME, Lenders JW, Schmits IC, Pistorius AM, Smit JW, Knoop H, et al. . Postural orthostatic tachycardia is not a useful diagnostic marker for chronic fatigue syndrome. J Intern Med. (2017) 281:179&#x2013;88. doi:&#xa0;10.1111/joim.12564</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12564</ArticleId><ArticleId IdType="pubmed">27696568</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell WM. Efficacy of rintatolimod in the treatment of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). Expert Rev Clin Pharmacol (2016) 9:755&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4917909</ArticleId><ArticleId IdType="pubmed">27045557</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarling JM, Schlais J, Eskra L, Greene JJ, Ts'o PO, Carter WA. Augmentation of human natural killer cell activity by polyinosinic acid-polycytidylic acid and its nontoxic mismatched analogues. J Immunol (1980) 124:1852&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">6154082</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Yang G, Kim Y, Kim J, Ha J. AMPK activators: mechanisms of action and physiological activities. Exp Mol Med (2016) 48:e224&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4855276</ArticleId><ArticleId IdType="pubmed">27034026</ArticleId></ArticleIdList></Reference><Reference><Citation>Toogood PL, Clauw DJ, Phadke S, Hoffman D. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Where will the drugs come from? Pharmacol Res (2021) 165:105465.</Citation><ArticleIdList><ArticleId IdType="pubmed">33529750</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheibenbogen C, Loebel M, Freitag H, Krueger A, Bauer S, Antelmann M, et al. . Immunoadsorption to remove &#xdf;2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME. PloS One (2018) 13:e0193672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854315</ArticleId><ArticleId IdType="pubmed">29543914</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, Albert PJ, Blaney GP, Lindseth IA, Benediktsson C, et al. . Immunostimulation in the era of the metagenome. Cell Mol Immunol (2011) 8:213&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4076734</ArticleId><ArticleId IdType="pubmed">21278764</ArticleId></ArticleIdList></Reference><Reference><Citation>T&#xf6;lle M, Freitag H, Antelmann M, Hartwig J, Schuchardt M, van der Giet ,M, et al. . Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Efficacy of Repeat Immunoadsorption. J Clin Med (2020) 9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7465279</ArticleId><ArticleId IdType="pubmed">32751659</ArticleId></ArticleIdList></Reference><Reference><Citation>Rekeland IG, Foss&#xe5; A, Lande A, Ktoridou-Valen I, S&#xf8;rland K, Holsen M, et al. . Intravenous Cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. An Open-Label Phase II Study. Front Med (Lausanne) (2020) 7:162.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7201056</ArticleId><ArticleId IdType="pubmed">32411717</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain SK, Parsanathan R, Achari AE, Kanikarla-Marie P, Bocchini JA, Jr.. Glutathione Stimulates Vitamin D Regulatory and Glucose-Metabolism Genes, Lowers Oxidative Stress and Inflammation, and Increases 25-Hydroxy-Vitamin D Levels in Blood: A Novel Approach to Treat 25-Hydroxyvitamin D Deficiency. Antioxid Redox Signal (2018) 29:1792&#x2013;807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6208166</ArticleId><ArticleId IdType="pubmed">30160165</ArticleId></ArticleIdList></Reference><Reference><Citation>Ignarro LJ. Physiology and pathophysiology of nitric oxide. Kidney Int Suppl (1996) 55:S2&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">8743501</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser JD. A prospective, proof-of-concept investigation of KPAX002 in chronic fatigue syndrome. Int J Clin Exp Med (2015) 8:11064&#x2013;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4565289</ArticleId><ArticleId IdType="pubmed">26379906</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya JG, Anderson JN, Adolphs DL, Bateman L, Klimas NG, Levine SM, et al. . KPAX 002 as a treatment for Myalgic Encephalomyelitis / Chronic Fatigue Syndrome ( ME / CFS ) : a prospective , randomized trial. (2018).</Citation></Reference><Reference><Citation>Castro-Marrero J, S&#xe1;ez-Franc&#xe0;s N, Segundo MJ, Calvo N, Faro M, Aliste L, et al. . Effect of coenzyme Q10 plus nicotinamide adenine dinucleotide supplementation on maximum heart rate after exercise testing in chronic fatigue syndrome - A randomized, controlled, double-blind trial. Clin Nutr (2016) 35:826&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pubmed">26212172</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Marrero J, Cordero MD, Segundo MJ, S&#xe1;ez-Franc&#xe0;s N, Calvo N, Rom&#xe1;n-Malo L, et al. . Does oral coenzyme Q10 plus NADH supplementation improve fatigue and biochemical parameters in chronic fatigue syndrome? Antioxid Redox Signal (2015) 22:679&#x2013;85.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4346380</ArticleId><ArticleId IdType="pubmed">25386668</ArticleId></ArticleIdList></Reference><Reference><Citation>Forsyth LM, Preuss HG, MacDowell AL, Chiazze L, Jr., Birkmayer GD, Bellanti JA. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann Allergy Asthma Immunol (1999) 82:185&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">10071523</ArticleId></ArticleIdList></Reference><Reference><Citation>Maksoud R, Balinas C, Holden S, Cabanas H, Staines D, Marshall-Gradisnik S. A systematic review of nutraceutical interventions for mitochondrial dysfunctions in myalgic encephalomyelitis/chronic fatigue syndrome. J Transl Med (2021) 19:81.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7890871</ArticleId><ArticleId IdType="pubmed">33596913</ArticleId></ArticleIdList></Reference><Reference><Citation>Fluge &#xd8;, Bruland O, Risa K, Storstein A, Kristoffersen EK, Sapkota D, et al. . Benefit from b-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. a double-blind and placebo-controlled study. PloS One (2011) 6(10):e26358. doi:&#xa0;10.1371/journal.pone.0026358</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026358</ArticleId><ArticleId IdType="pmc">PMC3198463</ArticleId><ArticleId IdType="pubmed">22039471</ArticleId></ArticleIdList></Reference><Reference><Citation>Adamowicz JL, Caikauskaite I, Friedberg F. Defining recovery in chronic fatigue syndrome: a critical review. Qual Life Res. (2014) 23:2407&#x2013;16. doi:&#xa0;10.1007/s11136-014-0705-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11136-014-0705-9</ArticleId><ArticleId IdType="pubmed">24791749</ArticleId></ArticleIdList></Reference><Reference><Citation>Devendorf AR, Jackson CT, Sunnquist M. Defining and measuring recovery from myalgic encephalomyelitis and chronic fatigue syndrome: the physician perspective. Disabil Rehabil. (2019) 41:158&#x2013;65. doi:&#xa0;10.1080/09638288.2017.1383518</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09638288.2017.1383518</ArticleId><ArticleId IdType="pmc">PMC6123286</ArticleId><ArticleId IdType="pubmed">28982247</ArticleId></ArticleIdList></Reference><Reference><Citation>Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. . Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U.S.A. (2011) 108 Suppl 1:4578&#x2013;85. doi:&#xa0;10.1073/pnas.1000081107</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1000081107</ArticleId><ArticleId IdType="pmc">PMC3063592</ArticleId><ArticleId IdType="pubmed">20668239</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamburini S, Shen N, Wu HC, Clemente JC. The microbiome in early life: implications for health outcomes. Nat Med. (2016) 22:713&#x2013;22. doi:&#xa0;10.1038/nm.4142</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4142</ArticleId><ArticleId IdType="pubmed">27387886</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PloS Biol. (2007) 5:e177. doi:&#xa0;10.1371/journal.pbio.0050177</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0050177</ArticleId><ArticleId IdType="pmc">PMC1896187</ArticleId><ArticleId IdType="pubmed">17594176</ArticleId></ArticleIdList></Reference><Reference><Citation>
DecodeME. (2023). Available at: https://www.decodeme.org.uk
</Citation></Reference><Reference><Citation>Shan ZY, Barnden LR, Kwiatek RA, Bhuta S, Hermens DF, Lagopoulos J. Neuroimaging characteristics of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): a systematic review. J Transl Med. (2020) 18:335. doi:&#xa0;10.1186/s12967-020-02506-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02506-6</ArticleId><ArticleId IdType="pmc">PMC7466519</ArticleId><ArticleId IdType="pubmed">32873297</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman KJ, Murovska M, Pheby DFH, Zalewski P. Our evolving understanding of ME/CFS. Medicina (Kaunas) 57. (2021). doi:&#xa0;10.3390/medicina57030200</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57030200</ArticleId><ArticleId IdType="pmc">PMC7996879</ArticleId><ArticleId IdType="pubmed">33652622</ArticleId></ArticleIdList></Reference><Reference><Citation>Nacul L, Authier FJ, Scheibenbogen C, Lorusso L, Helland IB, Martin JA, et al. . European network on myalgic encephalomyelitis/chronic fatigue syndrome (EUROMENE): expert consensus on the diagnosis, service provision, and care of people with ME/CFS in europe. Medicina (Kaunas) 57. (2021). doi:&#xa0;10.3390/medicina57050510</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050510</ArticleId><ArticleId IdType="pmc">PMC8161074</ArticleId><ArticleId IdType="pubmed">34069603</ArticleId></ArticleIdList></Reference><Reference><Citation>Open Medicine Foundation</Citation></Reference><Reference><Citation>The Charit&#xe9; Fatigue Center</Citation></Reference><Reference><Citation>WE&amp;ME Foundation</Citation></Reference><Reference><Citation>Tyson S, Stanley K, Gronlund TA, Leary S, Emmans Dean M, Dransfield C, et al. . Research priorities for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): the results of a James Lind alliance priority setting exercise. Fatigue: Biomedicine Health Behav. (2022) 10:200&#x2013;11. doi:&#xa0;10.1080/21641846.2022.2124775</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2022.2124775</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>